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Abstract 
Growing evidence exists for an association between fetal and early 
growth restriction and the subsequent development of various adult 
degenerative diseases such as type 2 diabetes and the insulin resistance 
syndrome. At highest risk are those individuals that were growth 
restricted in very early life but are obese in adult life. These factors have 
been addressed in the thrifty phenotype hypothesis. Central to this theory 
is that the malnourished fetus adapts its metabolism to aid short- and 
long-term survival but that this adaptation becomes detrimental to health 
later in life with adequate or overnutrition. The work described in this 
thesis attempted to model and test the thrifty phenotype hypothesis in the 
rat. Any role that the deposition of pancreatic amyloid, the most 
characteristic pancreatic lesion in individuals with type 2 diabetes, may 
have in the pathogenesis of type 2 diabetes through a thrifty phenotype 
was investigated by using rats which were transgenic for human amylin 
(the equivalent native peptide in the rat not precipitating as pancreatic 
amyloid) . 
Initially a new immunoenzymometric assay for amylin was 
investigated. Monoclonal antibodies used in this assay were then labelled 
w ith eu ropium to establish new sensitive time resolved fluorescence 
immunoassays for rat amylin and human amylin-like peptides. These 
assays were used to characterise the human amylin transgenic rats. As well 
as being genotypically transgenic for human amylin, these rats were 
shown to m ake and secrete human amylin in concentrations which are 
broadly equivalent to concentrations seen in the plasma of individuals 
with type 2 diabetes. Of all the organs studied the pancreata of the 
transgenic rats were shown to have the highest human amylin contents. 
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In modelling and testing the thrifty phenotype hypothesis fetal and 
early growth restriction was achieved by feeding a low protein diet to a 
pregnant rat and her offspring. At this stage the offspring had better 
glucose tolerances than equivalent control rats. The low protein offspring 
became obese in adult life by feeding them a cafeteria-style highly palatable 
diet. Up to twelve months of age obese rats had worse glucose tolerances 
than non-obese rats but there was no apparent effect of early growth 
restriction. Both early growth retardation due to protein restriction and 
obesity were associated with hypertension at this age. These associations 
were independent and additive. 
Between twelve and sixteen months of age there was a relative 
worsening of glucose tolerance in the low protein, early growth restricted 
rats . Impaired glucose tolerance was also still evident in obese rats in 
comparison to non-obese rats. Although the low protein rats had impaired 
glucose tolerance and were hypertensive they were not hyperlipidaemic. 
Obese rats, in contrast, were hyperlipidaemic. No pancreatic amyloid 
deposition was found in any of the rats. In summary, the low protein rat 
model with dietary-induced obesity exhibits a number of metabolic 
alterations which are consistent with changes pertaining to the thrifty 
phenotype hypothesis. 
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Chapter 1 
Introduction 
1.1 Diabetes Mellitus 
Diabetes mellitus is thought to affect at least 1,380,000 adults in the 
United Kingdom alone (Bennett et al., 1995). World-wide around 120 
million people are thought to suffer from it (World Health Organisation 
press release WH0/79, 14/11/96). Since it is known to cause an increased 
risk of developing both microvascular disease (such as retinopathy, 
neuropathy and nephropathy) and macrovascular disease (such as 
coronary artery disease and peripheral vascular disease), it represents a 
major cause of mortality and morbidity in the population. This is reflected 
in massive expenditure on diabetes treatment, e.g. in the United States 
alone it is thought that diabetes costs the country nearly $92 billion per 
year in health care and related costs for treatment and lost productivity 
(American Diabetes Association press release, 20/3/96). 
The hyperglycaemia characteristic of diabetes is caused by either an 
absolute or relative deficiency of the hormone insulin and the reason for 
the generation of this deficiency is used to classify diabetes into its major 
subtypes. Type 1 (insulin-dependent) diabetes is caused by an absolute 
insulin deficiency due to an autoimmune destruction of the pancreatic fs-
cells which produce insulin. This destruction generally produces a very 
sudden onset of symptoms in patients who are under 40 years of age. The 
only treatment available for this condition is a combination of dietary 
restriction with insulin injections. In contrast type 2 (non-insulin-
dependent) diabetes tends to present much more insidiously in patients of 
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middle age or beyond. Often these patients are obese. The insulin 
deficiency in this case, at least early in the course of the disease, is not 
absolute and may be the result of is-cell dysfunction, peripheral insulin 
resistance or more commonly a combination of both of these factors (De 
Fronzo, 1988). Treatment of this condition may be by dietary restriction 
alone or by a combination of diet with either tablets (e.g. sulphonylureas 
and biguanides) or insulin injections. 
Type 2 diabetes is by far the most common form of the condition, 
with up to 90 % of diabetics having this type (Harris et al., 1985). Around 
100 million people world-wide are thought to currently have it (WHO 
technical report series 844, 1994) and its prevalence is rising. This is in 
addition to other people with mild insulin resistance who may exhibit 
features of the insulin resistance syndrome such as glucose intolerance, 
hyperlipidaemia and hypertension (Reaven, 1995). Such people are also at 
risk from macrovascular disease. As treatment rather than cure remains 
the only practical approach to diabetes management, and treatment may 
merely delay rather than prevent the onset of diabetic complications 
(Diabetes control and complications trial research group, 1993), prevention 
of its occurrence remains the best way of reducing diabetes-associated 
mortality and morbidity. This makes understanding the aetiology of 
diabetes imp-ortant before strategies to reduce its incidence can be deduced 
and implemented. 
1.2 Pancreatic Islets of Langerhans 
Since diabetes-associated hyperglycaemia is caused by a relativ e or 
absolute deficiency of insulin, it is not unreasonable to assume that 
abnormalities of insulin synthesis, storage or secretion are involved in the 
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pathogenesis of diabetes. Insulin is produced in the pancreas by is-cells of 
the islets of Langerhans. These islets consist of small groupings of 
endocrine cells which are arranged diffusely throughout the exocrine 
region of the pancreas. Their relative importance is shown in rats by the 
disproportionate blood supply that they receive: even though they only 
make up 1-2 % of the mass of the adult pancreas, they receive around 10 % 
of the pancreatic blood supply during normoglycaemic periods (Jansson & 
Hellerstrom, 1983). The islets contain four major types of endocrine cells: 
a-cells which secrete glucagon, is-cells which secrete insulin, 3-cells which 
secrete somatostatin and PP-cells which secrete pancreatic polypeptide. In 
addition to these major cell types the islets also contain other less 
frequently occurring endocrine cells (which contain hormones such as 
serotonin and gastrin), as well as a layer of fibroblasts which form a thin 
islet capsule, a complex system of blood vessels and associated nervous 
tissue C~onner-Weir, 1991). 
Heterogeneity of islets exists at a number of levels. Firstly there is a 
regional distribution of cells based on differences in the embryological 
development of the pancreas. Thus the dorsal region of the pancreas is 
rich in a-cells but poor in PP-cells, whilst the ventral region is rich in PP-
cells but poor in a-cells. This distribution may have functional 
consequence-s as islets from the dorsal region appear to release more 
insulin in response to glucose, than do islets from the ventral region 
(Trimble et al., 1982). The second level of islet heterogeneity concerns islet 
size and blood supply. Numerically most of the islets in a rat pancreas are 
defined as being 'small' (i.e. having a diameter of less than 150 µm) . These 
islets are connected to the capillary network of the exocrine pancreas, such 
that efferent vessels passing out of the endocrine tissue go through 
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exocrine tissue before amalgamating as collecting venules (fig. 1.1). In this 
way an effective insuloacinar portal system is established (Bonner-Weir, 
1991; Jansson, 1994). Most of the islet volume of a rat pancreas is made up 
from numerically fewer 'large' islets (having diameters of greater than 
250 µm). These receive an arterial blood supply from one to three 
arterioles which branch into capillaries within the is-cell-rich core of the 
islets (fig. 1.1) (Jansson, 1994). These capillaries pass through the islet 
mantle of non-is-cells and then coalesce as collecting venules which are 
located within the islet capsule. In these islets coalescence is therefore 
complete before the blood system passes through the surrounding 
exocrine tissue. 
A further level of islet heterogeneity is the fact that individual is-
cells within an islet may have different glucose-induced insulin responses 
(Pipeleers, 1987) probably due to differences in glucokinase activities 
(Heimberg et al., 1993). Clearly, at least in large islets, ls-cells which are 
more peripherally located have the potential to be exposed to greater 
concentrations of insulin (that is blood-borne having been secreted from 
more centrally located ls-cells) and hormones from non-is-cells (which 
have diffused into the interstitial fluid). In contrast the more centrally 
located is-cells would largely only be exposed to concentrations of these 
hormones found in the systemic circulation. Responses to this hormonal 
milieu may regulate an individual is-cell's glucokinase activity. For this 
explanation to be valid blood flow in the islet must be from the central 
core out to the mantle. Anatomically both large and small islets appear to 
be arranged for blood flow in this direction. Studies using anterograde and 
retrograde infusion of antibodies in the in vitro perfused rat pancreas 
- 4-
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Figure 1.1 Diagram of the organisation of (a) a typical large rat 
islet (diameter greater than 260 µm) and (b) a typical small rat 
islet (diameter less than 160 µm). Adapted from Bonner-Weir 
and Ord (1982). 
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suggest that the order of islet cellular perfusion is indeed is-cells (located in 
the core) followed by a-cells and then o-cells (both located in the mantle) 
(Samols et al., 1988). 
1.2.1 Pancreatic is-cells 
The relative importance of pancreatic is-cells in comparison to other 
islet cells is suggested by this observation that the is-cells receive the blood 
supply prior to the non-is-cells . This means that they can respond first to 
the presence of nutrient secretagogues from the systemic circulation and 
relatively small changes in circulating hormone concentrations. Then 
they are able to influence the response of other islet cells positioned 
further downstream of the microcirculatory system by secreting large 
quantities of insulin and other peptides. Indeed islet hormones are known 
to modulate each other's secretion: insulin secretion is stimulated by 
glucagon and inhibited by somatostatin, glucagon secretion is inhibited by 
both insulin and somatostatin, and somatostatin secretion is stimulated by 
glucagon. In addition insulin may inhibit somatostatin secretion and both 
insulin and somatostatin may inhibit pancreatic polypeptide release 
(Unger & Foster, 1992). 
Further evidence for the relative importance of is-cells comes from 
their abundance. In the human pancreas there are around 250,000 
individual islets and each of these is thought to contain 3,000-4,000 is-cells 
(constituting around 70% of the cells in each of the islets) (Howell, 1995). 
Each of these is-cells contains up to 13,000 secretary granules, which 
contain large quantities of stored insulin. In addition to insulin around 
100 granule matrix and membrane proteins are present (Hutton et al., 
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1982), including amylin (section 1.2.1.2) and the endopeptidases involved 
in the conversion of proinsulin to insulin. 
Whilst pancreatic is-cells are obviously deficient or absent in type 1 
diabetics, the question as to whether they are reduced in pancreata of type 2 
diabetics is more controversial. Many studies of histological pancreatic 
sections from type 2 diabetics have failed to control for the effects of obesity 
on is-cells (Hales & Barker, 1992). However it is now generally believed 
that the number and total area of islets are reduced, mainly due to a large 
decrease in the total volume of is-cells (reviewed by Kloppel et al. , 1985). 
Rat models of type 2 diabetes have been able to be produced by reducing 
the number of functioning is-cells by a little over 50 %~ ithe/ihe use of 
streptozotocin or by pancreatectomy (Weir et al., 1986). ~ a group of 
previously healthy humans who underwent hemipancreatectomies (to act 
as transplant donors for relatives with type 1 diabetes) showed a marked 
deterioration in glucose tolerance one year after the _operation was 
performed (Kendall et al., 1990). 
1.2.1.1 Insulin 
Insulin is produced exclusively by pancreatic is-cells. After 
transcription of the insulin gene, preproinsulin mRNA is translated on 
membrane-bound ribosomes of rough endoplasmic reticulum. The 
emerging polypeptide chain is translocated into the cisternae of the 
endoplasmic reticulum, where the signal peptide is cleaved and the 
remaining polypeptide fo lds to form the 86 amino acid p recursor, 
proinsulin. Proinsulin is then transported by a microvesicular process to 
the cis face of the Golgi and then through the multiple compartments of 
the Golgi apparatus. Here the proinsulin is mixed with the endo- and exo-
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peptidases that are involved in its processing. Conversion of proinsulin to 
insulin begins in the trans Golgi network and then continues as the 
immature secretory granules bud off. Most of the proinsulin gets processed 
in these granules until the nascent insulin crystallises with zinc. The 
mature secretory granules make up a considerable reservoir of insulin, 
each is-cell being able to contain around 30 pg of insulin (Howell, 1995). 
Proinsulin requires the action of three enzymes for its conversion 
to insulin (fig. 1.2). Two endopeptidases, PC3 (also known as PCl) and PC2, 
are responsible for the cleavage of c-peptide from the proinsulin molecule 
(between amino acids 32-33 and 65-66, respectively) (Davidson et al., 1988). 
After the action of each of these enzymes an exopeptidase, 
carboxypeptidase H, removes a pair of basic amino acids (located C-
terminally) from the resultant products, such that the final products from 
this series of reactions are insulin and c-peptide. A number of lines of 
evidence suggest that, at least in humans, proinsulin processing proceeds 
in a preferred order (Rhodes & Alarcon, 1994). Firstly proinsulin is a poor 
substrate for the enzyme PC2, unlike the intermediate des 31,32 split 
proinsulin. Also both human plasma (Sobey et al., 1989) and extracts of 
human pancreas (Given et al., 1985) contain much higher concentrations 
of the intermediate des 31,32 split proinsulin than they do of des 64,65 split 
proinsulin. Pulse chase experiments monitoring the formation of insulin 
from proinsulin also would seem to favour a predominant route of 
processing via the formation of des 31,32 split proinsulin (Sizonenko et al., 
1993). 
Regulation of insulin biosynthesis and secretion is achieved 
through a variety of nutrients and hormones. In addition to glucose, 
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Figure 1.2 The possible routes of proinsulin conversion to insulin in 
human pancreatic B-cells. The preferred flux is via the des 31,32 split 
proinsulin intermediate (Rhodes & Alarcon, 1994). 
(PC: Proprotein convertase, A,B: insulin subunits, C: c-peptide). 
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Figure 1.2 The possible routes of proinsulin conversion to insulin in 
human pancreatic is-cells. The preferred flux is via the des 31,32 split 
proinsulin intermediate (Rhodes & Alarcon, 1994). 
(PC: Proprotein convertase, A,B: insulin subunits, C: c-peptide). 
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insulin production is stimulated by certain amino acids (including leucine 
and arginine) and hormones (such as glucagon like peptide 1 (7-37)). In 
contrast hormones such as somatostatin and galanin inhibit it. 
Pharmacological agents can be used clinically to either stimulate (e.g. 
sulphonylureas in the treatment of type 2 diabetes) or inhibit (e.g. 
diazoxide in the non-surgical treatment of insulinomas) insulin secretion. 
Once secreted insulin has many actions some of which are on the liver 
(e.g. the stimulation of glycogenesis and the inhibition of 
gluconeogenesis), the muscle (e.g. the stimulation of glucose uptake and 
glycogenesis) and adipose tissue (e.g. the stimulation of glucose uptake and 
triacylglycerol formation) (De Fronzo, 1988). 
1.2.1.2 Amylin 
Another hormone produced almost exclusively by pancreatic fs-
cells, at least in humans, is amylin. This 37 amino acid polypeptide was 
first isolated as the major protein constituent of pancreatic amyloid 
(hyalin) from human insulinoma tissue (Westermark et al., 1986). It was 
named islet amyloid polypeptide and the basic primary sequence of its first 
36 amino acids was deduced. Shortly afterwards the peptide was isolated 
from human pancreatic amyloid extracted from a type 2 diabetic (Cooper et 
al., 1987) and its first 36 amino acids found to be the same as those of islet 
amyloid polypeptide (fig. 1.3). These authors called the peptide amylin and 
were the first group to fully sequence the peptide including its amidated C-
terminal tyrosine residue. For this reason the peptide is referred to as 
amylin throughout this thesis (whilst acknowledging that many reports 
still appear in the literature referring to the same peptide as islet amyloid 
polypeptide). 
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Figure 1.3 The amino acid sequence of human (and rat) amylin 
showing the intra-molecular disulphide bridge and the carboxy-
terminal amido group. In rat amylin six amino acids are different from 
those in the human molecule as shown. 
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Amylin is part of a family of peptides related to calcitonin, all of 
which have structural and sequence similarities. Besides calcitonin other 
members of this family include the two calcitonin gene related peptides 
(CGRPs) (both of which share almost 50% amino acid sequence homology 
with amylin) (Westermark et al., 1986) and adrenomedullin. Each member 
of the family has an amidated C-terminus and an N-terminal ring 
sequence consisting of 6-7 amino acids joined together by a disulphide 
bridge. 
The amylin gene is located on chromosome 12 and its transcription 
and translation yields the 89 amino acid preproamylin in man (Sanke et 
al., 1988). From this precursor, a 22 amino acid signal peptide is cleaved in 
the endoplasmic reticulum to leave the 67 amino acid proamylin. This is 
presumably transported through the Golgi apparatus as, like insulin, its 
process~ng takes place mainly within fs-cell secretory granules which bud 
off from the trans Golgi network. The processing appears to involve the 
activity of the endopeptidase PC2, one of the enzymes involved in 
proinsulin processing (section 1.2.1.1) (Badman et al., 1996), which in this 
case removes both C- and N-terminal flanking peptides. In this way 
amylin is stored in the secretory granules along with insulin and c-
peptide, although while insulin largely makes up the electron-dense core 
of the granules amylin appears to locate itself in the soluble halo phase 
(Westermark et al., 1996). 
As well as being processed and stored in a similar manner to 
insulin, amylin is co-secreted with insulin (Kahn et al., 1990) in response 
to much the same secretagogues. Their genes appear to share some 
regulatory sequences (Bretherton-Watt et al ., 1996) and in health amylin 
and insulin tend to be secreted in a fixed ratio. However in obese patients 
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-with type 2 diabetes (Sanke et al., 1991) or in various rodent models of 
diabetes (Bretherton-Watt et al., 1989; Gedulin et al., 1991; Inoue et al., 
1992; Hiramatsu et al., 1994; Mulder et al., 1995a, 1995b & 1996) amylin to 
insulin ratios have been shown to increase either in terms of the 
pancreatic contents or in the amount of protein secreted and the mRNA 
expressed. Insulin and amylin genes must therefore have both shared and 
some distinct regulatory regions. Some investigators have suggested that 
this non-parallelism of amylin and insulin may be involved in the 
pathogenesis of type 2 diabetes (Inoue et al., 1992; Mulder et al., 1996). 
As the members of the calcitonin-like peptide family have sequence 
and structural similarities and because each member appears to have 
either an endocrine or a neuroendocrine role, much research activity has 
focused on defining the biological actions of amylin. So far a long list of 
actions, both metabolic and non-metabolic, have been putatively 
attributed to amylin (table 1.1). Since these actions have generally been 
found using pharmacological doses of amylin under experimental 
conditions in vitro or in viva, none of them can be described as being 
clearly defined (Sacks, 1996). Part of the confusion has no doubt resulted 
from the use of heterologous amylin preparations (Rodriguez-Gallardo et 
al., 1995) and from technical difficulties such as the tendency that amylin 
has to stick to plastic surfaces such as infusion lines and tissue culture 
dishes (Westermark, 1995). It has been suggested that many of the 
quantitative aspects of early amylin-related stu,dies may have been flawed 
due to inaccurate assay methodology or inadequate sample-handling 
(Cooper, 1994). The pharmacological concentrations of . amylin that have 
had to have been used to gain a response may have favoured the binding 
of amylin to CGRP receptors and hence non-physiological 'CGRP-like' 
responses. The one situation where large concentrations of amylin could 
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Table 1.1 Putative biological actions of amylin. 
ACTION 
GLUCOREGULATORY 
inhibition of skeletal muscle glycogenesis 
enhancement of skeletal muscle glycogenolysis, 
glycolysis and lactate production 
inhibition of insulin-stimulated glucose uptake 
in skeletal muscle 
enhancement of hepatic glycogenolysis 
inhibition of insulin biosynthesis / secretion 
DIGESTIVE 
delayed gastric emptying 
stimulation of pancreatic exocrine secretion and 
g<'!strin secretion 
CNS 
anorectic 
memory enhancement 
BONE METABOLISM 
inhibition of osteoclast-mediated bone resorption 
hypocalcaemic -
RENAL 
stimulation of renin activity 
CARDIOVASCULAR SYSTEM 
vasodilation 
tachycardia 
hypertension 
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REFERENCE 
Cooper et al., (1988) 
Young et al., (1992b) 
Young et al., (1991) 
Young et al., (1992b) 
Hothersall et al., (1990) 
Sheriff et al., (1992) 
Gomez-Foix et al., (1991) 
Degano et al., (1993) 
Young et al., (1995) 
Funakoshi et al., (1992) 
Arnelo et al., (1996) 
Flood & Morley (1992) 
Datta et al., (1989) 
Alam et al., (1993) 
Young et al., (1993b) 
Cooper M.E. et al., (1995) 
Brain et al. , (1990) 
Gardiner et al., (1991) 
Cooper M.E. et al., (1995) 
be physiologically relevant is in pancreatic islets where amylin may have a 
paracrine role in inhibiting insulin release. As amylin would be released 
simultaneously with insulin it may be involved in causing the pulsatility 
of insulin release (P0rksen et al., 1995). Effects are now gradually being 
seen in vitro using amylin doses encountered in other physiological 
situations (reported in Rink et al., 1993) and further insight into the 
biological actions of amylin is being gained through the use of amylin 
antagonists (Wang et al., 1991; Silvestre et al., 1993; Young et al., 1994a). 
If the postulated actions of amylin prove to be physiological, then it 
may play a crucial part in the pathogenesis of type 2 diabetes and the 
insulin resistance syndrome (Young et al., 1994b). Hyperamylinaemia may 
cause an insulin resistance at the skeletal muscle level by inhibiting 
glucose uptake and enhancing glycogenolysis and subsequent glycolysis to 
raise plasma lactate concentrations. In the fasting state this increase in 
lactate may stimulate gluconeogenic flux in the liver, such that hepatic 
glucose output increases (Cooper G.J.S., 1995). In the fed state the 
hyperlactataemia may indirectly stimulate the formation of fatty acids 
(lactate being a preferable substrate to glucose in fatty acid synthesis (Boyd 
et al., 1981)) and subsequently atherogenic lipoproteins (McGarry, 1994). 
These changes would raise circulating glucose concentrations, thereby 
stimulating pancreatic is-cells to produce more insulin. However this 
drive would be inhibited by the high levels of amylin. As such an insulin 
resistant, glucose intolerant, hyperlipidaemic state could be established. 
Excessive amylin-stimulated renin activity could also induce hypertension 
(Cooper M.E. et al., 1995) giving amylin a potentially central role in the 
development of both type 2 diabetes and the insulin resistance syndrome. 
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1.2.1.3 Amyloid Deposition 
The deposition of amyloid fibrils in a is-sheet conformation is the 
most characteristic lesion associated with pancreata from type 2 diabetics at 
autopsy. Indeed over 90% of such people are thought to be islet amyloid 
positive (Westermark et al., 1987). This type of perivascular deposition is 
seen similarly in more than 80% of cats with an age-associated form of 
diabetes (Johnson et al., 1989). Whilst this high degree of association 
between islet amyloid deposition and the presence of type 2 diabetes is 
unchallenged, whether the association is causal is at present unclear 
because even though many type 2 diabetics have islet amyloid deposition, 
its presence is not specific for the condition (Clark et al., 1993). Insulinoma 
tissue (Westermark et al., 1986) and the pancreata of a small proportion of 
aged individuals who are free from diabetes (Bell et al., 1959) have been 
shown to have islet amyloid deposits. In addition commonly used rodent 
models of type 2 diabetes are not associated with pancreatic 
amyloidogenesis. In favour of a role for amyloid in the pathogenesis of 
this type of diabetes, however, is its cytotoxicity to pancreatic is-cells 
(Lorenzo et al., 1994) through a free radical mediated mechanism 
(Schubert et al., 1995), which clearly may contribute towards the reduced is-
cell mass seen in the pancreata of type 2 d iabetics (Westermark & 
Wilander, 1978). 
A number of factors have so far been implicated in the formation of 
amyloid fibrils from amylin . The first of these is the amino acid sequence 
of the amylin molecules . In ter-species comparisons of sequences of 
amylin molecules, in species that do precipitate pancreatic amyloid (such 
as humans, other primates and cats) and those which do not (such as rats, 
mice and hamsters), have revealed that amyloidogenicity is related to the 
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amino acids in positions 20-29 (Westermark et al., 1990). This region 
shows both greatest inter-species variation and least homology with CGRP 
molecules (which are not themselves known to form insoluble 
precipitates). Of particular importance appear to be the amino acids at 
positions 25-28, the sequences of which are identical in humans and cats 
(alanine-isoleucine-leucine-serine: AILS) (fig. 1.3). In vitro single amino 
acid mutation · in this region appears to reduce the ability of amylin to 
form the is-pleated sheets characteristic of all forms of amyloid 
(Westermark et al., 1990). Further evidence is gained from secondary 
structure predictions that indicate the presence of a short segment of is-
sheet conformation at amino acid positions 25-29 (Betsholtz et al., 1989). 
The amylin amino acid sequence of a species is not the only factor 
that determines whether amyloid deposition will occur, however, as not 
all humans and cats develop pancreatic amyloid (Johnson et al., 1992). 
Pancreatic amylin concentration and/ or secretion rates also appear to 
contribute. This is best seen in dogs, which have an amylin sequence that 
includes the amyloidogenic AILS sequence and yet do not precipitate 
amyloid in canine forms of diabetes. However O'Brien et al. (1990) have 
shown the presence of amyloid deposits in the pancreata of dogs with 
insulinomas, probably due to a relative amylin hypersecretion in 
comparison to that seen in canine diabetes. Additional evidence for the 
importance of concentration is found in cats where those animals with 
impaired glucose tolerance have increased is-cell amylin immuno-
reactivity and a much higher incidence of islet amyloid than do age-
matched normal controls (Johnson et al ., 1989). Add itional evidence is 
found in humans where syndromes of severe insulin resistance (and 
therefore a high probability of hyperamylinaemia) are associated with 
severe islet amyloidosis (O'Brien et al ., 1994b; Garg et al., 1996). 
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In vitro studies of cultured islets have shown amyloid fibril 
formation to be both concentration and pH dependent (Westermark et al. , 
1990; Ashburn et al ., 1992). Thus at a neutral pH, islet fibrils were formed 
spontaneously in the presence of amylin concentrations as low as 1 
nmol/1. With a drop in pH, however, higher amylin concentrations were 
required for fibril formation. This means that in health within the mature 
is-cell secretary granule, with an acidic internal environment (Hutton, 
1982), some degree of protection against amylin precipitation is afforded. 
Alternative protection, however, must be present in the more neutral 
environs of the endoplasmic reticulum. Here it has been speculated that 
chaperon proteins may be present to limit amylin aggregation (Couce et 
al., 1996b ). 
A_ number of alternative possibilities for why amylin is able to form 
fibrils have been suggested. One such possibility is that an abnormal form 
of amylin is produced, either by enzymatic cleavage or amino acid 
substitution, which enhances self-aggregation. Indeed Westermark et al. 
(1989) found immunoreactivity for an N-terminal fragment of proamylin 
in pancreatic amyloid-containing tissue. Clark et al. (1993), however, failed 
to confirm this and the presence of such fragments have not been 
confirmed by amino acid sequence analysis of amyloid extracts (Johnson et 
al., 1992). In addition several studies have shown that sequences of amylin 
isolated from human pancreatic amyloid samples to be the same as that 
predicted by the DNA sequence of the human amylin gene (Sanke et al., 
1988; Betsholtz et al. , 1989; Roberts et al., 1989). Also in one study of cDNA 
predicted amylin sequences from 25 type 2 diabetics, there was no 
divergence from normal (Nishi et al. , 1990). Therefore any abnormal 
amylin molecules present in amyloid deposits must be there at a very low 
- 18 -
concentration. If they do have any role in amyloidogenesis it may be in 
initial precipitate formation, acting as nuclei for amylin molecules to bind 
as fibril formation progresses. Another suggested mechanism for amylin 
formation is by interaction of amylin with another protein, e.g. proinsulin 
(Porte & Kahn, 1989) or apolipoprotein E, or by abnormal heparan 
sulphate proteoglycan metabolism (Young et al., 1992a). Finally abnormal 
cellular handling of amylin may enhance amyloid formation (Castillo et 
al., 1995). 
1.3 Aetiology Of Type 2 Diabetes 
Whether type 2 diabetes is caused by insulin deficiency, insulin 
resistance, or a combination of both (Cahill, 1988) and whether pancreatic 
amyloid deposition is causal or is merely a related epiphenomenom 
(Wester-mark et al., 1987), a number of irrefutable facts have to be 
addressed in any theories regarding its aetiology. The first of these is the 
tendency that type 2 diabetes has to cluster in families. Thus in one study 
of type 2 diabetics about whom basic information had been stored on a 
computerised database of a British provincial teaching hospital 347 out of 
1326 type 2 diabetics had affected first degree relatives (Alcolado & 
Alcolado, 1991). Evidence has also been produced of high concordance 
rates amongst indentical twins. Early studies with volunteer based twin 
selections giving concordance rates of up to 83 % have recently been 
criticised as having flawed study designs (Hawkes, 1997) but more recent 
population based twin selection studies have shown probandwise 
concordance rates of 28 % (Newman et al., 1987), 34 % (Kaprio et al., 1992) 
and 33 % (Vaag et al., 1996) amongst monozygotic twins. Respective rates 
amongst dizygotic twins in the same studies were 28 %, 16 % and 23 %. All 
these rates are likely to have been higher than the percentages of people 
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with type 2 diabetes in the general populations from which the twins were 
taken. 
The second factor that has to be addressed in any theory of the 
aetiology of type 2 diabetes is its association with lower socioeconomic 
status, at least in some 'Westernised' populations. Thus in a study of 
annual 
people from nine towns in England and Wales theAincidence of type 2 
diabetes was 23 per 100,000 in the three towns with worst socioeconomic 
status, as against 10 per 100,000 in the other towns (Barker et al., 1982). This 
contrasted with little variation in the incidence of type 1 diabetes across 
the same age group and locations. In the San Antonio Heart Study the 
prevalence of type 2 diabetes fell with rising socioeconomic status two-fold 
in men and four-fold in women (Stern et ,al ., 1984). Also in a prospective 
study of 346 men and women aged 40-65 from the Isle of Ely, England and 
who underwent glucose tolerance tests, newly diagnosed people with 
either impaired glucose tolerance or type 2 diabetes were found to be 
significantly shorter than the remaining population (Brown et al., 1991). 
Population height is known to rise with a rise in socioeconomic status 
(Reading et al., 1993; Wright et al., 1992). 
Type _2 diabetes also shows in general a higher prevalence in urban 
rather than rural locations. In the large multinational study· by King and 
Rewers, (1993) on behalf of the World Hea_lth Organisation Ad Hoe 
Diabetes Reporting Group, this not only applied to migrants who relocated 
to coun tri.es where they w ere racial minorities, but also w as apparent 
amongst Chinese and In dian migrants relocated to Singap ore and 
Mauritius, respectively. Much of this migration would have been from 
rural to urban locations. 
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One of the strongest factors that has to be addressed in any theory 
regarding the aetiology of type 2 diabetes is the relatively rapid rises in its 
incidence and prevalence that have taken place this century. This holds 
true even when rates are standardised for age (King & Rewers, 1993). Both 
the lowest and highest prevalences of type 2 diabetes in the world are in 
people-groups that traditionally have lived hunter-gatherer or early 
agricultural lifestyles. Those groups that have continued to live in such 
circumstances in the 'least developed' communities, such as peoples in 
Tanzania and Chile, have prevalences of diabetes that are less than 3 %. In 
contrast the highest prevalences of diabetes are in those people-groups that 
sedentary 
have switched from traditional ways of life to more /\ 'Westernised' 
lifestyles. Thus in Micronesian Nauruans the prevalence of diabetes is 
around 40 % and in Pima and Papago Indians in Arizona it is closer to 
50 %. When combined with people who have impaired glucose tolerance, 
these prevalences become closer to 66 % for both people groups (King & 
Rewers, 1993). The rapid changes in the prevalence of diabetes in Pima 
Indians have been dramatic. It was rare 80 years ago and · still relatively 
uncommon 40 years ago, but by the late 1960s had reached around 40 % in 
subjects over 35 years of age (Bennett et al., 1971; West, 1974). In Nauruans, 
however, their is evidence which suggests that now the prevalence may 
actually be falling (Dowse et al., 1991). Further demonstration that the 
Westernisation of peoples who switch from a more traditional lifestyle 
leads to an increase in the prevalence of diabetes comes from young 
Ethiopian Jews who were airlifted to Israel during a time of severe famine 
(Cohen et al., 1988). After residing in Israel for only four years or less, 8.9 % 
of those studied had diabetes and another 8.9 % had impaired glucose 
tolerance. Remarkably for these prevalences, all the subjects studied were 
lean (at least by Western standards with body mass indices of less than 27) 
and were less than thirty years of age. 
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1.3.1 The Thrifty Genotype Hypothesis 
The clustering of type 2 diabetes in families, the degree of 
concordance amongst twins and the bimodal distribution of plasma 
glucoses in oral glucose tolerance tests (at least in some populations with 
high prevalences of diabetes) (Zimmet & Whitehouse, 1978) have largely 
been interpreted as suggesting that this form of diabetes is genetic in 
origin. Fervent searching for "diabetogenes" resulted in the discovery that 
defects in the pancreatic glucokinase gene were responsible for the 
development of maturity-onset diabetes of the young in some people 
(Vionnet et al., 1992), an important but numerically minor subset of 
people with type 2 diabetes. Given that this appears to be the only form of 
diabetes that follows classical Mendelian inheritance (in this case being 
autosomal dominant) (reviewed in Fajans et al., 1994) and that even after 
extensive searching no single genes responsible for causing diabetes in the 
majority of people has thus far been discovered, a genetic mode of 
inheritance for type 2 diabetes is largely assumed to be polygenic. 
Neel (1962) proposed the thrifty genotype hypothesis to try and 
explain the rapid changes that have occurred in the prevalence of type 2 
diabetes this · century (which have taken place over a time span which is 
too short for a major change in "diabetogenes" to enter the world-wide 
gene pool). He described how in the early stages of human evolution a 
series of genes could have been selected that gave a survival advantage to 
individuals who underwent cyclic changes in food availability associated 
with the hunter-:-gatherer or early agriculturist lifestyle. Expression of these 
genes would result in a "quick insulin trigger" in response to 
hyperglycaemia which would reduce urinary caloric loss in times of food 
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scarcity. This would therefore be a survival advantage through the more 
efficient use of dietary calories. In times when food was readily available 
this would allow the efficient storage of dietary calories as fat which would 
be available as an energy store for times when food was more scarce. Neel 
continued that with the availability of a more constant food supply these 
genes that produced a survival advantage when there was a cyclic 
availability of food, would become detrimental to health as this quick 
insulin response was over-stimulated in many people. This would lead to 
the production of insulin antagonists, which would gradually become 
more abundant and lead to a deficit in insulin action. Ultimately is-cell 
decompensation would result with the associated development of 
diabetes. 
The thrifty genotype hypothesis was modified two decades later 
(Neel, 1982) to take into account increases in knowledge of the distinction 
between the major subtypes of diabetes. Neel now applied it specifically to 
type 2 diabetes and removed the insulin antagonist suggestion, which by 
this time had become discredited. Instead Neel proposed three possible 
mechanisms for the thrifty genotype to produce type 2 diabetes in times of 
constant nutritional abundance (although suggested that these 
mechanisms were neither mutually exclusive nor exhaustive), all of 
which involv_ed a degree of insulin resistance: 
(i) over-responsive is-cells (to cause a "quick insulin trigger" which 
would allow more storage of fat and ,glycogen) could lead to 
hyperinsulinaemia in response to the constant food supply. This may 
then force a down regulation of insulin receptors to prevent 
hypoglycaemia. With time, as more and more fat was stored, there 
would be an obesity-associated insulin resistance (as well as the 
resistance caused by the down regulation of insulin receptors) and 
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later decompensation of is-cells would lead to the development of 
diabetes. 
(ii) there could be a genetically determined decrease in the number of 
available insulin receptors for any given level of circulating insulin 
leading to a relative insulin resistance. Again with time a 
decompensation of is-cells would then lead to the development of 
diabetes. 
(iii) there could be a selective resistance in insulin-stimulated glucose 
disposal. To prevent hyperglycaemia hyperinsulinaemia would 
develop. If the resistance was selective only for "glucose metabolic 
pathways" and not for "lipid metabolic pathways" the increase in 
circulating insulin concentrations would encourage "lipid trapping" 
and therefore, in times of constant nutritional abundance, the 
development of obesity. With time the obesity would be associated 
with a more generalised insulin resistance and combined with a 
decompensation of is-cells would then lead to the development of 
diabetes. 
In more recent years it has been speculated that there are probably 
more than one thrifty genotype made up of different selections from a 
panel of genes that produce a phenotypically similar syndrome (Dowse & 
Zimmet, 1993). Whether these theoretical selections of genes in the past 
did confer a survival advantage (as in other genetically inherited 
conditions such as sickle cell anaemia (Monteiro et al., 1989)) has not been 
d irectly proven. It is difficult to say that if they did not confer such an 
advantage they would gradually have been removed from the gene pool 
by natural selection. This is because, at least in populations with mild to 
moderate prevalences of diabetes, the onset of type 2 diabetes usually 
occurs at ages not normally associated with child-bearing. Clearly diabetes 
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ii 
that is left untreated is associated with a premature death (Andersson & 
Svardsudd, 1995) but there is only a little evidence from a population with 
a high prevalence of diabetes, that the condition itself is associated with 
reduced reproductive ability (which could lead to a reduction in the 
prevalence of the theoretical "diabetogenes" in the gene pool) (Dowse et 
al., 1991). 
1.3.2 The Thrifty Phenotype Hypothesis 
An alternative explanation for the aetiology of type 2 diabetes and 
the insulin resistance syndrome from the genetic-by-environment view of 
the thrifty genotype hypothesis, is the thrifty phenotype hypothesis 
suggested by Hales and Barker in 1992. This hypothesis arose to account for 
the factors described earlier in section 1.3 and from a series of 
epidemiological studies by Barker, Hales and colleagues which found 
associations between markers of fetal and early growth retardation and the 
subsequent development of adult degenerative diseases. An early 
observation was made by Forsdahl (1977) showing that in Norway 
geographical variations in current death rates from arteriosclerotic heart 
disease showed a significant positive relationship with geographical 
variations in past infant mortality rates (but not with current infant 
mortality rates). A similar study was performed by Williams et al. (1979) 
who found that in England and Wales geographical variations in death 
rates from ischaemic heart disease showed positive correlations with 
geographical variations in both current infant mortality rates and infant 
mortality rates from when those individuals whose deaths were 
considered were young. Barker and Osmond (1986) then also showed that 
the geographical pattern of mortality from cardiovascular disease in 
England and Wales resembled the pattern of maternal and neonatal 
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mortality earlier in this century . They found the distribution was more 
closely related to neonatal and maternal death rates in the past than to 
more recent postneonatal death rates (Barker & Osmond, 1987). 
An association was therefore established between poor maternal 
and neonatal health and subsequent disease many years later. Forsdahl 
(1977) proposed that the link was due to poverty during adolescence. In 
contrast Barker and Osmond (1986) suggested that the association was due 
to poor nutrition in early life. To clarify the reason for the association a 
population in whom early weight data were available was studied. Barker 
et al. (1989b) observed that there were increased death rates from 
ischaemic heart disease in men with low weights at birth and one year of 
age, favouring their initial hypothesis. Other populations in whom birth 
and early weight data were available were then studied especially in regard 
to recogµised risk factors for the development of ischaemic heart disease. 
One such factor known to increase the risk of developing ischaemic 
heart disease is hypertension. Barker et al. (1989a) found an inverse link in 
males and females at both 10 and 36 years of age between birth weight and 
systolic blood pressure. Current weight showed a positive association with 
systolic blood pressure at both age groups but the risk was independent 
from that associated with low birth weight. Thus the highest mean systolic 
blood pressures in both sexes and in both age groups were found in the 
groups with the lowest birth weights and the highest current weights. In a 
follow up study of 50 year olds born in Preston, hypertension was 
predicted by a combination of low birth weight and high placental weight 
(Barker et al., 1990). High body mass indices and alcohol consumption 
were positively associated with hypertension but these risks were 
independent from and of a lesser magnitude than those associated with 
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low birth weight and high placental weight. It was speculated that 
discordance between placental and fetal size may lead to circulatory 
adaptation in the fetus, altered arterial structure in the child and 
hypertension in the adult. 
Since these initial investigations a number of studies have looked 
at any possible associations between blood pressure and either birth weight 
or ponderal index (summarised in table 1.2). In outline these tend to 
strengthen the original findings of an inverse link between blood pressure 
and birth weight. This link has been found in every adult population that 
has been studied so far, but is generally detectable only after infancy. Since 
tracking of blood pressure becomes established after about six months of 
age (De Swiet et al., 1992) it would take the increase in blood pressure 
associated with the ageing process to be able to detect significant but small 
changes in childhood. Adolescence is another period when the 
relationship may be difficult to detect as the blood pressure tracking may 
be disturbed by rapid growth around and just after the onset of puberty 
(Law et al., 1995). 
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Table 1.2 Studies investigating the link between hypertension and low 
birth weight, ponderal index or head circumference. 
Significant Associations Found 
POPULATION 
Salisbury children (aged 4) 
British children (aged 5-7) 
European children (aged 5-7) 
Jamaican children (aged 6-16) 
Children and young adults (aged 7 and 18) 
Salisbury children (aged 7) 
Australian children (aged 8) 
Very low birth weight Scottish children 
(aged 8-9) 
Finnish prepubertal children and 
adolescencets 
British children (aged 8-11) 
Children, adolescents, young adults 
(aged 8-24) 
British children (aged 9-11) 
British children and adults (aged 10 and 36) 
Israeli army conscripts (aged 17) 
Mexican Americans and non-Hispanic 
whites, USA (aged 25-64) 
American nurses (aged 25-55) 
Army conscripts (aged 28) 
British men and women (aged 36) 
Preston men and women (aged 46-54) 
Danish people (median age 47) 
Sheffield men and women (aged 50) 
Men in Sweden (aged 50) 
Hertfordshire men (aged 59-70) 
Significant Associations Not Found 
POPULATION 
Attendants at a neonatal follow-up clinic 
(aged 2-191 weeks) 
Twins born in Florida, USA 
(aged 0, 0.5, 1, 3, 6 and 9 months) 
British children, born premature and 
weighing< 1850 g at birth (aged 7-8) 
Scottish adolescents (aged 15) 
Cardiff adolescents (aged 16) 
Reference 
Law et al. (1991) 
Whincup et al. (1988) 
Whincup et al. (1992) 
Forrester et al. (1996) 
Williams et al. (1992) 
Law et al. (1996) 
Moore et al. (1996) 
Mutch et al. (1994) 
Taittonen et al. (1996) 
Taylor et al. (1997) 
Zureik et al. (1996) 
Whincup et al. (1995) 
Barker et al. (1989a) 
Seidman et al. (1991) 
Valdez et al. (1994) 
Curhan et al. (1996a) 
Gennser et al. (1988) 
Holland et al. (1993) 
Barker et al. (1990) 
Vestbo et al. (1996) 
Martyn et al. (1995) 
Leon et al. (1996) 
Hales et al. (1991) 
Reference 
Dgani & Arad (1992) 
Levine et al. (1994) 
Lucas & Morley (1994) 
Macintyre et al. (1991) 
Matthes et al. (1994) 
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Another factor known to increase risk for ischaemic heart disease is 
diabetes. In a study of 40-65 year olds from the Isle of Ely, England it was 
found that people who were newly diagnosed with either type 2 diabetes 
or impaired glucose tolerance were significantly shorter than people in 
that population with normal glucose tolerance (Brown et al., 1991). Given 
that the adult height achieved can be related to indices of early growth 
such as birth weight (Seidman et al., 1993) and that both type 2 diabetes 
and impaired glucose tolerance are strong risk factors for cardiovascular 
disease, investigations were started to see whether glucose tolerance could 
also be related to such factors as weights at birth and one year. Hales et al. 
(1991) studied a population of men aged 59-70 from Hertfordshire, 
England in whom birth weight data were available. Each subject 
underwent an oral glucose tolerance test. The proportion of men with 
either type 2 diabetes or impaired glucose tolerance fell progressively from 
the lowest to the highest birth weight categories such that men born with 
the lowest weights were six times more likely to have impaired glucose 
tolerance or type 2 diabetes than men who were born with the highest 
weights. This relationship was even stronger when comparing 
proportions of glucose intolerant men with categories based on weights at 
one year of age (giving an odds ratio of 8.2). The highest plasma glucose 
concentrations two hours post-load were in men who were born light but 
currently ha.d the highest body mass indices. This study was followed by 
one of men and women in Preston, England aged 46-54 which found that 
those subjects that were glucose intolerant (either with type 2 diabetes or 
impaired glucose tolerance) had lower birth weights and smaller head 
circumferences (Phipps et al., 1993). In addition they were thinner at birth 
(as measured by their ponderal index). 
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Other studies have confirmed and extended the conclusions drawn 
from these early studies (summarised in table 1.3). The populations and 
age groups in which associations between reduced indices of early growth 
and subsequent worsening of glucose tolerances have been found have 
increased to include groups in whom insulin resistance is common, such 
as Pima Indians (McCance et al., 1994) and Indians (who in this case were 
only four years old) (Yajnik et al., 1995). Likewise in the Preston cohort 
insulin sensitivity appeared to be positively related to ponderal index at 
birth (Phillips et al ., 1994a). Even in one study, carried out in 10-11 year 
olds, where early indices of growth did not appear to be related to 
subsequent glucose tolerance, both birth weight and ponderal index were 
significantly negatively associated with fasting plasma insulin 
concentration~ (Whincup et al., 1997). Given that there were no significant 
associations between fasting glucose concentrations and indices of early 
growth, these results are consistent with a link between size at birth and 
insulin resistance. In another study, looking at a population of only 101 
first degree relatives of type 2 diabetics from 47 families, people with type 2 
diabetes did not have significantly different birth weights from those 
people with either impaired glucose tolerance or normal glycaemia (Cook 
et al., 1993). However as well as the low number of adults investigated, the 
study design was flawed in that the diabetic group contained more than 
twice as many men as w omen (unlike those with impaired glucose 
tolerance or normal glycaemia who had more even numbers of men and 
w omen) a factor which would tend to increa,se the mean birth weight 
(Davis et al., 1993). This may not have been adequately controlled for even 
when using growth centiles instead of true birth weights,. Even w ith these 
limitations, however, a link was found between b irth weight and 
subsequent is-cell function providing further evidence for a link between 
birth weight and subsequent pancreatic function. 
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Table 1.3 Studies linking worsened glucose tolerance or markers of 
insulin resistance with low birth weight or ponderal index. Adapted from 
Hales et al. (1997). 
POPULATION 
Indian children (aged 4) 
Jamaican school children (aged 6-10) 
Salisbury children (aged 7) 
Prepubertal children 
British children (aged 10-11) 
Salisbury men (aged 20) 
Pima Indian men and women, USA 
(aged 20-39) 
Mexican Americans and non-Hispanic 
whites, USA (aged 25-64) 
Reference 
Yajnik et al. (1995) 
Forrester et al. (1996) 
Law et al. (1995) 
Hofman et al. (1997) 
Whincup et al. (1997) 
Robinson et al. (1992) 
McCance et al. (1994) 
Valdez et al. (1994) 
Health Professional men, USA ( aged 40-75) Curhan et al. (1996b) 
Danish people (median age 47) Vestbo et al. (1996) 
Preston men and women (aged 46-54) Barker et al. (1993a) 
Phipps et al. (1993) 
Phillips et al. (1994a) 
Swedish men (aged 50 & 60) Lithell et al. (1996) 
Danish monozygotic and dizygotic Poulsen et al. (1997) 
twins (aged 55-74) 
Hertfordshire men (aged 59-70) Hales et al. (1991) 
British pregnant women Olah (1996) 
Australian Aborigines Hoy et al. (1996) 
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The strongest negative association of all in this series of studies was 
between low birth weight and the development of the insulin resistance 
syndrome (defined in terms of a subject's plasma glucose two hours after 
ingestion of 75 g glucose, their systolic blood pressure and their fasting 
serum triglyceride concentration) (Barker et al., 1993a). In the cohort of 
Hertfordshire men the odds ratio of those men with the lowest birth 
weight in comparison with those men with the highest birth weights for 
the insulin resistance syndrome was 18. The equivalent value for the men 
and women in the Preston cohort was 13.5. Further support for these 
results was gained in a study of men and women from a biethnic 
population in the U.S.A. (Valdez et al., 1994). Here birth weight was 
significantly negatively associated with fasting serum insulin 
concentrations and these concentrations tracked the distribution of the 
insulin resistance syndrome traits right across body mass index-birth 
weight tertile categories. 
An attempt to explain these various associations has been made 
with the thrifty phenotype hypothesis (shown schematically in fig. 1.4) 
(Hales & Barker, 1992). Central to this hypothesis is that the predisposition 
to the development of the conditions which cluster as the insulin 
resistance syndrome occurs through adaptations to malnutrition by a 
developing fetus. Low birth weight is a proxy for a variety of intra-uterine 
influences but world-wide is probably predominantly caused by maternal 
malnutrition. Maternal malnutrition may be ,(or have been) especially 
prevalent in the populations which have undergone rapid transitions this 
century from traditional to more Western lifestyles and in whom 
prevalences of type 2 diabetes are now extremely high (King & Rewers, 
1993), e.g. Ethiopian Jews who emigrated to Israel during a period of 
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Other organ 
malfunction, 
e.g. liver 
Decreased 
is-cell mass 
[ 
Insulin 
resistance 
Other maternal or 
placental abnormalities 
Abnormal 
vascular 
development 
Decreased 
nephron 
number 
Hyperlipidaemia jType 2 diabetes I I Hypertension I 
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Figure 1.4 Schematic representation of the "thrifty phenotype" hypothesis 
showing the centrality of fetal malnutrition in the development of the 
conditions which cluster together as the insulin resistance syndrome. 
Adapted from Hales & Barker (1992). 
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famine (Cohen et al., 1988). Thus the fetus would adapt or 'programme' its 
growth and metabolism to the expectation of poor or cyclic availability of 
nutrition post-natally. This could have survival advantages both for the 
present, in terms of targeting available nutrients to more essential organs 
such as the brain, and for the future, in terms of being more able to store 
energy as fat thus providing energy reserves for when food is scarce. These 
adaptations would provide survival advantages whenever there was 
constant relatively poor nutrition or cyclic availability of relatively good 
nutrition. As in the thrifty genotype hypothesis, however, these 
advantages would not be necessary when there was a constant supply of 
good nutrition and the adaptations would become detrimental to health 
with the possible development of the insulin resistance syndrome. 
The factors which change the adaptations made by the 
malnourished fetus from those conferring survival advantages to those 
detrimental to health are perceived as being the development of obesity, 
ageing and a sedentary lifestyle (Hales & Barker, 1992). Clearly the 
development of type 2 diabetes occurs most commonly in obese 
individuals who are middle aged or beyond (King & Rewers, 1993). Also a 
sedentary lifestyle would not protect against the development of obesity. 
In the Hertfordshire cohort those men with newly diagnosed type 2 
diabetes or impaired glucose tolerance w eighed less at birth and one year 
of age than the others, had higher current systolic blood pressures and 
higher current body mass indices (Hales et al., 1991). Also analysis of the 
men from the cohorts in both Preston and Hertfordshire showed that 
current waist-to-hip ratios fell progressively with increasing birth weights 
(independently of current body mass indices) suggesting that fetally-
malnourished babies have a greater tendency to store abdominal fat in 
later life (Law et al., 1992). This would be consistent with the idea that one 
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of the adaptations made by the malnourished fetus allows metabolism to 
be altered such that fat storage is favoured (which would be advantageous 
when food was scarce). The thrifty phenotype hypothesis suggests that the 
occurrence and timing of onset of the different conditions associated with 
the insulin resistance syndrome would depend upon the exact timing of 
growth impairment during fetal or infant life (Hales & Barker, 1992). 
Clearly the development of obesity, whether or not it arose as a result of 
having a 'thrifty' metabolism, could interact with the effects of fetal 
growth retardation to hasten the occurrence of such conditions. 
A number of possible mechanisms which could cause a thrifty 
phenotype have been suggested. The first of these is a deficiency of 
pancreatic is-cell function. In the study of Hertfordshire men plasma 32,33-
split proinsulin concentrations fell sharply with an increase in weight at 
one year (and showed a tendency to fall with an increase in birth weight) 
(Hales et al., 1991). Raised plasma 32,33-split proinsulin concentrations 
may reflect a deficit of is-cells. These would have to prov_ide the body's 
insulin requirements and therefore may secrete products before having 
been able to completely process proinsulin. A deficit of insulin production 
may be associated with fetal growth retardation as insulin is essential for 
early growth and development (Fow den, 1989) and small-for-dates babies 
have reduced numbers of pancreatic is-cells (Van Assche & Aerts, 1979). A 
deficit of is-cell function, perhaps combined with an associated insulin 
resistance, in later life would obviously render an individual more 
susceptible to type 2 diabetes or impaired glucose tolerance. 
Even though measu rements of insulin resistance had n ot been 
studied in relation to ind ices of early growth when the thrifty phenotype 
hypothesis was published, it was speculated that fetal malnutrition may in 
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some way induce insulin resistance (Hales & Barker, 1992). This is very 
important since insulin resistance is believed to be the common link that 
causes the traits of the insulin resistance syndrome (Reaven, 1988). Also it 
could explain the correlation found in the Hertfordshire men between the 
concentrations of 32,33-split proinsulin in the plasma and systolic blood 
pressure (i.e. fetal adaptations to the nutrition that it receives regulating 
future insulin sensitivity and therefore 'drive' on pancreatic B-cells) 
(Hales et al., 1991). A subsequent study of people with normal or impaired 
glucose tolerance in Preston suggested that the prediction in the thrifty 
phenotype hypothesis was indeed correct (Phillips et al., 1994a). By means 
of insulin tolerance tests, it was found that babies who were thin at birth 
were subsequently more insulin resistant in adulthood. This finding was 
strengthened by a study giving intra-venous glucose tolerance tests to 50 
year old men in Uppsala, Sweden (Lithell et al., 1996). After adjustment 
for the current body mass indices, birth weight and ponderal index were 
shown to be inversely related to both fasting and 60-minute post glucose 
load plasma insulin concentrations. These results suggest that adult 
insulin sensitivity, at least in part, may be determined in utero. 
A number of lines of evidence suggest that at least some of the 
effects of a thrifty phenotype are mediated through alterations in 
vasculature. _ Firstly animal studies (section 1.3.4) have shown that 
maternal protein restriction can dramatically reduce pancreatic islet 
vascularisation in the offspring (Snoeck et al_., 1990). If these changes 
reflect more widespread reductions, insulin resistance could result given 
that it has been shown to be associated with a lower density of capillaries 
in skeletal muscle (as well as alterations in muscle fibre types) (Lillioja et 
al., 1987). A less compliant vasculature could be more resistant to blood 
flow and therefore contribute towards the development of hypertension 
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(Martyn et al., 1995). The advantage to the developing fetus of such an 
altered vasculature could be that in times of sparse or cyclic availability of 
nutrition blood flow is targeted to essential organs such as the brain at the 
expense of other organs. Indeed blood flow to the brain has been shown to 
be increased in small-for-dates fetuses (Al-Ghazali et al., 1989). 
Other effects of the thrifty phenotype may be mediated through 
alterations in organ structure and function. Such alterations in hepatic 
structure may shift lipoprotein synthesis and cause the hyper-
triacylglycerolaemia observed in the strong inverse relationship between 
low birth weight and the development of the insulin resistance syndrome 
(Barker et al., 1993a). Alterations in kidney structure, with low birth 
weight being associated with a low nephron endowment, has been 
suggested as a cause of the hypertension seen in individuals with early 
growth !etardation (Mackenzie & Brenner, 1995). Further it has been 
suggested that when kidney growth lags behind somatic growth sodium 
retention is favoured, predisposing an individual to hypertension (Weder 
& Schork, 1994). 
1.3.3 The Surviving Small Baby Genotype Hypothesis 
An alternative explanation for the association of low birth weight 
with the subsequent development of type 2 diabetes was made by McCance 
et al. (1994) who suggested that because of the high rate of mortality 
associated with low birth weight, those genetically susceptible to 
developing diabetes could have a selective survival advantage. Further it 
was hypothesised that the genotype was likely to present as an insulin 
resistant phenotype. Over many generations the prevalence of diabetes in 
a population would therefore increase along with other traits of the 
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insulin resistance syndrome. The authors, however, focused this theory 
only on those people with low birth weight whilst at the same time 
observing that the vast majority of people with type 2 diabetes are born 
with seemingly 'normal' birth we1ghts. Since the prevalence of type 2 
diabetes or impaired glucose tolerance continues to drop with increasing 
birth weight (Hales et al., 1991) and not just between those with 'low' and 
those with 'normal' birth weights, the association is more correctly 
between the development of glucose intolerance and the failure to realise 
growth potential in utero (Leon et al., 1996). 
A number of studies have discredited this theory. Firstly results 
from a study of four year old children in India (an area with high rates of 
infant mortality) (Yajnik et al., 1995) were remarkably similar to those 
from a study of seven year olds in Salisbury, England (an area with low 
infant mortality) (Law et al., 1995). Also in a study of men aged 50 and 60 
in Uppsala, Sweden an association was found between low birth weight 
and the subsequent development of type 2 diabetes, in an area where 
when these men were born the infant mortality rates were close to the 
national average (Lithell et al., 1996). Even if the infant deaths were solely 
amongst the lowest birth weight babies the selection could only account 
for a prevalence ratio of 1.3 in the group with the lowest birth weights in 
comparison to the other groups. The strongest evidence discrediting the 
surviving small baby genotype hypothesis comes from a study looking at 
Danish twins disconcordant for type 2 diabetes (Poulsen et al., 1997). They 
found that in both mono- and di-zygotic twins birth weights were 
considerably lower in the diabetic twins in comparison to their non-
diabetic siblings. As each diabetic was matched there were clearly no 
alterations in survival even though there was still an association between 
lower birth weight and the development of d iabetes. Whilst this study 
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does not disprove any involvement that genetics may have in the 
development of type 2 diabetes, it does show that the relationship between 
birth weight and the development of diabetes can be independent of 
genetic involvement. 
1.3.4 Animal studies 
Experimental approaches to testing the thrifty genotype hypothesis 
have generally focused on rodent strains which inherently become obese 
and diabetic. These have been shown to have lower metabolic rates, 
defective thermoregulatory mechanisms and an enhanced ability to 
deposit fat and survive prolonged fasting (Shafrir, 1992). Of particular 
interest is the heterozygous cross between ob and db strains of mice which 
are able to withstand prolonged fasting better than normal controls even 
when at the start of the experiment they have normal body weights, 
insulin levels, blood glucoses and liver glycogen concentrations 
(Coleman, 1979). Positional cloning techniques have been used on 
genomic DNA from these strains to try and identify genes that are 
responsible for the diabetic phenotype. In this way defects in the leptin 
gene were identified in the ob/ob mouse (Zhang et al., 1994) and extensive 
studies have investigated what roles polymorphisms in this gene may 
have in hum~ns (Considine & Caro, 1996). A particular difficulty in using 
this type of approach to find genes that may contribute towards a thrifty 
genotype, however, is that whilst the thrifty genotype is considered to be 
polygenic all the rodent strains that spontaneously develop obesity and 
diabetes exhibit a homozygous recessive mode of inheritance (Neel, 1982). 
The thrifty phenotype hypothesis has proved somewhat easier to 
test experimentally as fetal malnutrition can be induced by maternal 
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dietary restriction in standard experimental animals. If a relevant 
phenotype is produced it then has to be shown that the insult producing 
the phenotype is relevant to the human situation. The most extensively 
studied animal model of the thrifty phenotype involves protein 
restricting rats. Subjecting the rats in utero to protein calorie malnutrition 
and/ or to similar restrictions in early post natal life reduces the number 
of pancreatic B-cells and the secretion of insulin (Weinkove et al., 1974; 
Swenne et al., 1987). Such changes can also be produced by maternal 
protein restriction during pregnancy and lactation alone (Snoeck et al., 
1990). In one study offspring of dams fed an adequate calorie but protein 
deficient diet had a greater than 50 % reduction in islet vascularisation, a 
reduced ability of the islets to proliferate and a reduction in insulin 
secretion (Snoeck et al., 1990). These changes are reminiscent of the 
changes in the pancreata of human growth retarded newborn infants who 
have reduced numbers of pancreatic B-cells and reduced insulin secretion 
(Van Assche & Aerts, 1979). It has been speculated that in the low protein 
rat the impaired insulin secretion may predispose it to the development 
of impaired glucose tolerance or diabetes (Swenne et al., 1987). Indeed 
maternal and early protein restriction in the rat has been shown to lead to 
both impaired glucose tolerance (Dahri et al., 1991) and hypertension 
(Langley & Jackson, 1994) in the adult. 
1.4 Objectives 
An increasing number of studies have shown associations between 
markers of early growth restriction and the subsequent development of 
traits of the insulin resistance syndrome. Those at most risk are 
consistently those with early growth retardation who subsequently 
become obese. Whilst defects or deficiencies in insulin action are thought 
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to be intimately involved in this process, amylin may be important for 
the development of the insulin resistance syndrome (Young et al., 1994b). 
In trying to test and model the thrifty phenotype hypothesis in rats the 
series of studies described were designed to test two main hypotheses. The 
first of these was that combined effects associated with early growth 
restriction and adult obesity interact in causing glucose intolerance and 
possibly other features of the insulin resistance syndrome. As islet 
vasculature may be reduced in early growth retardation (Snoeck et al., 
1990) possibly leading to a reduced capacity to clear secreted amylin and an 
enhanced tendency to deposit pancreatic amyloid (Westermark et al., 
1995), the second major hypothesis tested was that early growth restriction 
may lead to enhanced pancreatic amyloid deposition particularly if the 
pancreatic is-cells are subsequently stressed by adult obesity. 
Firstly sensitive, precise and accurate immunoassays for the 
measurement of amylin had to be developed. Once established these 
assays could then be used to test any potential associations that circulating 
or pancreatic amylin concentrations may have with amyloid deposits or 
metabolic parameters in the subsequent rat model. 
Previous studies in rats have shown that maternal protein 
restriction during pregnancy can lead to reduced islet size and insulin 
secretion in the pancreata of the offspring (Snoeck .et al., 1990; Dahri et al., 
1991). It is not known whether islet hormones are permanently 
programmed by this procedure but a reduction in pancreatic insulin 
content (or an elevation in pancreatic glucagon content) may render a rat 
more susceptible to the development of glucose intolerance. A study was 
therefore set up to test the hypothesis that islet cell hormone contents in 
male and female rats may be programmed by maternal protein restriction. 
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Dietary-induced obesity was then introduced to test the hypothesis that 
any such programming may not be permanently fixed, but rather may be 
flexible around an altered 'set-point'. 
As rat amylin does not deposit as pancreatic amyloid and one of the 
major hypotheses to be tested in this series of studies concerned the 
tendency to deposit pancreatic amyloid, a rat line transgenic for human 
amylin (which does precipitate as amyloid in the human pancreas) was 
then characterised to ensure that it was both genotypically and 
phenotypically transgenic for human amylin. 
In humans results pertaining to the thrifty phenotype hypothesis 
suggest that the development of the insulin resistance syndrome occurs 
in individuals with particular bodily forms (associated with early growth 
restriction and subsequent obesity). The next hypothesis tested was 
therefore that similar changes in bodily form to these could be reproduced 
in rats by a combination of maternal and early protein restriction followed 
by subsequent feeding of a highly palatable, cafeteria-style diet. 
The validity of the two main hypotheses investigated in this series 
of studies were tested using these low protein, cafeteria-fed, transgenic rats 
along with appropriate controls. The first hypothesis that effects associated 
with early growth retardation combined with effects of adult obesity 
interact in causing the insulin resistance syndrome was investigated by 
performing glucose tolerance tests and plasma triacylglycerol measure-
ments at various ages. Blood pressures were also measured in 12 month 
old rats. The hypothesis that early growth restriction may be associated 
with an enhanced tendency to deposit pancreatic amyloid was 
investigated using pancreatic histological staining. 
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Chapter 2 
General Materials And Methods 
2.1 MATERIALS 
Antibodies F002, F024 and F025-27 were supplied by Amylin 
Pharmaceuticals, Inc. (San Diego, California, U.S.A.). All the buffers (with 
the exception of the coating buffer) for DELFIATM assays were bought from 
Wallac Oy, Turku, Finland. Microtitre plates (Nunc-immunomodule, 
Maxisorp F16) were obtained from Nunc, Roskilde, Denmark. Rat insulin 
and glucagon radioimmunoassay kits were from Biogenesis (Poole, U.K.); 
somatostatin and pancreatic polypeptide kits were from Peninsula 
Laboratories (St. Helens, U.K.). Microcuvettes for the measurement of 
blood glucose were purchased from Hemocue Ltd. (Sheffield, U.K.). 
Thermus acquaticus DNA polymerase and all DNA .markers were 
purchased from Gibco BRL (Paisley, U.K.). DNA extraction columns were 
from Qiagen (Dorking, U.K.). All DNA oligonucleotide primers were 
bought from Oswel DNA Service (Edinburgh, U.K.). Pharmacia (St. 
Albans. U.K.) supplied the ultrapure dNTPs. SYBR green was from 
Flowgen Instruments Ltd. (Sittingbourne, Kent, U.K.). All other chemicals 
were purchased from either Sigma Chemical Co. (Poole, U.K.) or BDH 
(Poole, U.K.) . 
Transgenic male Sprague Dawley rats were a gift from Dr. D. 
Murphy, Dr. Z. Qi and Professor Y. Tan (Neuropeptide laboratory, Institute 
of Molecular And Cell Biology, National University of Singapore, 
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Singapore). Female Sprague Dawley rats were purchased from Interfauna 
(Wyton, Huntingdon, U.K.). 
2.1.1 BUFFERS 
2.1.1.1 Phosphate Buffered Saline (PBS), pH 7.5 
One litre of this buffer contained 1.459 g Na2HP04.2H20, 0.281 g 
NaH2P04.2H20 and 8.76 g NaCL 
2.1.1.2 Bicarbonate Coating Buffer (0.1 M), pH 9.2 
One litre of this buffer contained 1.06 g anhydrous Na2CQ3 and 
7.56 g NaHC03. 
2.1.1.3 DELFIA Assay Buffer, pH 7.75 
Each litre of this contained 50 mmol Tris/HCl (pH 7.75), 9 g of NaCl, 
0.9 g of sodium azide, 0.5 g of bovine serum albumin, 0.5 g of bovine 
gamma globulin, 0.1 ml of Tween 20 and diethylenetriaminepentaacetic 
acid (an inert dye). 
2.1.1.4 DELFIA Wash Buffer, pH 7.75 
This buffer was supplied as a 25x concentrate. One litre of dilute 
wash buffer contained 0.6 g Tris, 50 µl Tween 20, 0.9 g NaCl, and 0.5 g 
sodium azide in · doubly distilled water corrected to pH 7.75 with 
hydrochloric acid. 
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2.1.1.5 DELFIA Enhancement Solution 
Each litre of this buffer contained 1 g of Triton X-100, 6.8 mmol of 
potassium hydrogen phthalate, 100 mmol of acetic acid, 50 µmol of tri-n-
octylphosphine oxide and 15 µmol of 2-naphthoyltrifluoroacetone in 
doubly distilled water. 
2.1.1.6 Tris-borate EDT A (TBE) Buffer 
This was made as a lOx concentrate, each litre of which contained 
109 g Tris, 55.6 g boric acid and 9.3 g EDTA. 
2.1.1.7 Agarose Gel Loading Buffer, pH 8.0 
This buffer was made as a 5x concentrate containing 50 % (v / v) 
glycerol, 50 mM EDTA (pH 8.0), 0.125 % (w /v) bromophenol blue and 
0.125 % (w / v) xylene cyanol. 
2.1.1.8 Linco Insulin Assay Buffer, pH 7.4 
This buffer was 0.05 M phosphate buffered saline (pH 7.4) 
containing O.Q25 M EDTA, 1 % (w /v) bovine serum albumin and 0.1 % 
(w /v) sodium azide. 
2.1.1.9 Linco Glucagon Assay Buffer, pH 8.8 
This buffer was 0.2 M glycine (pH 8.8) containing 0.03 M EDTA, 1 % 
(w /v) bovine serum albumin and 0.1 % (w /v) sodium azide. 
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2.1.1.10 Amersham Rat Corticosterone Assay Buffer, pH 7.4 
This buffer was 20 mM borate buffer, pH 7.4, also containing 0.1 % 
(w /v) sodium azide. 
2.1.2 SYNTHETIC RAT DIETS 
Five synthetic rat diets were used during the course of the various 
studies. The 8 and 20 % (w /w) protein diets given to pregnant and 
lactating female rats (and some of their offspring as described in chapter 6) 
were purchased from Hope Farm (Woerden, Netherlands). Their 
compositions are shown in table 2.1. PRD pellets were from Labsure 
(Poole, U.K.) and their composition is shown in table 2.2. LADl and 
Porton Combined Diet were purchased from Special Diet Services 
(Witham, Essex, U.K.); table 2.3 shows their basic composition. 
2.2METH0DS 
2.2.1 Rat Insulin Assay 
The Linco rat insulin radioimmunoassay was performed according 
to the manufacturer's instructions. 100 µl of 125!-rat insulin was added to 
tubes containing 100 µl of rat insulin standards, controls or samples (i.e. 
rat plasma or pancreatic extract diluted with assay buffer). After vortexing, 
100 µl of rat insulin antibody was then added to each of the tubes. These 
were then vortexed again and allowed to incubate for 18 hours at 4 ° C. The 
following morning 1 ml of precipitating reagent was added to each tube 
and the tubes were incubated for a further 20 mins. at 4 ° C. The tubes were 
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Table 2.1 Composition of the 8 and 20 % protein diets fed to pregnant and 
lactating female rats (g / 100 g dry weight of diet). 
DIET 
Mineral and vitamin mixture 
Casein (88 g protein/ 100 g) 
DL-Methionine 
Maize starch 
Cellulose 
Soyabean oil 
Cerelose 
OVERALL COMPOSITION 
Protein (g/ 100 g dry weight) 
Carbohydrate 
(g/ 100 g dry weight) 
Fat (g/100 g dry weight) 
Energy (kJ / 100 g dry weight) 
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Control 
5.05 
22.00 
0.20 
8.00 
5.00 
4.30 
55.15 
20.0 
63.2 
4.3 
1537 
Low 
Protein 
5.45 
9.00 
0.08 
8.00 
5.00 
4.30 
68.17 
8.0 
76.2 
4.3 
1528 
Table 2.2 Composition of PRD pellets (g/ 100 g dry weight of diet) . 
Vitamins & Minerals 4.0 
Ash 6.2 
Crude Oil 3.0 
Crude Protein 19.8 
Crude Fibre 5.4 
Carbohydrate 53.0 
(including starch) (32.0) 
Digestible Energy 1260 
(kJ/ 100 g dry weight) 
Table 2.3 Composition of LADl and Porton Combined Diet (g/ 100 g dry 
weight of diet) . 
DIET LADl 
Vitamins & Minerals 3.4 
Digestible Crude Oil 3.0 
Digestible Crude Protein 19.6 
Digestible Carbohydrate 49.1 
Total Dietary Fibre 10.7 
Digestible Energy 1400 
(kJ/100 g dry weight) 
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Porton Combined 
Diet 
4.0 
2.7 
17.9 
44.8 
16.1 
1200 
then centrifuged at 3,000 g for 20 mins. and the supernatant withdrawn by 
aspiration. The remaining pellet was then counted using a y-counter. 
Insulin concentrations were calculated by reference to an appropriate 
standard curve. 
2.2.2 Rat Glucagon Assay 
The Linco glucagon assay was performed according to the 
manufacturer's instructions. 100 µl assay buffer was added to tubes 
containing 100 µl human glucagon standard, control or sample (i.e. either 
rat plasma or pancreatic extract diluted with assay buffer). Then 100 µl 
glucagon antibody was added to each of the tubes. After vortexing, the 
tubes were incubated for 18 hours at 4 ° C. The following morning 100 µl 
12sr-human glucagon was added and the tubes were vortexed. After a 24 
hour incubation at 4 ° C, 1 ml of precipitating reagent was added to each 
tube and a further 20 minute incubation at 4 ° C was started. The tubes 
were then centrifuged at 3,000 g for 20 mins. and the supernatant 
withdrawn by aspiration. The remaining pellet was then counted using a 
y-counter. Glucagon concentrations were calculated by reference to an 
appropriate standard curve. 
2.2.3 Rat Som_atostatin Assay 
The Peninsula somatostatin assay was performed according to the 
manufacturer's instructions. 100 µl of rabbit anti-somatostatin serum was 
added to tubes containing 100 µl somatostatin standard or sample (i.e. 
pancreatic extract diluted with PBS, pH 7.4). After vortexing, the tubes 
were incubated for 18 hours at 4 ° C. The following day 100 µl of 12sr-
somatostatin (diluted such that 100 µl gave 12,000 counts per minute) was 
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added to each of the tubes, before allowing them to incubate at 4 ° C for a 
further 24 hours. The following day 100 µl rabbit serum and 100 µl goat 
anti-rabbit IgG serum was added to each of the tubes and allowed to 
incubate for 90 mins. at room temperature. Following the addition of 
500 µl of assay buffer, the tubes were then centrifuged at 1,700 g for 20 
mins. (at 4 ° C). The supernatants were withdrawn by aspiration and the 
remaining pellets were counted using a y-counter. Somatostatin 
concentrations were calculated by reference to an appropriate standard 
curve. 
2.2.4 Rat Pancreatic Polypeptide Assay 
The pancreatic polypeptide assay was run using the same conditions 
as the somatostatin assay (section 2.2.3) with appropriate human 
pancreatic polypeptide standards, tracer and antisera. This antisera cross-
reacted 10 % with rat pancreatic polypeptide; measurements from rat 
pancreata are presented uncorrected. 
2.2.5 Rat Corticosterone Assay 
The Amersham rat corticosterone assay was performed according to 
the manufacturer's instructions. Firstly 12.5 µl plasma was diluted to 
250 µl with assay buffer (i.e. a 1 in 20 dilution) and then incubated at 60 ° C 
for 30 mins. 100 µl aliquots of this were added to tubes containing 100 µl 
antisera (raised in rabbits against rat corticosterone) and 100 µl 125I-rat 
corticosterone. After vortexing, the tubes were incubated for 2 hours at 
room temperature. Then 400 µl donkey anti-rabbit antisera was ad ded to 
each tube and the tubes allowed to incubate at room temperature for a 
further 10 mins. After centrifugation at 3,000 g for 10 mins. (at 4 ° C), the 
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supernatants containing the unbound tracer were aspirated off. The 
remaining pellet was then counted using a y-counter. Plasma 
corticosterone concentrations were calculated by reference to an 
appropriate standard curve. 
The manufacturers of the rat corticosterone kit give the following 
cross-reactivities for the antisera: rat corticosterone 100 %, 11-
deoxycorticosterone 2.4 %, progesterone 0.7 % and less than 0.1 % for 
cortisol, 11-deoxycortisol, 21-deoxycortisol, 17-hydroxyprogesterone, 
oestradiol and testosterone. 
2.2.6 Triacylglycerol Assay 
Triacylglycerol was measured using an adaptation of the method of 
McGowan et al. (1983) (Sigma triglycerides kit, Poole, Dorset, U.K.). 
Reagent 'A' contained 375 µmol/1 ATP, 3.75 mmol/1 of a magnesium salt, 
188 µmol / 1 4-aminopyrine, 2.11 mmol/1 sodium-N-ethyl-n(3-sulpho 
propyl) m-anisidine, 1,250 U / 1 glycerol kinase, 2,500 U / 1 glycerol 
phosphate oxidase, 2,500 U / 1 horseradish peroxidase and 0.05 % (w / v) 
sodium azide. It was buffered to pH 7.0. Reagent 'B' contained 250,000 U / 1 
lipase and 0.05 % (w / v) sodium azide. 3 µl plasma was diluted with 10 µl 
distilled wate~ and then mixed with 120 µl reagent A and 30 µl reagent B 
(which themselves were diluted with 10 µl distilled water). The reaction 
was allowed to proceed at 37 ° C for 5 mins. before the change in 
absorbance over a 10 second period at 550 nm was monitored. This assay 
was used to measure the sum of triacylglycerol and glycerol in the samples 
(by comparing the change of absorbance with that from known standards). 
The assay was then repeated replacing reagent B with distilled water to 
measure the free glycerol in the samples. The plasma triacylglycerol 
- 51 -
I 
concentration was calculated by expressing the free glycerol concentration 
in 'triacylglycerol equivalents' and taking this value away from that 
gained in the original assay. 
2.2.7 Cholesterol Assay 
Total cholesterol was measured using an adaptation of the method 
of Allain et al. (1974) (Sigma cholesterol kit, Poole, Dorset, U.K.). The 
cholesterol reagent contained 300 U / 1 cholesterol oxidase, greater than 
100 U / 1 cholesterol esterase, 1,000 U / 1 horseradish peroxidase, 300 µmol/1 
4-aminoantipyrine and 30 mmol/1 p-hydroxybenzenesulphonate. It was 
buffered to pH 6.5. 2 µI of plasma was diluted with 10 µI distilled water and 
then mixed with 200 µI of the cholesterol reagent (which itself was diluted 
with 10 µI distilled water). The reaction was allowed to proceed at 37 ° C for 
6 mins. before the change in absorbance over a 10 second period at 500 nm 
was monitored. Cholesterol concentrations were calculated by comparing 
this change in absorbance with that of a known standard. 
2.2.8 Creatinine Assay 
Creatinine was measured using an adaptation of the method of 
Fabiny and Ertingshausen (1971) based on a kinetic modification of the 
Jaffe reaction (Sigma creatinine kit, Poole, Dorset, U.K.). 7 µI plasma 
samples were diluted with 15 µI distilled water and then 150 µI of a 
reagent containing 18.5 mmol/1 picric acid 'and 150 mmol/1 sodium 
hydroxide (itself diluted with 10 µI distilled water) was added to each 
sample. The formation of the red Janovski product at 37 ° C was followed 
at 520 nm. 
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Chapter 3 
Development Of Sensitive Time Resolved 
Fluorescence Immunoassays Of Amylin 
3.1 INTRODUCTION 
Since amylin may have important metabolic functions (Rink et al., 
1993) and its concentration appears to be a factor that contributes to 
pancreatic amyloid formation (Couce et al., 1996a), its accurate 
measurement in biological fluids would appear desirable. In this way it 
could be ascertained whether amylin concentrations in accessible tissue, 
such as the plasma, are an independent risk factor for the development of 
type 2 diabetes or hypertension. To this end, shortly after its discovery and 
characterisation, radioimmunoassays for the measurement of plasma 
amylin were developed (Nakazato et al., 1989; Butler et al., 1990; Van 
Jaarsveld et al., 1990). All these early assays, with the exception of one 
where amylin was measured directly in the plasma of a patient with an 
amylin-producing islet cell tumour (Stridsberg et al., 1992), relied on prior 
extraction of the amylin from plasma. This was generally achieved using 
Sep-Pak C18 cartridges (Nakazato et al., 1989; Butler et al., 1990; Van 
Jaarsveld et a}., 1990; Hartter et al., 1991; Sanke et al., 1991; Eriksson et al., 
1992), although Van Hulst et al. (1994) developed an acid-acetone 
extraction procedure which they claimed was easier to perform, quicker 
and more reproducible. The use of the extraction procedure minimised 
matrix effects in the subsequent radioimmunoassays, removed some of 
the potential cross reactants and also concentrated the sample, a major 
advantage as often fasting plasma levels of amylin were found to be at or 
below the minimum detectable concentrations (MDCs) in both normal 
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and diabetic individuals. However this was achieved at the expense of 
having sample to sample variations in extraction efficiencies, the 
requirement of having to use large sample volumes of up to 5 ml (Hartter 
et al., 1991) and increasing the labour intensity and overall time taken to 
complete the assays (up to about 5 days). These disadvantages, combined 
with a lack of agreed reference material, led to a marked variation in assay 
results from different laboratories (Leighton, 1992) and highlighted the 
need for improvements in amylin assay methodology. 
To obviate the requirement for extraction, improvements in assay 
sensitivity were needed to be able to measure the low circulating amylin 
levels in plasma. With other circulating polypeptides, improvements in 
assay sensitivity have largely been achieved by switching from limited 
reagent assay systems to those employing excess reagents (i.e. where 
instead of tracer and analyte competing for binding to a limited number of 
antibody binding sites, the antibodies are present in excess to bind as much 
of the analyte as possible) (Miles & Hales, 1968). Of particular importance 
in this respect has been the use of the two-site assay (Addison & Hales, 
1971), a technique greatly facilitated by the ability to produce monoclonal 
antibodies (Kohler & Milstein, 1975). Here two antibodies, known to bind 
separate epitopes of an antigen, are employed: one of which is solid-phase 
bound and is used to 'capture' the analyte and the other of which is 
labelled and is used to generate a signal in proportion to the concentration 
of bound analyte. A 'sandwich' is therefore formed with the analyte being 
bound between the capture and signal antibodies. The need for the 
presence of two available epitopes means that these assays have improved 
specificity over conventional techniques. The use of excess reagents has 
led to improvements in assay sensitivities and reduced incubation times 
compared to limited reagent systems (where assay sensitivity can be 
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improved by reducing the number of available antibody binding sites but 
only at the expense of increased incubation times). Also the use of a solid 
phase has allowed more stringent washing procedures to improve the 
separation of free and bound reagents. All these factors combined with the 
move towards the use of non-isotopic labels has allowed improvements 
in assay automation, a factor which is important for large scale prospective 
studies in diabetes research (Hales et al., 1996a). In terms of enhancing our 
knowledge about possible pathophysiological roles of amylin, clearly such 
assays would provide enormous benefits over the older, extraction-
requiring radioimmunoassays (Sacks, 1996). 
Recently two of these two-site immunoassays have been described 
for the measurement of amylin in unextracted plasma (Percy et al., 1996). 
These were based on the use of combinations of various monoclonal 
antibodies: F002 (raised against amylin bound to thyroglobulin by 
glutaraldehyde crosslinking and thought to bind an epitope that has 
conformational requirements and at least partially extends beyond amino 
acid 20 of the amylin molecule but not as far as the amidated C-terminus), 
F024 (raised against amylin bound to thyroglobulin by glutaraldehyde 
crosslinking and thought to bind an epitope that requires an intact 
disulphide bridge between cysteine residues at positions 2 and 7) and F025-
27 (raised against unconjugated full-length human amylin and thought to 
bind an epitope that either includes or requires the conformation caused 
by the presence of the C-terminal amide group). One assay (with F024 as 
the capture antibody and F025-27 as the signal antibody) was found to be 
able to measure intact human and rat amylin (although with slightly 
different affinities). 
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Consistently higher results than those gained with the F024 / F025-27 
assay, however, were found with an assay that employed F002 as the 
capture antibody and F025-27 as the signal antibody (although this 
combination was found not to be suitable for the measurement of rat 
amylin). Studies involving extraction followed by reversed phase high 
performance liquid chromatography (HPLC) were performed to help 
reveal why these higher results were obtained. It was found that as well as 
binding the fraction corresponding to the native human amylin, two 
further peaks from the HPLC fractions contained material that was 
immunoreactive towards F002. Western blot analyses revealed that this 
immunoreactive material had a higher molecular weight than that of 
native amylin and that it was not reactive towards F024. This suggested 
the possibility that the material was either proamylin or post-
translationally modified amylin such that the epitope bound by F024 is 
removed either chemically or by a change in conformation. By a 
combination of mass spectrometry, amino-terminal amino acid 
sequencing, chemical deglycosylation techniques, western blotting and 
glycosidase digestion studies, three modified molecular species that were 
immunoreactive to F002 were shown to be normally processed amylin 
with 0-linked carbohydrate groups in the N-terminal region (Rittenhouse 
et al., 1996). One of these glycosylated amylin species was identified as a 
monosialated pentasaccharide linked at Thr-9 having the following partial 
oligosaccharide structure: [NeuAc, HexAc2] Gal (Bl-3) Gal Nac (a-Thr-9) . 
Two other glycosylated amylins had similar oligosaccharide structures 
linked respectively at Thr-6 and at both Thr-6 and Thr-9. 
Both these assays employed F025-27 as the signal antibody. A 
number of different labels were assessed for suitability including those 
with radioactive, colourimetric, chemiluminescent and fluorescent end 
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points (Percy et al., 1996). Labelling the F025-27 with alkaline phosphatase 
and employing the substrate 4-methylumbelliferyl phosphate was chosen 
to be the best detection system due to the low MDC of the assay (1 pmol/1) 
and the wide availability of the substrate. The steps in the immuno-
enzymometric assays (IEMAs) of amylin are represented schematically in 
fig. 3.1. Compared to the older radioimmunoassays these assays had the 
following advantages: (1) no extraction required, (2) high sensitivity, (3) 
quicker (after an overnight coating of a microtitre plate with capture 
antibody they can be completed within one day), (4) improved precision, 
(5) smaller sample size required (50 µl in triplicate) and (6) they are more 
amenable to automation (Sacks, 1996). 
With the move towards automation of immunoassays of high 
sensitivity a number of non-isotopic labels have been developed to 
overcome the difficulties associated with the use of 125J-radiolabels (such 
as extra operator safety requirements, short shelf life and relative difficulty 
in automation). Whilst each of the labels has a theoretical minimum 
detection limit, often at vastly lower concentration than that of 
radiolabels, in practice there is often little variation in assay MDCs when 
comparing the use of different labels. This means that often when 
developing two site assays the label of choice will depend on such factors 
as what detection equipment is already available within a particular 
laboratory, rather than on the theoretical sensitivity of assays it produces 
(Hales et al., 1996a). 
One case which requires a dedicated instrument . for detection is 
where an antibody is labelled with a chelate of the lanthanide europium 
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(5) Emitted fluorescence is 
read and is present in 
proportion to the amylin 
content of the sample 
Methylumbelliferone 
4-Methyl umbelliferyl 
Phosphate ( 4) 4-methylumbelliferyl phosphate (50 µI 
at 50 mg/I) added to wells and incubated at 
room temperature for 40 minutes, followed 
by addition of 50 µI stop solution 
(3) Alkaline phosphatase-labelled F025-27 
(added 50 µI at 40 ng/ml) binds to captured 
amylin (3 hour incubation at room 
temperature), followed by washing 
(2) Amylin in 50 µI sample binds to capture 
antibody (1 hour incubation at room 
temperature), followed by washing 
(1) Capture antibody (F024 or F002) 
50 µI coated 10 µg/ml overnight at 
4 °C, followed by washing & blocking 
Solid Phase (microtitre plate well) 
Figure 3.1 A schematic representation of the amylin IEMA. 
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in dissociation enhanced lanthanide fluoroimmunoassays (DELFIAs) 
(Soini & Kojala, 1983; Hemmila et al., 1984). When bound to an antibody 
by an EDTA derivative, europium is relatively non-fluorescent. At the 
end of an immunoassay, however, addition of enhancement solution 
(containing is-deketone, trioctylphosphine and Triton X-100 at pH 3.2) 
strips the europium from the antibody to allow the formation of highly 
fluorescent europium micelles (fig. 3.2). The fluorescence of the europium 
is measured using a time resolved fluorometer. Here a xenon lamp pulses 
for 1 µsec at 340 nm. Lanthanides exhibit a long-lived signal when excited 
in this way. The background signal composed of light scattering and non-
specific fluorescence is allowed to decay such that when the fluorescence is 
actually read by the machine, 400-800 µsees. after excitation, background 
fluorescence is minimised (fig. 3.3). Detection takes place at 613 nm, due to 
the large Stoke's shift of europium, further reducing the effect of 
background fluorescence. The xenon lamp pulses once every msec., 
therefore as each microtitre plate well has its fluorescence measured for 
1 sec., it undergoes 1,000 cycles of excitation and emission. 
The object of the work reported in this chapter was to check the 
characteristics of the amylin immunoassays developed by Percy et al., 
(1996) and using the antibodies from these assays to try to develop 
sensitive time resolved immunoassays for the measurement of rat and 
human amylin in plasma and pancreatic extracts. 
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F024 Amylih F025-27 
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.... 
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Figure 3.2 Basic principle of a DELFIA. When antibody bound the europium is 
relatively unfluorescent. The low pH of the enhancement solution releases the 
europium to form a highly fluorescent micelle with components of the 
enhancement solution. 
Excitation A=340 nm, emission A=613 nm 
0 
Flouorescence of 
europium 
chelate 
I 
Background 
fluorescence 
/ 
Delay 
time 
400 
1000 cycles/sec. 
New Cycle 
800 1000 Time (µsec.) 
Figure 3.3 The principle of time resolved fluorescence measurement showing 
the long lived fluorescence of the europium chelate in comparison to that of 
background fluorescence. 
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3.2METH0DS 
3.2.1 Characteristics Of The Amylin IEMAs 
The immunofluorometric assay of amylin supplied in kit form was 
performed according to Percy et al. (1996). Black microtitre plates were 
coated overnight at 4 °C with 50 µI/well of 10 µg/ml coating antibody 
(F024 or F002) in 50 mmol/1 sodium carbonate, pH 9.6. The following 
morning the plates were washed 3 times with 300 µI/well wash buffer (tris 
buffered saline; TBS) (containing 50 mmol / 1 Tris, 150 mmol/1 sodium 
chloride and 0.02 % (w / v) sodium azide), before being blocked with 
100 µI/well of 1 % (w / v) skimmed milk powder in 50 mmol/1 sodium 
carbonate (pH 9.6) at room temperature for 1 hour. The plates were then 
washed a further 3 times with 300 µI/well TBS before 50 µl standards or 
controls were pipetted into each well in triplicate. After a 1 hour 
incubation at room temperature and a further 3 washes with 300 µI/well 
TBS, 50 µl alkaline phosphatase-labelled F025-27 (40 ng/ ml) in TBS plus 
0.1 % v / v Tween 20 and 2 mg/ 1 irrelevant mouse antibodies were added to 
each of the wells . The plate was incubated like this for 3 hours at room 
temperature. Then, after 3 more washes with 300 µI / well TBS, 50 µl 
50 mg/ 1 4-methylumbelliferyl phosphate in 1 mol / 1 diethanolamine (pH 
9.8) containing 0.5 mmol/1 magnesium chloride was added to each well. 
The reaction was allowed to proceed for 40 minutes at room temperature 
before being stopped by the addition of 50 µI/well 100 mmol/1 phosphate 
and 1.5 mol/1 sodium chloride, pH 7.4. The relative fluorescence was 
measured by emission at 460 nm after excitation at 355 nm using a 
Fluoroskan II fluorometer (Flow Laboratories) . Relative fluorescence units 
were correlated with concentration using Multicalc software (LKB Wallac) 
and calibration curve data. 
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Initial assessment was performed on the F024/F025-27 assay using 
rat amylin standards and controls. Intra- and inter-assay precision was 
tested, along with an estimation of the MDCs. Two pancreata were 
removed from Wistar rats and their hormones extracted into acidified 
ethanol (section 4.2.2) overnight. The following morning the extracts were 
diluted with 1 % (w /v) bovine serum albumin (BSA) in PBS (pH 7.5) and 
spiked with known amounts of rat amylin to assess recovery. Similar 
precision studies were performed using human amylin standards and 
controls and using the F002/ F025-27 IEMA. 
3.2.2 Europium Labelling Of Antibodies F025-27, F024 and F002 
Europium labellings of antibodies F025-27, F024 and F002 were 
performed using DELFIA europium-labelling kits (Wallac, Turku, 
Finland) and were carried out according to the manufacturer's 
instructions. Before labelling 1 mg of each antibody underwent buffer 
exchange. PD-10 columns (Pharmacia Biotechnology, Milton Keynes, U.K.) 
were first pre-equilibrated with 50 ml labelling buffer (50 mmol/1 sodium 
hydrogencarbonate, 140 mmol/1 sodium chloride, pH 9.8). The antibody 
was then added to the top of the column and the column rinsed with 
labelling buffer. Fractions (500 µl) were collected from the column and 
their absorbance at 280 nm monitored to check for the presence of protein. 
Protein-containing fractions (i.e. those absorbing at 280 nm) were pooled 
(to make a total volume of up to 3.5 ml) and then concentrated down to 
500 µl using a Centri-Con 30 membrane (Amicon, Stonehouse, U.K.) and 
centrifugation. 
The 500 µl antibody solution was added to the europium-labelling 
reagent vial (containing 200 µg NL(p-isothiocyanatobenzyl)-diethylene 
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triamine-Nl,N2,N3,N3-tetraacetic acid chelated with europium) and was 
allowed to incubate for 18 hours at room temperature. The following 
morning a gel filtration column (containing 3 ml Sephadex G-50 above 
8 ml Sepharose 6B) was pre-equilibrated with 50 ml elution buffer 
(containing 50 mmol/1 Tris-hydrogeri chloride pH 7.8, 140 mmol/1 sodium 
chloride and 0.05 % (w / v) sodium azide). The reaction mixture was added 
to the head of the chromatography column and was washed through with 
elution buffer. Then 500 µl fractions (40-75) were collected from the 
column and the europium concentration of each fraction was measured 
(after diluting the fractions 1:10,000 with DELFIA enhancement solution 
(section 2.1.1.5) and comparing these results with those from a 1 nmol/1 
europium standard solution). 
Those fractions thought to contain the labelled proteins (from the 
profile of the europium contents of the fractions) were pooled and the 
final protein concentration of the pool estimated from its absorbance at 
280 nm (after subtracting the absorbance resulting from the formation of 
aromatic thiourea bonds) (the kit manufacturers giving 1.34 as the 
absorptivity value of a 1 mg / ml solution of IgG of molecular weight 
160,000). Finally purified BSA was added to the pool to a final 
concentration of 0.1 % (w / v) to increase the stability of labelled proteins. 
When one of the labelled antibodies (F024) was involved in an 
assay that gave very few counts with both rat and human amylin (i.e. was 
very insensitive), the europium labelling of that antibody was repeated 
using the labelling reagent at 4 °C instead of room temperature. This was 
to reduce the labelling yield in case the antibody paratopes were being 
significantly europium-labelled such that they were no longer able to bind 
amylin . 
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3.2.3 Optimisation Of The Rat Amylin DELFIA 
The optimum concentration of F024 to coat microtitre plates (Nunc 
Immunomodule Maxisorp, Nunc, R9skilde, Denmark) was determined as 
follows: 
Firstly wells were coated overnight at 4 °C with 100 µl F024 at 5, 10 
and 20 µg / ml in bicarbonate coating buffer, pH 9.2 (section 2.1.1.2). The 
following morning the plates were washed 4 times with 300 µI/well 
DELFIA wash buffer (section 2.1.1.4) and then blocked with 300 µl 5 % 
(w / v) BSA in PBS, pH 7.5 (section 2.1.1.1), for 1 hour at room temperature. 
After this and a further 3 washes, 50 µl rat amylin standards or controls 
were added to each well in duplicate, along with 50 µl DELFIA assay buffer 
(section 2.1.1.3). The plates were shaken slowly for 4 hours at room 
temperature. Europium-labelled F025-27 was diluted from stock with 
DELFIA assay buffer to a concentration of 162.5 ng/ ml and was filtered 
through a 0.2 µm membrane to remove any build up of antibody 
aggregates. The plates were washed 4 times and then 100 µI/well 
europium-labelled F027-27 was pipetted into each of the wells. After 
slowly shaking the plates for 2 hours at room temperature they were 
washed 8 times with wash buffer. Finally 100 µl DELFIA enhancement 
solution was added to each well and the plates were shaken slowly for 5 
minutes at room temperature. Fluorescence was measured using a time 
resolved fluorometer (1234 DELFIA Research Fluorometer, Pharmacia 
Wallac, U .K.) and counts were analysed using Multicalc. Once the 
optimum coating concentration of F024 was chosen it was used 
throughout. 
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The optimum concentration of europium-labelled F025-27 to use was 
determined as follows: 
Firstly wells were coated overnight at 4 °C with F024 at its optimum 
concentration in bicarbonate coating buffer. Then the rat amylin DELFIA 
was run as previously described except that europium-labelled F025-27 was 
used at 40.65, 81.3 and 162.5 ng/ ml. 
The optimum assay format was determined as follows: 
The 'standard' assay format was run as previously using the 
optimum concentrations of F024 and europium-labelled F025-27. In 
another format the europium-labelled F025-27 (50 µI/well) was added to 
the plates with the sample, at double the concentration found to be 
optimum. This simultaneous addition plate was slowly shaken for 6 
hours at room temperature before being washed 8 times with wash buffer. 
Then enhancement solution was added as previously and the time 
resolved fluorescence was measured. In a third format the assay was run 
as per the assay with the simultaneous addition of sample and europium-
labelled F025-27, except that the incubation of these with the coated 
microtitre plates was overnight at 4 °C. In the final format tested the 
sample was incubated with slow shaking for 4 hours at room temperature 
as in the standard assay. Then the plate was washed 4 times with wash 
buffer before ·the addition of 100 µI/well europium-labelled F025-27 at the 
optimised concentration for an overnight incubation at 4 °C. 
Once optimised precision .studies were performed using rat amylin 
controls and cross reactivity with human amylin was checked using 
human amylin controls. 
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3.2.4 Optimisation Of Other Amylin DELFIAs 
Other amylin DELFIAs using different combinations of F002, F024 
and F025-27 as capture and europium-labelled antibodies were optimised 
for the measurement of human amylin and related molecules in a similar 
manner to that for the rat amylin DELFIA. 
3.3 RESULTS 
3.3.1 Characteristics Of The Amylin IEMAs 
A typical rat amylin IEMA standard curve is shown in fig. 3.4. 
Given that the MDC of an assay is the lowest concentration whose signal 
can be differentiated from that of a zero standard, the rat amylin IEMA had 
a MDC of 2.8 pmol/1 (which gave a signal three standard deviations away 
from the signal given by the zero standard). The working range of the 
assay extended from the MDC up to 100 pmol/1 after which the standard 
curve became curvilinear. The inter-assay imprecision (coefficient of 
variation) was 5.1 % at 11.6 pmol/1, 5.9 % at 43.1 pmol/1 and 6.3 % at 
89.5 pmol/1 (all n=6). The intra-assay imprecision was 3.4 %, 2.1 % and 
2.9 %, respectively (all n=5). Spiking the extracts from the two rat pancreata 
gave recoveries of 104.8 % and 113 % at 701 and 1352 ng amylin/ g pancreas, 
respectively. -
Using the same antibody combination with human amylin 
standards and controls gave a MDC of 1.6 pmol/1. The inter-assay 
imprecision was 20.2 % at 6.2 pmol/1, 15.2 % at 34.2 pmol/1 and 7.3 % at 
78.7 pmol/1 (n=6~9). The intra-assay imprecision was 15.9 %, 8.7 % and 
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Figure 3.4 A typical rat amylin IEMA standard curve. A linear response was 
seen up to 100 pmol/1 after which the increase in response with increase in rat 
amylin concentration was curvilinear. A similar response was seen on at least 10 
separate occasions. 
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2.5 %, respectively (all n=5). Using F002 as the capture antibody along with 
alkaline phosphatase-labelled F025-27, gave a MDC of 2.3 pmol/1. The 
intra-assay imprecision was 11.5 % at 3.2 pmol/1, 20.2 % at 30.5 pmol/1 and 
0.6 % at 76.1 pmol/1 (all n=2). 
3.3.2 Europium Labelling Of Antibodies F025-27, F024 and F002 
Figure 3.5 shows the elution profile of the fractions from the gel 
filtration column after the europium-labelling of F025-27. Fractions 12-15 
were pooled giving a protein concentration of 358 µg/ml (71.6 % protein 
recovery) or 2.23 µmol IgG /1. The europium concentration of the pooled 
fractions was 24.11 µmol/1, giving a yield of approximately 11 molecules of 
europium per molecule of antibody. 
In the initial europium-labelling of F024 fractions 27-39 were pooled 
giving a protein concentration of 60.6 µg/ml (39.4 % protein recovery) or 
0.379 µmol IgG/1. The europium concentration of the pooled fractions was 
3.72 µmol/1, giving a yield of approximately 10 molecules of europium per 
molecule of antibody. When the labelling was repeated at 4 °C, fractions 
26-38 were pooled giving a protein concentration of 61.5 µg/ml (36.9 % 
protein recovery) or 0.384 µmol IgG/1. The europium concentration of the 
pooled fractions was 1.95 µmol/1, giving a yield of approximately 5 
molecules of ·europium per molecule of antibody. 
In the europium-labelling of F002 fractions 26-34 were pooled 
giving a protein concentration of 39.9 µg/ml (22.3 % protein recovery) or 
0.249 µmol IgG/1. The europium concentration of the pooled fractions was 
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Figure 3.5 The elution profile from Sephadex G-50 and Sepharose 6B 
column chromatography of europium labelled F025-27. 
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3.07 µmol/1, giving a yield of approximately 12 molecules of europium per 
molecule of antibody. 
3.3.3 Optimisation Of The Rat Amylin DELFIA 
Figure 3.6 shows the effect of using three different coating 
concentrations of antibody F024 on the standard curve of the rat amylin 
DELFIA. Using the antibody concentrations described (section 3.2.3) the 
standard curves were essentially linear at least up to the 400 pmol/1 rat 
amylin standard (the highest concentration tested). Given that in two site 
immunoassays the steepness of the slope of the standard curve is related 
to the assay sensitivity (Porstmann et al., 1985), the two higher 
concentrations of F024 used were judged to be superior to using a coating 
concentration of 5 µg / ml. Since there was very little difference in the slope 
between these two higher concentrations, a coating concentration of 
10 µg / ml (so as to save on antibody usage) was judged to be optimum. 
Figure 3.7 shows the effect of using three different concentrations of 
europium-labelled F025-27 on a microtitre plate with wells coated with 
F024 at 10 µg / ml. Using the antibody concentrations described (section 
3.2.3), again the standard curves using all three concentrations of signal 
antibody were almost linear (at least up to 400 pmol/1 rat amylin). In this 
case the slope of the standard curve increased with a rise in the 
concentration of signal antibody used. However the MDC of each of the 
assays was in the range 2-3 pmol/1. To save on the amount of labelled 
antibody that was used, the assay using a concentration of 40.65 ng / ml was 
considered acceptable. 
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Figure 3.6 Standard curves from three rat amylin DELFIAs using different 
coating concentrations of F024 with 162.5 ng/ml (100 µI/well) europium 
labelled F025-27. 
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Figure 3.8 shows the effect of using different assay formats on the 
lower end of the rat amylin standard curve. Again format 1 (the standard 
assay) gave a MDC of around 2 pmol/1. In format 2 (where the sample and 
signal antibody were added simultaneously to the plate) a similar MDC to 
that gained with format 1 was obtained. When this simultaneous addition 
was extended to an overnight incubation at 4 °C (format 3) a MDC of 
0.8 pmol/1 was found. In format 4, where the sample was incubated with 
the coated plate as in format 1 along with an overnight 4 °C incubation of 
europium-labelled F025-27 at 81.3 ng/ml, a MDC of 1.3 pmol/1 was 
achieved. 
This combination of F024 as capture antibody and europium-
labelled F025-27 as signal antibody, gave an inter-assay imprecision 
(coefficient of variation) of 14.7 % at 12.5 pmol/1, 9.1 % at 52.7 pmol/1 and 
10.1 % at 79.7 pmol/1 (n=2-5). The intra-assay imprecision was 8.1 %, 2.2 % 
and 5.7 %, respectively (all n=3). 
3.3.4 Optimisation Of Other Amylin DELFIAs 
The F024 and europium-labelled F025-27 combination was also used 
to set up a standard curve for human amylin measurement. Figure 3.9 
shows the comparison of standard curves for rat and human amylin 
DELFIAs. The assay was much less sensitive for human amylin ( e.g. 
giving a MDC of 23.2 pmol/1). Given this difference in standard curves 
and values gained from human quality control samples used in assays 
with rat amylin standard curves, . human amylin appeared to be measured 
by this antibody combination with only around 30 % of the efficiency of 
that with rat amylin. 
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Figure 3.8 The lower end of standard curves in rat amylin DELFIAs 
(using F024 as the capture antibody and europium-labelled F025-27 as 
the signal). Format 1 is the standard assay with a four hour incubation 
with sample and a two hour incubation with signal antibody. Format 2 
involves a six hour incubation with the sample and signal antibody 
added simultaneously. Format 3 also involves a simultaneous incubation 
of coated. microtitre plate with sample and signal antibody, but 
overnight at 4 °C. Format 4 involves a four hour incubation of the sample 
with the coated microtitre plate, followed by an overnight incubation at 
4 °C with signal antibody. 
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used as coating antibody at 10 µg/ml and europium-labelled F025-27 as 
signal antibody at 40.65 ng/ml. 
5000 
4000 
3000 
2000 
1000 
. . . . 
·····r r·r··r·· 
···············r ........... 1··········r··· ·r 
• r· ·················I· ····· · · J · : ··1:~~~:.2.~~~~~06; 
0 
0 20 40 60 80 100 
Human Amylin (pmol/1) 
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Rat and human DELFIAs using F025-27 as the capture antibody and 
europium-labelled F024 as the signal antibody, were extremely insensitive. 
Standards in the range 100-104 pmol/1 gave 7,908 relative fluorescence 
units for human amylin and 9,239 for rat amylin (compared with around 
38,000 for rat amylin using the alternative antibody configuration). F024 
was therefore relabelled at 4 °C to reduce any potential europium-labelling 
of antibody paratopes which might have reduced the antibody's ability to 
bind amylin. However assays using this newer europium-labelled F024 
were even less sensitive (having less europium molecules bound per 
molecule of signal antibody), the standards in the range 100-104 pmol/1 
giving 3,943 relative fluorescence units for human amylin and 4,780 for rat 
amylin. 
Figure 3.10 shows standard curves gained in human amylin 
DELFIAs using the F002/F025-27 combinations (alternating which is the 
capture and which the signal antibody). Again the assays were rather 
insensitive to human amylin, the 103.9 pmol/1 standard giving 4,364 
relative fluorescence units with europium-labelled F025-27 and 3811 units 
with europium-labelled F002. To increase the sensitivity of the latter assay, 
the europium-labelled F002 was then used at four times its previous 
concentration (320.8 ng/ml instead of 80.2 ng/ml). This gave 11,330 units 
for the 103.9 pmol/1 human amylin standard, although there was a rise in 
background fluorescence. The MDC using the stated conditions (with f025-
27 at 10 µg/ml as capture antibody) was 5.7 pmol/1. 
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3.4 DISCUSSION 
The amylin IEMA of Percy et al. (1996) has considerable advantages 
over conventional amylin radioimmunoassays. Firstly it does not require 
prior sample extraction which results in a much faster assay time and it 
requires a much smaller sample volume (which may be important when 
trying to measure amylin in rodent samples in physiological studies). Also 
inter-sample variations in extraction efficiencies are eliminated. The 
IEMA is clearly very sensitive and has good precision. The use of the 
microtitre plate format means that automation of this procedure should 
be straightforward, allowing large scale prospective studies of human 
samples to assess whether circulating amylin represents an independent 
risk factor for the development of diseases such as type 2 diabetes and 
hypertension (Sacks, 1996). 
The amylin IEMA is the second reported assay that can measure rat 
amylin without prior extraction. The radioimmunoassay of Pieber et al. 
(1994) had a reported MDC of 2.5 pmol/1 (equivalent to 250 amol/tube) and 
gave results around 20 % higher than when the samples went through a 
Sep-pak extraction procedure. In comparison the amylin IEMA described 
in this study was more sensitive (the 2.8 pmol/1 MDC found in this study 
being equivalent to 140 amol in a 50 µl sample) and quicker to complete 
(after an overnight antibody coating incubation the assay being completed 
within one day as opposed to seven days of incubations in the 
radioimmunoassay). Precision in the two assays was comparable. 
The rat amylin DELFIA, which used the same antibodies, had a 
comparable MDC to that of the IEMA when using similar incubation 
times. The sensitivity, however, was shown to be improved when the 
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incubation with europium-labelled F025-27 was extended to overnight (as 
little as 40 amol being detectable in a 50 µ1 sample). This slight 
improvement is potentially important in rat studies where many of the 
fasting concentrations of plasma amylin are close to assay MDCs (Pieber et 
al., 1994). The lengthening of total assay incubation times is unlikely to 
present a major problem for rodent studies, where sample numbers are 
naturally smaller than in human prospective studies. It remains to be seen 
whether increasing the incubation time with signal antibody in the IEMA 
would cause a similar improvement in assay sensitivity. The precision of 
the rat amylin DELFIA was acceptable but was slightly worse than with the 
IEMA. This could be expected as the DELFIA was performed on sample 
duplicates as opposed to triplicates in the IEMA. Apart from the 
improvement in assay sensitivity, the use of the DELFIA gave a wider 
dynamic range using the reported antibody concentrations. Also its use 
extends the range of detection instruments that can be used for the 
immunometric measurement of rat amylin. 
The two human amylin IEMAs of Percy et al. (1996) were both 
shown to have low MDCs. In contrast to the use of alkaline phosphatase as 
a label, none of the formats tested with europium labelled antibodies gave 
assays with particularly low human amylin MDCs. In fact with the 
standard assay format of F024 as capture antibody and labelled F025-27 as 
the signal antibody, human amylin was shown to give less than one third 
the signal generated by an equivalent concentration of rat amylin. This 
compares unfavourably with the equivalent IEMA, which has different 
but similar binding characteristics for rat and human amylin giving assays 
with broadly similar MDCs. Antibodies labelled with alkaline phosphatase 
tend to bind one (large) molecule of enzyme per molecule whereas 
europium chelates at several residues around antibody molecules 
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(depending upon the reaction conditions used during the labelling). 
Presumably in the case of the antibodies studied here, one or more 
europium molecules chelate at amino acid residues such that the stability 
of the sandwich formed between the F025-27 and the F024-bound human 
amylin was compromised. This compromise would not necessarily reduce 
the binding stability of F025-27 to F024-bound rat amylin, with its six 
amino acid residue difference from human amylin. 
The most sensitive of the human amylin DELFIAs tested employed 
F025-27 as the capture antibody and europium-labelled F002 as the signal 
antibody. This assay had a MDC which was a little over twice that of the 
equivalent IEMA. As this combination of antibodies binds both amylin 
and various glycosylated amylins (Rittenhouse et al., 1996), the MDC of 
this DELFIA would appear to be low enough to detect fasting circulating 
concentrations of total amylin like peptides in people with normal glucose 
tolerance (where at least 30 % of immunoreactive material appears to be 
glycosylated peptide) (Percy et al.,, 1996). Although not as sensitive as the 
equivalent human amylin IEMA, as with the rat amylin DELFIA the use 
of europium labelling extends the range of detection instruments that can 
be used for the immunometric measurement of human amylin-like 
peptides. Technology already exists that would be suitable for the partial 
automation of the DELFIA (Hebles-Duvison et al., 1995) making it suitable 
for the clinical evaluation of amylin like peptides (Sacks, 1996). 
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3.5 SUMMARY 
(1) A new immunoenzymometric assay was shown to be both sensitive 
and precise for human and rat amylin measurement. 
(2) Using the same antibody combination with a europium-labelled 
signal antibody, an even more sensitive delayed enhanced 
lanthanide fluoroimmunoassay for rat amylin was established. 
(3) Europium labelling of these antibodies appeared less suitable for the 
measurement of human amylin. However one assay was 
established for the measurement of human amylin like peptides 
which had a minimum detectable concentration lower than the 
fasting plasma concentration of these peptides reported in 
individuals with normal glucose tolerance. 
- 79 -
Chapter 4 
Programming Of Pancreatic Hormones By 
Maternal Protein Restriction1 
4.1 INTRODUCTION 
Since the studies that led to the development of the thrifty 
phenotype hypothesis (Hales & Barker, 1992; reviewed in section 1.3.2) 
interest in nutritional programming has escalated (Lucas, 1994). 
Programming itself has been defined as the process whereby a stimulus or 
insult when applied at a critical or sensitive period of development results 
in a long term or permanent effect on the structure or function of the 
organism (Lucas, 1991). Non-nutritional programming has long been 
recognised in nature, e.g. ducklings following the first moving object that 
they sense as 'mother.' Hormonal signals at critical periods can also 
programme future behavioural patterns. In the rat the development of 
internal male genitalia is programmed by testosterone secreted by fetal 
testes. If a female rat pup is androgenised at two days of age by a single dose 
of testosterone future sexual behaviour is permanently altered (Angelbeck 
& Du Brul, 1983). As protein, carbohydrate, fat, minerals and vitamins are 
all essential for growth and development it is perhaps not surprising that 
a nutritional insult at a sensitive period of cell division can permanently 
alter the structure or function of an organ or metabolic process. 
1 This work was performed using animals set up for a larger study by Dr. Mina Desai, the remainder of 
which is recorded in her PhD thesis: "Fetal Programming Of Hepatic Glucose Metabolism" (Cambridge 
University, 1995). 
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Nutritional programming 1n animals has largely been 
demonstrated in rats. It has been shown that poor nutrition during critical 
periods of brain development can have permanent effects on brain size 
and cell number as well as behaviour and memory in rats (Smart, 1986). 
By manipulating . litter size (and · therefore abundance of postnatal 
nutrition) plasma levels of cholesterol and insulin, and activities of 
hepatic phosphoenolpyruvate carboxykinase and adipose fatty acid 
synthetase and 3-hydroxy-3-methylglutaryl-CoA reductase can be 
permanently altered in rats (Hahn, 1984). Nutritional programming has 
also been demonstrated in primates. Lewis et al. (1986) fed newborn 
baboons milk formulas with varying energy contents until weaning; after 
this all the baboons were given the same diet. When studied at five years 
of age, especially in females, those animals who initially had been given 
the milk formula with the highest energy contents postnatally had greater 
fat depot masses than those fed the other formulas. 
Given that insulin deficiency contributes towards the pathogenesis 
of type 2 diabetes any nutritional insult that programmed pancreatic 
insulin production or secretion to be lower than normal could predispose 
an individual to the development of diabetes. Contributions to the 
development of glucose intolerance could also be made by other islet 
hormones if they were programmed. Thus higher glucagon production 
and secretion· could contribute towards glucose intolerance by stimulating 
hepatic gluconeogenesis and higher somatostatin production and 
secretion could contribute by constraining 'insulin release. In vitro 
(Younoszai & Dixit, 1980; Swenne et al., 1988), in viva (Weinkove et al., 
1976; Levine et al., 1983; Swenne et al., 1987; Picarel-Blarichot et al., 1995) 
and ex viva (Levine et al., 1983) studies have shown insulin release to be 
lowered in rats by feeding them diets that are deficient in either calories or 
- 81 -
more specifically protein-calories. Swenne et al. (1988) found that feeding 
rats a protein-calorie deficient diet between three and six weeks of age 
caused an impairment of insulin secretory response that was still evident 
at twelve weeks of age. This led them to conclude that protein-calorie 
malnutrition early in life persistently impairs insulin secretion and that 
this may result in an impaired ability to respond to diabetogenic and 
nutritional challenges and a predisposition for diabetes. 
The object of the work reported in this chapter was to investigate 
whether the pancreatic contents of five principal islet-cell specific 
hormones (amylin, insulin, glucagon, somatostatin and pancreatic 
polypeptide) could be programmed in the offspring by maternal protein 
restriction during pregnancy and lactation in the rat. In addition the 
question was addressed as to whether any new 'set-point' of pancreatic 
contents of one or more of these hormones was fixed or was flexible 
around that point. 
4.2 METH0DS 
4.2.1 Cafeteria Study Design 
Virgin female Wistar rats (weighing 240-260 g) were mated and day 
one of pregnancy was taken as the day that a vaginal plug was expelled. 
Nine rats were then fed a 20 % protein ('control') diet, whilst five of the 
rats were given a 8 % protein ('low protein') diet (section 2.1.2). The rats 
were allowed to feed ad libitum throughout and were housed singly at 
22 + 2 °C with a 12:12h light-dark cycle. Pups were born at around day 22 of 
pregnancy and two days after birth their litter size was standardised to 8 
pups (4 males, 4 females). The mothers continued feeding on the control 
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and low protein diets throughout the suckling period, until the pups were 
weaned onto the LAD1 diet at 21 days of age (section 2.1.2). The offspring 
rats remained on this diet for 3 weeks before half of them were put onto 
PRD diet (a pelleted laboratory chow) (section 2.1.2), and the remaining 
half were given a highly palatable cafeteria-style diet ('cafeteria' diet). This 
diet consisted of a mix of 330 g/kg PRD diet ground to a fine powder, 
330 g/kg Nestles full fat condensed milk, 70 g/kg sugar and 270 g/kg water 
(Wilding et al., 1992). This diet provided 13 % of its calories as fat, 69 % as 
carbohydrate and 18 % as protein. In contrast the PRD diet provided 9 % of 
its calories as fat, 66 % as carbohydrate and 25 % as protein. The rats 
remained on these diets for 6 weeks until, at a total age of 12 weeks, they 
were starved for 48 hours and then killed. Their body weights were 
recorded and their pancreata were removed and weighed, ready for 
hormone extraction. 
4.2.2 Pancreatic Hormone Extraction And Measurement 
As soon after death as possible the pancreata were put into 10 ml of 
0.18 M hydrochloric acid in 75 % (v /v) ethanol (Eriksson et al., 1980) and 
placed on ice. The pancreata were then minced with scissors and sonicated. 
After this they were incubated overnight at 4 °C. The following morning 
the tubes were centrifuged at 800 g (KR422 centrifuge, Jouan Ltd., Tring, 
Herts., U.K.) for 15 minutes and the supernatants separated and stored at 
-20 °C prior to analyses. Amylin was measured in the extracts by an 
immunoenzymometric assay (section 3.2.1) . Radio-immunoassay kits 
were used for the measurement of insulin (section 2.2.1), glucagon (section 
2.2.2), somatostatin (section 2.2.3) and pancreatic polypeptide (section 2.2.4). 
In each case the pancreatic extracts were diluted in 5 % (w /v) BSA in PBS 
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(section 2.1.1.1) so that the hormone concentration present in the diluted 
sample was within the limits of the assay standard curve. 
4.2.3 Statistical Analyses 
Pancreatic hormone contents, body weights and pancreatic weights 
in the different groups were compared using three-way ANOV A. The sex 
of the animals, the maternal diet and the adult diet were used as 
independent variables. Pancreatic hormone contents data were log-
transformed prior to analysis to reduce the skewed nature of their 
distributions. 
4.3 RESULTS 
4.3.1 Pancreas And Body Weights 
In male rats the pancreas weights (shown as mean (SD)) were: 
control-PRD 0.966 (0.181) g, control-cafeteria 0.967 (0.140) g, low protein-
PRD 1.083 (0.202) g and low protein-cafeteria 0.986 (0.212) g. In female rats 
the pancreas weights were as follows: control-PRD 0.809 (0.147) g, control-
cafeteria 0.754 (0.150) g, low protein-PRD 0.788 (0.094) g and low protein-
cafeteria 0.756 (0.076) g. The male rats had heavier pancreata than the 
females (F=45.-776, p<0.0001). Neither the use of the maternal low protein 
diet (F=0.785, p =0.378) nor feeding the rats the cafeteria diet during adult 
life (F=l.912, p =0.170) was associated with detectable changes in pancreas 
weights. There were no significant statistical interactions between any of 
the independent variables (F=0.005-1.371, p=0.245-0.943). 
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In male rats the body weights (shown as mean (SD)) were: control-
PRD 440.4 (25.4) g, control-cafeteria 532.7 (36.9) g, low protein-PRD 398.2 
(46.7) g and low protein-cafeteria 475.0 (50.3) g. In female rats the body 
weights were as follows: control-PRD 277.9 (23.9) g, control-cafeteria 345.0 
(41.7) g, low protein-PRD 237.8 (12:2) g and low protein-cafeteria 287.4 
(31.5) g. The male rats were significantly heavier at post-mortem than the 
female rats (F=441.163, p<0.0001). Those animals whose mothers had been 
given the low protein diet were significantly lighter than those whose 
mothers had been given the control diet (F=35.366, p<0.0001). Animals 
given the cafeteria diet were significantly heavier than those given the 
PRD pellets (F=73.928, p<0.0001). There were no significant statistical 
interactions between any of the independent variables (F=0.003-2.473, 
p=0.120-0. 953). 
4.3.2 Pancreatic Amylin Contents 
The pancreatic amylin contents in the various groups is shown in 
fig. 4.1 (a). The male rats had significantly greater pancreatic amylin 
contents than female rats (F=21.227, p<0.0001). Those animals whose 
mothers had been given the low protein diet had significantly reduced 
pancreatic amylin contents in comparison to animals whose mothers had 
been given the control diet (F=5.665, p=0.019). Feeding the animals the 
cafeteria diet was associated with significantly increased pancreatic amylin 
contents (F=16.890, p<0.0001). There were no significant statistical 
interactions between any of the independent 'variables (F=0.015-1.683, 
p=0.198-0.903). 
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Figure 4.1 Pancreatic amylin contents of 12 week old rats expressed per pancreas 
and relative to pancreas and body weights. Results shown are geometric means 
(95 % CI) of the number of rats indicated. PRD = PRD pellets, Caf = cafeteria diet. 
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The pancreatic amylin contents expressed per unit pancreas weight 
in the various groups is shown in fig. 4.1 (b). Male rats had significantly 
greater pancreatic amylin contents per unit pancreas weight than female 
rats (F=4.789, p =0.031). Those animals whose mothers had been given the 
low protein diet had significantly reduced amylin contents per unit 
pancreas weight in comparison to animals whose mothers had been given 
the control diet (F=7.022, p=0.010). Feeding the animals the cafeteria diet 
was associated with significantly increased amylin contents per unit 
pancreas weight (F=21.479, p<0.0001). There were no significant statistical 
interactions between any of the independent variables (F=0.038- 1.519, 
p=0.0.221-0.845). 
The pancreatic amylin contents expressed per unit body weight in 
the various groups is shown in fig. 4.1 (c). Neither the sex of the animal 
(F=0.012, p =0.914) nor the use of the maternal low protein diet (F=0.337, 
p=0.563) was associated with changes in pancreatic amylin content per unit 
body weight. Feeding the rats the cafeteria diet was associated with 
significantly increased pancreatic amylin contents per unit body weight 
(F=6.305, p =0.014). There were no significant statistical interactions 
between any of the independent variables (F=0.002-2.127, p=0.148-0.968). 
4.3.3 Pancreatic Insulin Contents 
The pancreatic insulin contents of the various groups is shown in 
fig. 4.2 (a). The male rats had higher pancreatic insulin contents than those 
of female rats (F=7.605, p=0.007). Feeding the animals the cafeteria diet was 
not associated with a significant change in pancreatic insulin contents 
(F=0.145, p=0.704). Also maternal protein restriction during pregnancy and 
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Figure 4.2 Pancreatic insulin contents of 12 week old rats expressed per pancreas 
and relative fo pancreas and body weights. Results shown are geometric means 
(95 % Cl) of the number of rats indicated. PRD = PRD pellets, Caf = cafeteria diet. 
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lactation did not appear to significantly alter pancreatic insulin contents 
(F=l.874, p =0.175). There were no significant statistical interactions 
between any of the independent variables (F=0.006-0.287, p=0.594- 0.938). 
The pancreatic insulin contents expressed per unit pancreas weight 
in the various groups is shown in fig . 4.2 (b) . None of the independent 
variables were associated with a significant change in insulin contents per 
unit pancreas weight: sex of the animal (F=2.350, p=0.129), maternal diet 
(F=l.584, p =0.212), adult diet (F=0.014, p=0.905), interactions (F=0.002- 0.337, 
p =0.563-0.965). 
The pancreatic insulin contents expressed per unit body weight in 
the various groups is shown in fig. 4.2 (c). Neither the sex of the animal 
(F=0.125, p=0.724) nor the adult diet used (F=l.708, p =0.195) was associated 
with changes in pancreatic insulin contents per unit body weight. Those 
rats whose mothers had been fed the low protein diet had significant 
increases in pancreatic insulin contents per unit body weight (F=S.534, 
p =0.021). There were no significant statistical interactions between any of 
the independent variables (F=0.017- 0.242, p =0.624-0.907). 
4.3.4 Pancreatic Glucagon Contents 
The pancreatic glucagon contents of the various groups is shown in 
fig. 4.3 (a) . Both the sex of the animals (males having more) (F=30.534, 
p<0.0001) and the maternal diet used (offspring of dams given the low 
protein diet having less) (F=8.243, p=0.005) were associated with significant 
differences in pancreatic glucagon contents. Differences, · however, w ere 
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Figure 4.3 Pancreatic glucagon contents of 12 week old rats expressed per pancreas 
and relative to pancreas and body weights. Results shown are geometric means 
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not associated with the adult diet used (F=l.132, p=0.290). Neither were 
there significant statistical interactions between any of the independent 
variables (F=0.029-1.070, p=0.304-0.866). 
The pancreatic glucagon contents expressed per unit pancreas 
weight in the various groups is shown in fig. 4.3 (b ). Neither the sex of the 
animal (F=2.543, p=0.114) nor the adult diet used (F=0.075, p=0.784) were 
associated with significant differences in glucagon contents per unit 
pancreas weight. Those animals whose mothers had been fed the low 
protein diet had significantly lower glucagon contents per unit pancreas 
weight (F=9.268, p=0.003). There were no significant statistical interactions 
between any of the independent variables (F=0.003-0.689, p=0.409-0.956). 
The pancreatic glucagon contents expressed per unit body weight in 
the various groups is shown in fig. 4.3 (c). Neither the sex of the animal 
(F=2.453, p=0.121) nor the maternal diet used (F=0.0001, p=0.990) were 
significantly associated with changes in pancreatic glucagon contents per 
unit body weight. Those animals given the cafeteria diet had significantly 
lower pancreatic glucagon contents per unit body weight than those 
animals given the PRD diet (F=l4.604, p<0.001). There were no significant 
statistical interactions between any of the independent variables 
(F=0.039-0.918, p=0.341-0.844). 
4.3.5 Pancreatic Somatostatin Contents 
The pancreatic somatostahn contents of the various groups is 
shown in fig. 4.4 (a). Neither the sex of the animals (F=0.015, p=0.902), nor 
the adult diet used (F=l.803, p=0.183) was associated with significant 
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Figure 4.4 Pancreatic somatostatin contents of 12 week old rats expressed per pancreas 
and relative to pancreas and body weights. Results shown are geometric means (95 % 
CI) of the number of rats indicated. PRD = PRD pellets, Caf = cafeteria diet. 
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changes in pancreatic somatostatin content. The use of the maternal low 
protein diet tended to be associated with lower pancreatic somatostatin 
contents in the offspring but statistical significance was not reached 
(F=3.313, p =0.072). There were no significant statistical interactions 
between any of the independent variables (F=0.004- 1.183, p=0.280-0.948). 
The pancreatic somatostatin contents expressed per unit pancreas 
weight in the various groups is shown in fig. 4.4 (b ). Somatostatin contents 
per unit pancreas weight were significantly higher in females than in 
males (F=l2.355, p<0.001) and significantly lower in rats whose mothers 
had been given the low protein diet (F=4.536, p =0.036). There was no 
significant effect associated with which adult diet was used (F=0.298, 
p =0.587) and there were no significant statistical interactions between any 
of the independent variables (F=0.060-2.148, p=0.146-0.807). 
The pancreatic somatostatin contents expressed per unit body 
weight in the various groups is shown in fig. 4.4 (c). Both the sex of the 
animal (females having more) (F=56.016, p<0.0001) and the adult diet used 
(cafeteria-fed animals having less) (F=l6.735, p<0.0001) had significant 
effects associated with the pancreatic somatostatin contents per unit body 
weight. This significant association was not seen with the maternal diet 
used (F=2.412, p=0.124). Neither were there any significant interactions 
between any of the independent variables (F=0.498-2.757, p=0.100-0.482). 
4.3.6 Pancreatic Polypeptide Contents 
The pancreatic contents of pancreatic polypeptide in the various 
groups is shown in fig. 4.5 (a). Neither the maternal diet used (F=0.166, 
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p =0.684), nor the adult diet used (F=l.198, p=0.277) was associated with a 
significant variation in pancreatic polypeptide content. Male rats tended to 
have more pancreatic polypeptide than female rats but statistical 
significance was not reached (F=3.319, p=0.072). There were no significant 
statistical interactions between any of the independent variables 
(F=0.044-1.406, p=0.239-0.834). 
The pancreatic polypeptide contents expressed per unit pancreas 
weight in the various groups is shown in fig. 4.5 (b ). Neither variations in 
the maternal diet (F=0.069, p =0.794) nor the adult diet (F=0.011, p =0.917) 
were associated with significant changes in pancreatic polypeptide content 
per unit pancreas weight. There were no significant statistical interactions 
between any of the independent variables (F=0.0002-2.569, p =0.113- 0.989). 
The pancreatic polypeptide contents expressed per unit body weight 
in the various groups is shown in fig. 4.5 (c). Significant increases in 
pancreatic polypeptide content per unit body weight were associated with: 
(a) the rats being female (F=55.332, p<0.0001), (b) the rats' mothers being 
given the low protein diet during pregnancy and lactation (F=16.473, 
p =0.0001) and (c) the rats being given the PRD diet in adult life (F=23.547, 
p<0.0001). There were no significant statistical interactions between any of 
the independent variables (F=0.044- 0.942, p=0.334-0.835). 
4.4 DISCUSSION 
This study was performed to investigate whether maternal protein 
restriction in the rat could programme the pancreatic contents of five 
principal islet cell hormones in the offspring. The regime followed causes 
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growth retardation in the rat offspring (Desai et al., 1996) and a reduction 
in body weight which was still evident in twelve week old rats in the 
present study. The gross pancreas as a whole appeared to be relatively 
protected from the effects of maternal protein restriction as those 
pancreata from rats whose mothers were fed the low protein diet were not 
detectably lighter than those from offspring of control mothers. However 
although the pancreata appeared to be of normal size, there was clear 
programming of their metabolic activity. This was apparent from the 
differences in their hormonal contents. Both pancreatic amylin and 
glucagon contents were programmed to be significantly reduced in the 
adult offspring of rats fed the low protein diet during pregnancy and 
lactation. The reduction in contents of both of these hormones appeared to 
be proportional to the reduction in body weight. Somatostatin contents of 
the pancreata of low protein offspring also showed a tendency to be lower 
than those of controls, although significance was only reached when the 
results were expressed relative to a standardised pancreas weight. Again 
this reduction appeared to be proportional to the reduction in body weight. 
In the rat islet amylin appears to be able to be synthesised in both is-cells 
and in a subset of somatostatin-producing 8-cells (De Vroede et al., 1992; 
Mulder et al., 1993). Given that the offspring of dams given the low 
protein diet had slightly lower pancreatic somatostatin contents than that 
of controls part of the reduction in pancreatic amylin contents of the low 
protein offspring (that was not paralleled by a reduction in pancreatic 
insulin contents) may have been caused by a reduction in amylin 
synthesised in 8-cells. 
Neither the pancreatic insulin nor the pancreatic polypeptide 
contents appeared to be significantly altered by maternal protein 
restriction. This applied whether the results were stratified to a 
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standardised pancreas size or not. The reduction in body weights of those 
animals whose mothers had been protein restricted meant that when 
stratified for body weight both pancreatic insulin and pancreatic 
polypeptide contents were raised in the maternal low protein offspring. 
No previous studies have investigated the effects of maternal protein 
restriction on the pancreatic hormone contents of the offspring. However 
several studies have investigated pancreatic hormone contents in rats 
weaned onto low protein diets. Harel and Tannenbaum (1995) found no 
change in pancreatic insulin or somatostatin contents (expressed per unit 
pancreas weight) in twelve week old rats after feeding them a low protein 
diet between three and six weeks of age. Younoszai and Dixit (1980) found 
an increased somatostatin content (expressed per unit pancreas weight) in 
ten to twelve week old rats who had been fed a low protein diet since 
weaning. The pancreatic insulin contents were unchanged (when 
expressed per unit pancreas weight) or raised (when expressed relative to 
the reduced body weights). Weinkove et al. (1976) found an increased 
pancreatic insulin content (when expressed relative to reduced body 
weights) in six week old rats fed a low protein diet since weaning. In the 
present study most of the above findings were mirrored by restricting the 
protein intake of just the mother during pregnancy and lactation alone. 
Maternal low protein diets during pregnancy are known to reduce 
delivery of certain amino acids to the developing fetus (Malandro et al., 
1996), thus reducing nutrient delivery in a manner similar to that of 
feeding a low protein diet later in life. 
The increase m body weight caused by cafeteria feeding was 
associated with a significant increase in pancreatic amylin content 
irrespective of the maternal diet used. Thus although amylin was 
programmed to have lower contents in the offspring of protein restricted 
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mothers there was flexibility around that lowered set-point. This meant 
that although maternal low protein caused a lowering of pancreatic 
amylin contents those offspring who were subsequently fed the cafeteria 
diet had similar values to those from offspring of control dams who were 
subsequently fed . the PRD diet. In the present study although the 
pancreatic contents of the other hormones that were programmed did not 
exhibit flexibility around their particular set-points this may have been 
procedure related . Obesity has an established effect on amylin 
concentrations as it is associated with hyperamylinaemia in humans 
(Enoki et al., 1992) and with increased islet amylin contents in rats 
(Tokuyama et al., 1992). Other islet hormones that were programmed by 
maternal protein restriction may have exhibited flexibility with the use of 
alternative diets (e.g. by the use of high protein diets (Morley et al., 1982)). 
Maternal low protein has previously been shown to cause a slight 
improvement in glucose tolerance in offspring studied at the same age as 
those animals used in the present study (Hales et al., 1996b ). Plasma 
hormone concentrations of the rats used in the present study were not 
measured but the pancreatic hormone concentrations found could be 
considered consistent with that improvement in glucose tolerance, i.e. a 
lowering of amylin and glucagon with no change or a slight rise in 
insulin. Amylin and insulin tend to be secreted in a fixed ratio. However 
in various rodent models of diabetes (Bretherton-Watt et al., 1989; Gedulin 
et al., 1991; Inoue et al., 1992; Hiramatsu et al., 1994; Mulder et al., 1995a, 
1995b & 1996) amylin to insulin ratios have been shown to increase in 
terms of their pancreatic contents, the amount of protein secreted or the 
mRNA levels expressed. Thus in a rodent model where glucose tolerance 
appears slightly improved a lowered ratio of amylin to insulin appears 
entirely feasible . The use of the low protein diet in the present study 
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during pregnancy and lactation in the rat would not appear to be sufficient 
to reduce pancreatic insulin contents in the offspring and therefore 
predispose them to insulin deficiency and the development of diabetes. 
However Weinkove et al. (1976) found that rats fed a 4 % protein diet 
from weaning until six weeks of age had increased pancreatic insulin 
contents (when expressed per unit body weight, i.e. similar results to those 
found in the present study) but reduced fasting plasma insulins. Their rats 
had a slower insulin-mediated glucose clearance rate. Thus if the rats had 
been allowed to carry on feeding on their same dietary regimes diabetes or 
impaired glucose tolerance may still have developed at an older age 
without an obvious defect in insulin production (Hales et al., 1996b). 
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4.5 SUMMARY 
(1) Pregnant rats were given either a 20 % ('control') or 8 % ('low 
protein') diet throughout pregnancy and lactation. Litter sizes were 
standardised to eight and the pups weaned onto laboratory chow at 
21 days of age. The young rats remained on this diet for a further 
three weeks and were then swapped onto either an alternative 
chow or a highly palatable cafeteria-style diet. They stayed on these 
diets for six weeks before, at a total of twelve weeks of age, they were 
killed and their pancreata removed. Amylin, insulin, glucagon, 
somatostatin and pancreatic polypeptide concentrations were 
measured in pancreatic extracts. 
(2) Maternal low protein was associated with programming of 
pancreatic amylin and glucagon contents to be lower than thrneof 
controls. There was also a tendency for this programming in terms 
of somatostatin contents. Pancreatic insulin and pancreatic 
polypeptide contents did not appear to be programmed by this 
method. 
(3) Cafeteria feeding was associated with an increase in pancreatic 
amylin contents irrespective of the maternal diet used. Thus 
offspring of low protein dams who were cafeteria fed had pancreatic 
amylin contents that were similar to those from offspring of control 
dams who were subsequently chow fed. 
(4) Maternal protein restriction in rats is therefore capable of being used 
to programme selective pancreatic hormone contents in rats. This 
programming may still allow some flexibility in actual content. 
-100 -
Chapter 5 
Characterisation Of Human Amylin 
Transgenic Rats 
5.1 INTRODUCTION 
It appears that pancreatic amylin sequence and concentration are 
important factors in pancreatic amyloid deposition (section 1.2.1.3). 
However the exact requirements for in viva amyloid fibril formation 
remain elusive. In addition it is not known whether the high degree of 
association between type 2 diabetes and the presence of pancreatic amyloid 
reflects causality or whether they are just linked by a third factor such as 
insulin resistance. Rodent models of type 2 diabetes are known to have 
high levels of pancreatic amylin mRNA and circulating amylin 
concentrations (Huang et al., 1992), as well as having high amylin 
secretion rates (Gedulin et al., 1991). However their amylin molecules are 
not amyloidogenic (see section 1.2.1.3) and therefore they are not suitable 
models to be used for the study of pancreatic amyloid formation. With the 
advent of suitable technology allowing the production of transgenic 
animals (e.g. for use in diabetes research (reviewed by Moller, 1994)), this 
problem has been addressed by inserting genes coding amyloidogenic 
amylin molecules (such as the human amylin gene) into the genome of 
rodents. These transgenes are inserted fused to insulin promoter genes to 
target the expression of the amylin to pancreatic is-cells. In this way the 
formation of several mouse lines transgenic for human amylin have been 
reported (Fox et al., 1993; Hoppener et al., 1993; Verchere et al., 1994; Yagui 
et al. , 1995; Couce et al., 1996a). 
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In comparison to making transgenic mice, making transgenic rats 
requires more sophisticated equipment and technical expertise (Phang, 
1993) and is more expensive (Moller, 1994). Rats transgenic for human 
amylin have not been reported so far. However such rats could have 
considerable advantages over similar mouse lines: (a) a lengthened 
average life span which may favour amyloid deposition if it is age 
dependent (Yagui et al., 1995), (b) the ability to take blood samples which 
are sufficiently large to measure individual circulating amylin 
concentrations (i.e. without the need to pool samples from different 
animals) without killing the animals, and (c) easier general handling of 
larger animals to assess factors that may be important in the pathogenesis 
of diabetes and the insulin resistance syndrome (e.g. being easier to 
measure blood pressures, glucose tolerances and indices of organ growth 
and development). In this chapter the phenotypic characterisations of two 
rat lines transgenic for human amylin are reported. 
The transgenic rats were produced in the laboratory of Professor Y. 
Tan (Neuropeptide laboratory, Institute of Molecular and Cell Biology, 
National University of Singapore, Singapore) according to the method of 
Murphy and Carter (1993). Briefly, several female Sprague Dawley rats 
were injected intraperitoneally with 100 µl of 50 IU /ml human follicle 
stimulating hormone in order to initiate superovulation. Two days later 
the same rats were injected with 100 µl of 50 IU /ml human chorionic 
gonadotrophin and then mated with stud Sprague Dawley male rats. At 
the same time some mature female rats were mated with vasectomised 
males to initiate pseudopregnancy. The following morning fertilised one 
cell eggs were collected from the superovulated females into M2 tissue 
culture media (Murphy and Carter, 1993). These eggs were then rendered 
transgenic by the microinjection of 2 pl of a 3 m g / m l cloned DNA 
-102 -
fragment solution (fig. 5.1; containing the rat insulin promoter 1, human 
amylin genes and a polyadenosine tail; constructed by Amylin 
Pharmaceuticals Ltd., San Diego, U.S.A.) . Following this, those fertilised 
cells that survived the microinjection procedure were implanted into the 
pseudopregnant Sprague Dawley rats, which then acted as surrogate 
were 
mothers. Pups were born around day 22 and 1 cm tail biopsies,_taken from 
these when they were 21 days of age for DNA analysis. 
Genomic DNA was extracted from the tail biopsies by proteinase K 
digestion and phenol extraction (Murphy, 1993). Those pups which were 
transgenic were identified by Southern blot analysis (Southern, 1975) using 
a labelled DNA probe consisting of partial sequences from introns of the 
rat insulin promoter 1 and human amylin genes. Using this technique, 
two hemizygous transgenic lines were identified and labelled as having 
'high' and 'low' copy numbers of the human amylin gene construct. These 
original male offspring were mated with female wild type Sprague Dawley 
rats (as a check of fertility) . Offspring from these matings were screened for 
the presence of the transgene, again using Southern blot analysis, and 
those male rats shown to be transgenic were used to set up a breeding 
colony in Singapore. 
Reverse transcriptase-polymerase chain reaction assays were 
performed in -Singapore on RNA extracted from organs removed from 
rats belonging to the two transgenic lines. Both the 'high' and 'low' copy 
number rat lines were shown to express human amylin mRNA in their 
pancreata (whilst the 'high' copy number rats were also shown to express it 
ectopically at low levels 'in the brain and liver) (Murphy, personal 
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Abbreviation: pUCRipAmy 
Description: rat insulin promoter 1 driving transcription of the 
human amylin gene (exons 1,2,3) 
Size: 12 kb approx. 
Rat insulin Human amylin gene 
promoter 1 
(0.85 kb) (8.5 kb) 
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Figure 5.1 Clone chart for the DNA fragment that was inserted into 
Sprague Dawley rat genomic DNA by microinjection to make human 
amylin transgenic rats. 
communication of unpublished results). The work reported in this 
chapter addresses whether the transgenic rats described above were both 
genotypically and phenotypically transgenic for human amylin and 
whether this leads to 'spontaneous' loss of glucose tolerance in aged rats 
with associated pancreatic amyloid deposition. 
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5.2METH0DS 
5.2.1 Production Of A Colony Of Transgenic Rats 
One of the 'high' copy number males and two of the 'low' copy 
number males were exported to Britain and then labelled as being 
'founders'. These three transgenic rats were mated with virgin, female, 
wild type Sprague Dawley rats (weighing 250 g) to start a colony of rats 
expressing the human amylin transgene. Twenty-one days after birth 
5 mm tail biopsies were taken from the offspring for genomic DNA 
extraction to screen for the presence of the transgene using the polymerase 
chain reaction (PCR) (Saiki et al., 1985). The breeding of the hemizygous 
transgenic males with female Sprague Dawley rats allowed the 
establishment of transgenic colonies for use in further studies. 
5.2.2 Extraction Of Genomic DNA From Rat Tail Biopsies 
Genomic DNA was extracted from the tail tissue biopsies using spin 
columns (QIAamp tissue kits, Qiagen Ltd., Dorking, Surrey, U.K.), based 
on the high affinity that DNA has for glass in the presence of chaotropic 
salts (Vogelstein and Gillespie, 1979). The tail biopsy was incubated for 
3 hours (with occasional vortexing) at 55 °C in 200 µl tissue lysis buffer, 
which contained sodium dodecyl sulphate and 1.8 mg/ml proteinase K. At 
the end of the-incubation period the tail digests were spun at 10,000 g for 
5 mins. and the digested material separated from the undigested hairs. 
Following this, 200 µl buffer AL (containing glyc'erol and salts) and 210 µl 
100 % (v /v) ethanol were added to the tail digest supernatants, and the 
whole mixture applied to the spin column. The column was then spun at 
10,000 g for 3 mins. and the filtrate discarded. Wash buffer (containing 
ethanol and salts) (500 µl) was then added to each of the columns and they 
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were spun at 10,000 g for a further minute. This wash step was then 
repeated. The DNA was eluted from the columns twice with 200 µI 
preheated distilled water by incubating the columns with the water for 5 
mins. at 70 °C. This was followed by a further centrifugation step at 10,000 g 
for 3 mins. Finally the DNA was precipitated by incubating overnight at 
-20 °C with 40 µI 3M sodium acetate (pH 5.2) and 1 ml of 100 % (v / v) 
ethanol. The following day the DNA was pelleted by centrifugation, 
washed with 70 % (v / v) ethanol and then reconstituted in 50 µI distilled 
water. This DNA solution was used directly in the PCR reactions. 
5.2.3 Screening For The Presence Of The Transgene By PCR 
Sequences of the primers used for the amplification of a sequence of 
DNA across an intron of the human amylin gene are shown in fig. 5.2. 
The PCR mixture for the amplification process consisted of a final volume 
of 50 µI and contained Tris-HCI buffer (labelled as 'lOx PCR buffer') (pH 8.4, 
10 mM), KCI (50 mM), MgCh (1.2 mM), each deoxynucleoside triphosphate 
(0.2 mM), primers A127 and A128 (0.5 µM each), Thermus acquaticus 
DNA polymerase (1.25 units) and genomic DNA isolated from the rat tails 
(around 0.5 µg). The mixture in each of the tubes was overlaid with 30 µI 
mineral oil. Three cycles of amplification were then performed at 97 °C 
(1 min., denaturing temperature), 60 °C (30 sees., annealing temperature) 
and 72 °C (1 min., elongation temperature). This was followed by 7 cycles 
of 94 °C (1 min.), 60 °C (30 sees.) and 72 °C (1 min.). Then 25 cycles of 94 °C 
(30 sees.), 60 °C (30 sees.) and 72 °C (1 min.) were performed. Finally the 
tubes were heated to 72 °C for 7 mins. After amplification 10 µI of the 
amplified reaction mixture was run (along with 4 µI 5 x agarose gel 
loading buffer (pH 8.0) (section 2.1.1.7) and 6µ1 1 x TBE (section 2.1.1.6)) on 
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Primer A127 (Human exon 1; upstream coding strand; positions 
613-642) 
5'-CTATCAGAAGCATTTGCTGATATTGCTGAC-3' 
Primer Al28 (Human exon 2; downstream non-coding strand; 
positions 1004-1033) 
5'-GAGAAATACTTGCAGCTTCAGGATGCCCAT-3' 
Primer A311 (Rat exon 1; upstream coding strand; positions -36 to 
-16) 
5'-ATTGCTGCCACTGCCCACTGA-3' 
Primer A310 (Rat exon 2; downstream non-coding strand; 
positions 4-24) 
5'-TGGCAGCCTGGAGATGCACCT-3' 
Figure 5.2 The DNA sequences of the oligonucleotide primers used in the 
amplification of sequences of genomic DNA corresponding to partial sequences 
of introns in the human (primers A127 and A128) and rat (primers A311 and 
A310) amylin genes. (A=adenine, G=guanine, T=thymine, C=cytosine). 
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a 1.6 % (w /v) agarose gel in 1 x TBE, precast with either ethidium bromide 
or SYBR green. Amplification across the intron of the human amylin gene 
produced a product of 421 bp (fig. 5.3); thus rats whose genomic DNA 
produced a PCR product of this size were considered transgenic. 
Of those genomic DNA samples that did not show amplification of 
the correct size band using the above procedure, a further PCR reaction 
was attempted using the same conditions as before with primers A311 and 
A310 (the sequences of which are shown in fig. 5.2). Amplification using 
these primers produced a sequence of 349 bp across an intron of the rat 
amylin gene (fig. 5.3). Rats whose DNA had not produced the correct size 
band with primers A127 and A128 but did with primers A311 and A310 
were considered wild type. 
5.2.4 Measurement Of Human Amylin-Like Peptides In Transgenic Rat 
Plasma And Organ Extracts 
The three founder transgenic rats were kept as studs until they were 
10 months old (weighing 825-925 g). Then they were anaesthetised with 
4 % (v /v) halothane in oxygen until the foot reflex was absent. Blood 
(10 ml) was withdrawn by cardiac puncture and placed into lithium 
heparin coated tubes containing aprotinin (500 KIU /ml). The blood was 
centrifuged at 2",500 g for 15 mins. and separated. The plasma was frozen at 
-20 °C until analysis. Organs from the rats were removed shortly after 
death and were frozen at -20 °C in 2 ml phosphate buffered saline (PBS) 
(pH 7.5) (section 2.1.1.1) containing pepstatin A (10 µM), phenyl-
methylsulphonyl fluoride (100 µM) and transepoxy-succinyl-L-
leucylamido-(4-guanidino)-butane (20 µM) . 
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Figure 5.3 Agarose gels of electrophoretically separated PCR products from 
genomic rat DNA samples (a) using primers which span an intron of the human 
amylin gene and, (b) using primers which span an intron of the rat amylin gene. 
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Human amylin-like peptides and rat amylin were measured in the 
plasma from the transgenic rats using the appropriate DELFIA (sections 
3.3.3 and 3.3.4, the rat amylin assay cross-reacting 30 % with human 
amylin). The organs which had been stored in PBS were minced with 
scissors in 3 ml 0.18 M hydrochloric acid in 75 % (v /v) ethanol (Eriksson et 
al., 1980). Then they were sonicated for 20 sees. before being incubated at 
4 °C overnight, to allow extraction. The following morning the tubes were 
centrifuged at 2,500 g for 15 mins. and the pellets discarded. Human 
amylin-like peptides were then measured in the supernatants using the 
appropriate DELFIA (section 3.3.4). The protein contents of these 
supernatants were measured by adding 200 µ11 % (w /v) bicinchoninic acid 
solution (pH 11.25) containing 0.08 % (w /v) copper (II) sulphate, 2 % (w /v) 
sodium carbonate, 0.16 % (w /v) sodium tartrate, 0.4 % (w /v) sodium 
hydroxide and 0.95 % (w / v) sodium hydrogencarbonate, to 50 µl of the 
organ extracts (Smith et al., 1985). The optical density at 540 nm was then 
measured and the protein content of the extracts calculated with reference 
to a curve made using BSA standards. 
5.2.5 Intraperitoneal Glucose Tolerance Tests Of Aged Transgenic Rats 
Transgenic sons of the founder rats were used as studs to establish 
the transgenic colony of rats. After their reproductive performance dipped 
the rats were allowed to reach relative old-age. Intra-peritoneal glucose 
tolerance tests were performed on 12 'second generation' rats between the 
ages of 18 and 20 months. The tests were all performed after a 14 hour fast. 
Conscious rats were injected intra-peritoneally with 1 ml/100 g body 
weight of a solution of 10 % (w /v) glucose in 0.9 % (w /v) saline. Blood was 
collected from the tail vein and blood glucose was measured using a 
Hemocue Glucose Analyzer (Hemocue, Sheffield, U .K.) 0, 15, 30, 60, 120 
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and 180 mins. after the glucose injection. Following these tests the rats 
were maintained until they died naturally. On the day of death their 
pancreata were removed and fixed in 4 % (v / v) neutral buffered 
formaldehyde and sectioned for the preparation of histological slides 
stained to reveal any pancreatic amyloid. 
5.2.6 Histological Staining Of Aged Transgenic Rat Pancreata 
Pancreatic sections were stained to test for the presence of amyloid 
with the procedure used by Kammesheidt et al. (1992). They were firstly 
deparaffinised by incubating them for 20 mins. in 1:1 absolute ethanol 
/ chloroform at room temperature. They were then rinsed three times for 
1 min. in 95% (v / v) ethanol, 3 mins. in 70 % (v / v) ethanol, 3 mins. in 
50 % (v / v) ethanol and 3 mins. in water. After this the sections were 
incubated for 4 mins. with 1 % (w / v) thioflavin S in water and 
differentiated in 80 % (v / v) ethanol. 
5.3 RESULTS 
5.3.1 Production Of A Colony Of Transgenic Rats 
The male transgenic offspring from the three founder transgenic 
rats were themselves mated with wild type Sprague Dawley females to 
establish a colony of transgenic rats . Particular attention was paid to 
establishing a colony of 'high copy number' transgenic rats. During the 
duration of this study three generations of male transgenic rats descending 
from the founder rat were established (fig. 5.4). 
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Figure 5.4 A paternal family tree of the male high copy number human amylin transgenic rats bred as studs during the duration 
of this study. Each number in brackets represents one rat and arrows represent its male transgenic offspring. 
5.3.2 Concentrations Of Human Amylin-like Peptides In The Plasma Of 
The Founder Transgenic Rats 
The founder 'high-copy' number transgenic rat had a non-fasting 
t--M: 
plasmar mylin concentration of 19.9 pmol/1. Human amylin-like peptides 
were present at 53.2 pmol/1. The two 'low-copy' number transgenic rats 
,J 
had! amylin concentrations of 15.6 and 8.8 pmol/1 in their plasma. Their 
plasma concentrations of human amylin-like peptides were 16.4 and 
13.3 pmol/1 respectively. 
5.3.3 Concentrations Of Human Amylin-Like Peptides In Organ Extracts Of 
The Founder Transgenic Rats 
The concentration of human amylin-like peptides in the organ 
extracts of the 'high copy' number founder transgenic rat is shown in fig. 
5.5. When related to the protein contents of the organ extracts, the 
pancreas contained the highest concentration with 7179.9 pmol/g protein. 
This compares with a value for the spleen, with the next highest 
concentration, of 727.6 pmol/ g protein. Figure 5.6 shows the 
concentrations of these molecular species in organ extracts from one of the 
'low copy' number founder transgenic rats. As with the high copy number 
founder transgenic rat, the pancreas contained the highest concentration 
of human amylin-like peptides with a value of 4224.3 pmol/ g protein. 
Again the second highest concentration was found in the spleen (with a 
value of 237.0 pmol/ g protein). 
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Figure 5.5 Human amylin-like peptides content of organ extracts from 
the founder high copy number human amylin transgenic rat. 
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Figure 5.6 Human amylin-like peptides content of organ extracts from 
one of the founder low copy number human amylin transgenic rats. 
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5.3.4 Intraperitoneal Glucose Tolerance Tests Of Aged Transgenic Rats 
The glucose tolerance test results from the eight high copy number 
and the four low copy number aged transgenic rats are shown in fig. 5.7. 
One of the high copy number rats had a glucose tolerance test which might 
be consistent with impaired glucose tolerance, but the remaining rats 
appeared to have normal glucose tolerance. 
5.3.5 Histological Staining Of Aged Transgenic Rat Pancreata 
Thioflavin S staining of pancreatic sections from the aged 
transgenic male rats failed to reveal any deposits that were consistent with 
the presence of pancreatic amyloid. 
5.4 DISCUSSION 
The work described in this chapter shows the successful 
establishment of two colonies of rats which both genotypically and 
phenotypically appeared to be transgenic for human amylin. The 
preliminary studies measuring the amylin-like species in the plasma from 
the founder rats show concentrations which are similar to those seen in 
the plasma of humans with impaired glucose tolerance (and presumably 
also those at an early stage of type 2 diabetes) two hours after a 75 g oral 
glucose load (Percy et al., 1996). In both colonies of rats, using a pair of 
antibodies that cross react with human amylin and its glycosylated forms 
but not with rat amylin, the preponderant organ for human amylin-like 
peptides contents was the pancreas (as would be expected with the 
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Figure 5.7 lntraperitoneal glucose tolerance tests of (a) high copy number and 
(b) low copy number human amylin transgenic male rats, aged 18-20 months. 
-117 -
transgene construct containing the rat insulin promoter 1). The organs 
were not lyophilised prior to amylin-extraction but were stored in PBS. 
Any blood remaining in the organs could have provided a source of 
human amylin-like peptides and the contents measured from well-
perfused organs such as the spleen would be consistent with this. Thus the 
results from the organ extract studies were consistent with the human 
amylin being synthesised, stored and secreted from the rat pancreas (and 
probably not from any other organ). Both the blood and pancreatic amylin 
concentrations appeared to show a degree of gene dosage effect, with 
concentrations from the low copy number founder rats being 25-60 % of 
that seen in the high copy number founder rat. 
Currently no other rat lines transgenic for human amylin have 
been described. Initial reports detailing the production of mouse lines 
transgenic for human amylin failed to show any of the amylin depositing 
as pancreatic amyloid (Fox et al., 1993; Hoppener et al., 1993; D'Alessio et 
al., 1994; Yagui et al., 1995). This was despite islets from these animals 
being able to form amyloid fibrils in vitro (de Koning et al., 1994; 
Westermark et al., 1995a) and human amylin being able to be extracted 
from the pancreata of these animals that had biological potency in terms of 
calcitonin receptor-mediated stimulation of cAMP accumulation in T47D 
human breast carcinoma cells (van Hulst et al., 1997). As in the present 
study the hyperamylinaemia caused by the transgene also appeared not to 
be associated with hyperglycaemia (Hoppener et al., 1993; Yagui et al., 
1995). 
More recently reports have appeared detailing mouse lines that do 
deposit human amylin as amyloid. Each of these have undergone some 
sort of manipulation that would increase the amount of human amylin 
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secreted from the pancreas in comparison to those lines reported not to 
deposit pancreatic amyloid. The first human amylin transgenic mouse 
that was shown to deposit pancreatic amyloid had previously been 
reported not to deposit amyloid (D'Alessio et al., 1994), but a change of diet 
to one with a doubling of fat content led to approximately 80 % of male 
transgenic mice having extensive amyloid deposition when over thirteen 
months of age (Verchere et al., 1996). Further in younger rats although the 
prevalence of amyloid deposits was lower, in those rats where amyloid 
was deposited the fasting plasma glucose concentrations were always 
greater than 22 mmol/1. The second report of a transgenic line that 
deposited human amylin as amyloid used mice that were homozygous for 
human amylin (Janson et al., 1996) instead of the hemizygotes used in all 
the other reported studies. In this case the male transgenic mice 
spontaneously developed diabetes by eight weeks of age with associated 
selective :ls-cell death and impaired insulin secretion. Small intra- and 
extracellular amorphous amylin aggregates were present in the mouse 
islets during the development of diabetes. Results from this study contrast 
with the experience of Verchere et al. (1996) who found amyloid 
deposition with a change of laboratory chow and not solely with the use of 
homozygotes. Hemizygous mice made severely insulin resistant by 
treatment with growth hormone and dexamethasone have also been 
shown to be able to form pancreatic amyloid deposits (Couce et al., 1996a). 
In this case the ·amyloid was associated with a mild hyperglycaemia. 
One further study has used an alternative procedure to investigate 
the deposition of human amylin µS amyloid in mice. Here human islets 
were transplanted to the subcapsular space of the kidneys of nude mice 
(Westermark et al., 1995b). After just two weeks 16 out of 22 transplanted 
mice showed signs of amyloid deposited in the transplanted islets. 
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However there was no clear difference in occurrence of amyloid between 
ordinary nude mice and those made diabetic before the islet transplant by 
the administration of alloxan. This suggests that the amyloid deposits 
were not solely formed as a result of increased amylin secretion in 
response to the hyperglycaemia. Indeed the diabetic mice had a lower 
frequency of amylin-positive cells in the transplanted material. 
In the present preliminary study histological investigations failed to 
reveal any amyloid deposition in the pancreata of eight high copy number 
and four low copy number male transgenic rats (aged 18-20 months). 
Submicroscopic amyloid deposits would not have been detected and it 
would be necessary to do any future analysis with an electron microscope 
to detect them (as in Couce et al., 1996a). Comparisons with results from 
the various human amylin-transgenic mouse lines reveal some areas of 
investigation that may in future help to elucidate the deposition of 
pancreatic amyloid in these rats. The first of these is the promotion of 
whole body insulin resistance in the rat (which would presumably 
enhance the production and secretion of human amylin). This could be 
done either pharmacologically with injections of hormones with actions 
which are antagonistic to the actions of insulin (as in Couce et al., 1996a) or 
through feeding high fat diets (Storlien et al., 1986). An alternative 
mechanism of increasing the production of human amylin would be to 
increase the gene dosage effect by producing homozygotes. Verchere et al. 
(1996) report that simply making homozygotes or chemically inducing 
insulin resistance was not associated with islet a·myloid formation in their 
transgenic mice. Moreover although they attribute the amyloid deposition 
in their mice to be associated with the increased fat content of the 
laboratory chow and something to do with the male gender, increased 
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human amylin production did not appear to be associated with either 
increased dietary fat intake or with male gender. 
A third mechanism by which pancreatic amyloid deposition may be 
enhanced, although perhaps somewhat more speculative, is to reduce the 
rate at which pancreatic amyloid may be cleared from the pancreatic ls-cells 
(Hales & Barker, 1992; de Koning et al., 1994; Westermark et al., 1995a). 
Poor clearance of amylin, thereby effectively increasing local pancreatic 
concentrations, may enhance the tendency that amylin has to form 
extracellular fibrils. Such initial formation of small fibrils may then act as 
niduses for further fibril growth (Jarrett & Lansbury, 1993). Evidence that 
poor clearance of amylin may enhance amyloid deposition comes from 
the study of Westermark et al. (1995b). Human islets were transplanted 
into the subcapsular space of the kidneys of nude mice, and amyloid 
deposits were detected just two weeks later. It is highly unlikely that 
during this time neogenesis of blood vessels within the transplanted 
material would have occurred. Thus in this study the lack of clearance of 
human amylin may well have been more important for amyloid 
deposition than any hypersecretion. Further evidence that lack of amylin 
clearance may enhance amyloid deposition comes from poorly 
vascularised islet tumours which have substantial amyloid deposits 
(Westermark et al., 1986; Nieuwenhuis et al ., 1992). 
One final factor that can not be altered with the present rat lines but 
which may be relevant to the deposition of amyloid is the insulin 
promoter that is used in the transgene construct. Thus all three reports of 
successful amyloid deposition in mice transgenic for human amylin used 
constructs containing the rat insulin promoter 2 (Janson et al., 1996; 
Verchere et al., 1996; Couce et al., 1996a). At least one of the mice lines in 
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which amyloid did not deposit used the rat insulin promoter 1 (Fox et al ., 
1993) as was used with these rats. Little is known about the difference in 
effects produced by these two different promoters (as suggested by one 
report detailing differential expression of the two rat insulin genes (Kakita 
et al., 1982) and another detailing co-ordinated expression (Giddings & 
Carnaghi, 1988)). However some subtle, as yet unknown, differences in 
regulation of the human amylin formation caused by the use of different 
rat insulin promoters may either enhance or tend to inhibit amyloid 
deposition. 
In conclusion the rat lines described both genotypically and 
phenotypically appeared to be transgenic for human amylin. They secrete 
amylin in concentrations similar to thoffiseen in the plasma of humans 
with impaired glucose tolerance and therefore should be useful for 
investigating the role of amylin and potentially amyloid deposition in the 
pathogenesis of type 2 diabetes. Given the difference in longevity between 
humans and rats the deposition of pancreatic amyloid in rats may require 
more severe conditions (to speed the process up) than is necessary for such 
deposition in humans. 
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5.5 SUMMARY 
(1) Two rat lines were shown to be both genotypically and phenotypically 
transgenic for human amylin. Using a pair of antibodies that do not 
cross-react with rat amylin, the amylin-like peptide contents of 
various organ extracts showed that the preponderance of these 
peptides were present in the pancreas. The circulating concentrations 
of these peptides appeared to be in the range seen in humans with 
impaired glucose tolerance or early type 2 diabetes. Both the blood 
results and those from the pancreas appeared to show a gene dosage 
effect, with the line shown to have a greater number of copies of the 
human transgene inserted into its genome having relatively higher 
concentrations of both circulating and pancreatic human amylin-like 
peptides. 
(2) The glucose tolerance tests of twelve transgenic male rats (aged 18-20 
months) showed that one of the rats from the 'high copy number' 
line appeared to have slightly impaired glucose tolerance, whilst the 
remaining seven rats from this line and four rats from the 'low copy 
number' line appeared to have normal glucose tolerance. 
(3) Histological staining using thioflavin S failed to reveal any pancreatic 
amyloid deposition in any of the animals. 
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Chapter 6 
Growth Characteristics Of Early Low Protein 
Rats With Subsequent Diet-Induced Obesity 
6.1 INTRODUCTION 
The strong associations found between markers of fetal and early 
growth restriction and the subsequent development of adult degenerative 
diseases ( outlined in section 1.3.2) have raised interest in how early bodily 
form can bt: connected to disease pathogenesis many years later. One 
example of particular importance appears to be the asymmetrically growth 
restricted fetus which has a disproportionately large head and a small 
abdominal viscera. The thrifty phenotype hypothesis (Hales & Barker, 
1992) suggests that the malnourished fetus diverts nutrients away from 
the visceral organs to "spare" the brain the full effects of the 
malnourishment. This may have survival advantages in the short term 
but in the longer term visceral organs which had nutrients diverted away 
from them in utero may malfunction when stressed by the adult 
environment, e.g. by the development of obesity. Evidence for a diversion 
of nutrients away from visceral organs comes from post-mortem studies 
of asymmetrically growth restricted stillbirths of known gestational age 
(Hinchliffe et al., 1992). Glomerular numbers in kidneys from five out of 
six of these stillbirths were reduced in comparison with those from 
stillbirths who were not growth restricted. Evidence that this asymmetrical 
growth restriction is associated with adult degenerative disease comes 
from a study performed in Preston, England where an increased risk of 
hypertension was found in people born with apparently normal birth 
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weights but who were short m relation to their head circumference 
(Barker et al., 1992). 
Other forms of intra-uterine growth restriction appear also to be 
associated with an increased risk for the subsequent development of 
hypertension. Whereas asymmetrical growth restriction may be caused by 
feta! undernutrition during the latter part of pregnancy (when growth 
trajectory patterns appear already to have been established) symmetrical 
growth restriction may be caused by undernutrition in early pregnancy, 
thus promoting a low growth trajectory (Godfrey & Barker, 1995). This 
early growth restriction may be associated with an increased risk of 
developing hypertension. However if subsequent growth postnatally 
remains relatively reduced, there may not be much of an increased risk of 
developing type 2 diabetes (Godfrey & Barker, 1995). This appears not to be 
true for the intermediate form of intra-uterine growth restriction 
characterised by babies that are born thin and have low birth weights (and 
may associated with feta! undernutrition around the middle of 
pregnancy). If their catch-up growth is fast they are at increased risk of 
developing insulin resistance, type 2 diabetes and hypertension (Phillips et 
al., 1994a). Fetal nutrition can be compromised by factors at any one of 
several stages: maternal malnutrition, poor maternal nutritional stores, 
poor maternal transfer of nutrients to the placenta or by inefficient passage 
of nutrients across the placenta (Godfrey & Barker, 1995). Clearly the 
timing of any feta! or early malnutrition can affect distinct organs 
differently as development of the various tissues occurs over different 
time courses in pre- and post-nataUife (Hales & Barker, 1992). 
Feta! and post-natal growth restriction are not the only 
characteristics of bodily form that are associated with an increased 
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incidence and prevalence of type 2 diabetes later in life. Adult obesity is a 
major risk factor for the development of diabetes (Cassano et al., 1992) in 
both men (Chan et al., 1994) and women (Colditz et al., 1990). It is also one 
of the cluster of signs and symptoms used to define the insulin resistance 
syndrome (Reaven, 1995). Of particular interest in terms of the thrifty 
phenotype hypothesis is the added burden that obesity puts on the risk of 
developing the features of the insulin resistance syndrome for an 
individual that exhibited fetal and post-natal growth restriction. This was 
clearly shown in a study of 64 year old men in Hertfordshire (Hales et al., 
1991). Plasma glucoses two hours after ingestion of a 75 g glucose load are 
shown in table 6.1. The men are categorised according to both their weight 
at one year of age and their current body mass indices (which are used as 
an index of total body adiposity). There is a graded pattern of glucose 
values with higher values being associated with both lowest weights at 
one year of age and highest current body mass indices. Thus the lowest 
glucoses were in men who were heaviest at one year of age but had the 
lowest current body mass indices. This suggests that in adult life keeping a 
low body mass index offers a degree of protection against the detrimental 
effects associated with having a low weight at one year of age. Also 
suggested is that being heavy early in life offers some degree of protection 
against the detrimental effects associated with having a high body mass 
index later in life. 
The overall objective of the work described in this chapter was to 
model in the rat the growth changes pertaining to those described in the 
thrifty phenotype hypothesis as leading to an increased risk for the 
development of type 2 diabetes and features of the insulin resistance 
syndrome (i.e. namely fetal and early growth restriction and subsequent 
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Table 6.1 Mean plasma glucoses two hours after a 75 g oral glucose load in 
64 year old Hertfordshire men stratified according to their weights at 1 year 
of age and current body mass indices. Taken from Hales et al. (1991) . The 
number of men in each category is shown in brackets. 
Weight at one iear (kg) 
Adult body 
mass index .::;.9.75 9.76-10.66 >10.66 All 
(kg/m2) 
.::;.25.4 6.6 (45) 6.1 (39) 5.8 (36) 6.2 (120) 
25.4-28 6.7 (47) 6.9 (44) 5.9 (36) 6.5 (127) 
>28 7.7 (39) 7.4 (43) 6.6 (41) 7.2 (123) 
All 7.0 (131) 6.8 (126) 6.1 (113) 6.6 (370) 
obesity). This was attempted by feeding protein deficient diets to pregnant 
female rats (using a regime known to cause fetal growth restriction 
(Snoeck et al., 1990; Desai et al., 1996)) and later on inducing obesity with 
the use of a highly palatable, cafeteria-style diet. 
6.2 METH0 DS 
6.2.1 Animals And Diets Used 
Virgin female Sprague Dawley rats, weighing 240-255 g, were caged 
individually and maintained on a 12:12 h light-dark cycle at 22 °C. They 
were mated with males transgenic for human amylin (chapter 5). From 
the first day of pregnancy (the day when a vaginal plug was expelled) rats 
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were fed either a 20 % (w /w) ('control') protein diet (n=20) or an isocaloric 
8 % (w /w) ('low protein') diet (n=23) (table 2.1; section 2.1.2). The rats were 
maintained on these diets throughout the gestational and suckling periods 
and were allowed to feed ad libitum . The offspring were born at about day 
22 of pregnancy and the litter size recorded. Body weights and food intakes 
of the pregnant and lactating females were recorded daily. Litter sizes and 
weights were recorded two days after birth and on days 7, 14, 21 and 28. 
At 21 days of age 5 mm tail biopsies were taken from the suckling 
rats to screen for the presence of the human amylin transgene (section 
5.2.3). According to the results of the screening some of the rats were 
randomly allocated into experimental groups, whilst the remaining rats 
were killed at 28 days of age. Those rats allocated to the groups were 
removed from their mothers and weaned onto the diet that their mothers 
had been given. They were allowed to eat ad libitum throughout. One 
group of animals was set up to be studied at 70 days of age, one to be 
studied at 140 days of age and one group set up to be studied on a longer 
term basis. 
Until 70 days of age animal weights and food intakes were recorded 
daily. The rats that were studied at 70 days of age were weighed and their 
body lengths measured on that day. They were then killed and their 
organs removed and weighed. Of the remaining rats half of them were 
given Porton Combined Diet ('pellet') (table 2.3; section 2.1.2). The other 
half were fed a high fat, cafeteria-style diet ('cafeteria'). This was a 
modified version of the diet of Wilding et al. (1992) and was designed to be 
highly palatable to encourage the rats to eat large amounts of it . It 
contained 330 g/kg ground Porton Combined Diet, 330 g /kg Nestles full fat 
sweetened condensed milk, 70 g/kg sucrose and 270 g / kg water. This 
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cafeteria diet provided 16.7 % of its energy content as protein, 67.3 % as 
carbohydrate and 16.0 % as fat. In comparison the pellet diet provided 
28.7 % of its energy content as protein, 61.7 % as carbohydrate and 9.6 % as 
fat. The rats remained on these diets until the study time points and 
throughout the study were allowed to eat ad libitum. Food intakes and 
body weights were recorded daily until the animals were 140 days of age. 
The second set of animals were killed and underwent post-mortems at 140 
days of age. The final set of animals were then weighed weekly 
throughout and allowed to continue feeding ad libitum until they died of 
natural causes. 
In this study there were three different combinations of effects being 
studied (i.e. any effects due to whether the rats were transgenic or not, 
whether the rats were protein restricted early in life or not and whether 
the rats were cafeteria-fed or not) (fig. 6.1). The study was therefore largely 
set up to be performed just on female rats in order to keep animal 
numbers down. However so as not to miss any major effects that may 
only 
have manifested themselves,.in male rats two 'extreme' male groups were 
set up for each of the study time points. This meant that at 70 days the two 
male rat groups were 8 % protein-fed transgenic animals and 20 % protein-
fed wild type animals. At the two older study time points the transgenic, 
low protein rats were cafeteria-fed after 70 days of age and rats in the wild 
type, control group were pellet-fed. 
6.2.2 Statistical Analyses 
Comparisons of pregnant and lactating female rats given the control 
or low protein diets were performed using unpaired Student's t-tests. The 
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Figure 6.1 Groups of rats in the present study having taken into account 
variations in maternal and early diets (i.e. control or low protein), genetic 
status (i.e. transgenic or wild type) and adult diets (i.e. pellet or cafeteria). 
penetrance of the transgene between the sexes and the different dietary 
groups were assessed using the x2-test. Results from 70 day animals were 
compared using two-way ANOV A with the genetic status and the early diet 
as independent -variables. Results from both the two older sets of animals 
were compared using three-way ANOV A with the genetic status, the early 
diet and the adult diets used as the independent variables. The one 
exception to this was where individual dietary groups were compared 
which was achieved using Duncan's multiple range test. In each case if 
necessary the variables were log-transformed prior to analysis to allow the 
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appropriate use of parametric statistical testing. Numbers in brackets are 
standard deviations unless stated otherwise. 
6.3 RESULTS 
6.3.1 Maternal Food Intakes And Body Weights 
The mean mating weight of female rats given the control diet was 
257.8 (11.1) g. This was not significantly different from that of the rats given 
the low protein diet (mean mating weight 256.9 (16.0) g, p=0.824). During 
the first two days of pregnancy, there was no significant difference between 
the food intakes of the two groups of rats (fig. 6.2 (a)). However from the 
third to the tenth day of pregnancy those female rats given the low protein 
diet, ate significantly more food than those given the control diet (all 
p<0.01). During this time there was no significant difference in the body 
weights of the groups of animals (all p>0.05) (fig. 6.2 (b)). 
From the eleventh to the eighteenth day of pregnancy there was 
neither a significant difference in the food intakes nor in the body weights 
between the two groups (all p>0.05). By the nineteenth day of pregnancy 
whilst there was no significant difference in the food intakes of the two 
groups (p>0.05), those rats given the control diet were significantly heavier 
than the rats given the low protein diet (p<0.05) (fig. 6.2 (b)). From the 
following day onwards until parturition the low protein rats ate less (all 
p<0.05) and weighed less (p<0.01) than the controls. 
Post partum daily food intakes were significantly greater in those 
mothers given the 20 % protein diet (all p<0.01; except 2 days after the birth 
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Figure 6.2 (a) Food intakes and (b) body weights of pregnant rats given 
the 20 % protein ('control') and 8 % protein ('low protein') diets 
throughout pregnancy. Data are mean (standard error of the mean). 
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where p =0.063) (fig. 6.3 (a)). The post partum weight changes between the 
two groups were largely not significantly different (i.e. p>0.05), except on 
days 4, 7, 9, 11, and 14 where those mothers on the 8 % protein diet lost 
more weight than those mothers given the 20 % protein diet (p<0.05) . 
Overall weight changes of the dams during the post-natal period from two 
days post partum until twenty one days were divergent: control animals 
barely changed in weight (the mean weight gain being 0.73 (19.00) g), 
whereas low protein dams lost weight (mean weight loss being 31.60 
(44.20) g) (p=0.048). 
6.3.2 Litter Sizes And Weights 
The maternal diet used did not have a detectable effect on litter sizes: 
control 13.9 (2.2) pups per litter (n=20), low protein 14.1 (3.3) pups per litter 
(n=23) (p=0.791). Two days after birth mean pup weights were significantly 
lower in the low protein pups (5.33 (0.56) g) in comparison to the control 
pups (6.39 (0.89) g) (p<0.0001). The mean pup weights remained 
significantly lower in the low protein litters right up to weaning (all 
p<0.0001) (fig. 6.3 (b)). The penetrance of the human amylin transgene did 
not vary significantly between pups whose mothers had been given the 
different diets (38/94 control males, 68 / 136 control females, 35/101 low 
protein males and 43/111 low protein females) (p>0.10). 
6.3.3 Body Weights And Food Intakes 
The female offspring of low .protein mothers when weaned onto the 
low protein diet both started lighter than equivalent offspring of control 
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Figure 6.3 (a) Food intakes of rat dams fed the 20 % protein ('control') and 8 % 
protein ('low protein') diets throughout the suckling period and (b) mean pup 
weights in each of their litters. Data are mean (standard error of the mean). 
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mothers and remained that way up to 70 days of age (all p<0.0001) 
(fig. 6.4 (a)). In addition the growth trajectory of the low protein rats was 
lower than that of controls. There was no detectable effect on body weights 
associated with the presence of the transgene (all p>0.490). Food intakes 
were always lower in the low protein animals than in the controls (all 
p<0.001) but the presence of the transgene was not associated with an 
alteration in any of the food intakes (all p>0.240) (fig. 6.4 (b)). At 70 days of 
age the body lengths were: wild type-control 21.0 (0.4) cm, transgenic-
control 21.2 (0.8) cm, wild type-low protein 18.0 (0.8) cm, transgenic-low 
protein 17.9 (1.4) cm (all n=8; association with genetic status p=0.863; 
association with diet used p<0.0001; interaction p=0.688). 
Similar patterns to these were seen in the female rats studied at 140 
days of age. Cafeteria-fed rats showed excessive weight gain (at week 20 
p<0.0001), especially those that were controls (interaction between early and 
adult diets at week 20: p<0.001) (fig. 6.5 (a)). The early low protein rats 
remained lighter than equivalent controls (at week 20: p<0.0001). There 
was never any detectably significant effect on body weights associated with 
the genetic status of the rats (at week 20: p=0.513; all other interactions 
p>0.05). The changes in body weights associated with the dietary 
manipulations meant that low protein rats fed the cafeteria diet caught up 
in body weight with control rats fed the pellet diet by week 17 (i.e. the 
weights for the first time were not statistically significantly different for the 
first time at week 17; p =0.087 using Duncan's multiple range test). At 140 
days of age body lengths in the different dietary groups were: control-pellet 
22.8 (1.1) cm, control-cafeteria 23.7 (0.6) cm, low protein-pellet 21.4 (1.0) cm, 
low protein-cafeteria 22.1 (0.9) cm (all n=16; association with genetic status 
p=0.715, association with early diet p<0.0001, association with adult diet 
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Figure 6.4 (a) Body weights, and (b) weekly food intakes of female rats fed either 
the control or low protein diets (as had their mothers). During week 9 each rat 
underwent a 14 hour fast. Results are means (standard error of the means). 
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Figure 6.5 (a) Body weights, and (b) weekly food intakes of female rats fed either 
the control or low protein diets (as had their mothers) until 10 weeks of age, 
followed by 10 weeks of either pellet or cafeteria diets. During week 19 each rat 
underwent a 14 hour fast. Results are means (no error bars shown for clarity). 
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p<0.0001, all interactions p>0.05). Food intakes were greater in cafeteria-fed 
animals than in those that were pellet-fed (at week 20: p<0.0001) especially 
in controls (at week 20 interaction between early and adult diets p<0.001). 
Also food intakes were greater in controls than in low protein rats (at week 
20: p<0.0001) (fig. 6.5 (b)). The presence of the transgene was not associated 
with an alteration in food intakes (at week 20: p =0.513; all other 
interactions p>0.05). 
Pictures of female rats from each of the four dietary combination 
groups is shown in fig. 6.6. The relative differences in body weights in rats 
studied at 140 days of age was maintained in the rats maintained for a 
longer term (fig. 6.7). The low protein-cafeteria group having caught up 
body weights with the control-pellet then overtook them by week 33 
(p=0.040 using Duncan's multiple range test). The relative differences in 
body weights between rats in the different dietary groups were then 
established. Eventually in the cafeteria-fed rats there was an age-associated 
reduction in body weights prior to death. 
In male rats at 70 days of age body weights were: wild type-control 
349.28 (49.58) g and transgenic-low protein 167.67 (29.61) g (both n =8; 
p<0.0001). Respective body lengths were 23.5 (1.2) cm and 19.0 (1.0) cm 
(p<0.0001) . Body weights at 140 days of age were: wild type, control, pellet 
506.88 (54.93) g-and transgenic, low protein, cafeteria 454.70 (79.50) g (both 
n=8; p=0.149). Equivalent body lengths were 26.4 (0.7) cm and 25.3 (1.0) cm, 
respectively (p=0.019). At 12 months of age body ·weights were: wild type, 
control, pellet 713.85 (51.76) g and transgenic, low protein, cafeteria 
784.57 (111.84) g (p=0.150). 
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(a) 
(b) 
Figure 6.6 Nine month old female Sprague Dawley rats who had been fed either 
the pellet or cafeteria diets: (a) litter mates whose mother had been fed the control 
diet during pregnancy and lactation and who had been weaned onto this diet until 
they were 70 days old, and (b) litter mates whose mother had been fed the low 
protein diet during pregnancy and lactation and who had been weaned onto this 
diet until they were 70 days old. Scale: diameter of weighing pan is 22.1 cm. 
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Figure 6.7 Body weights of (a) female and (b) male rats fed the pellet or cafeteria 
diets throughout adult life. Results are means (no error bars shown for clarity) . 
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6.3.4 Organ Weights 
In female rats at 70 days of age, where body weights in female rats 
were reduced by around 39 % in low protein animals, all the organs 
studied were lower in weight in low protein animals than in controls (all 
p<0.001). With the exception of the lungs (where transgenic animals had 
heavier lungs than wild type animals (p=0.006; interaction between genetic 
status and early diet p=0.003)) there was no association between the genetic 
status of the animals and weights of any of the organs studied (all p>0.05; 
all interactions p>0.05) .. When expressed relative to body weights the 
genetic status of the animals had no influence upon organ weights (all 
p>0.05; interactions all p>0.05). When the organ weights were expressed 
relative to body weights and weights from low protein animals were 
compared with those from controls, there was some variation in the 
effects seen that were associated with the maternal and early protein 
restriction. Some organs, such as the brain and thymus (table 6.2) showed 
reductions in organ weight that were proportionally less than the 
reduction in body weights (both p<0.001) . Other organs, namely the 
kidneys and gastrocnemius muscles (table 6.3), showed weight reductions 
that were proportionally greater than the reductions in body weights (both 
p<0.05). Most organs (table 6.4) showed weight reductions that were 
proportional to the reduction in body weights. 
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Table 6.2 Organ weights where the reduced weight in 70 day old female 
low protein rats was proportionally less than the reduction in body 
weights. 
Transgenic, Transgenic, Wild type, Wild type, 
Control Low Protein, Control, Low Protein, 
(n=8) (n=8) (n=8) (n=8) 
Brain (g) 1.784 (0.107) 1.492 (0.177) 1.739 (0.116) 1.497 (0.162) 
(% body 0.678 (0.073) 1.001 (0.182) 0.704 (0.052) 0.964 (0.167) 
weight)a 
Thymus (g) 0.672 (0.117) 0.485 (0.086) 0.618 (0.111) 0.483 (0.076) 
(% body 0.254 (0.038) 0.322 (0.055) 0.250 (0.046) 0.308 (0.046) 
weight)a 
ap < 0.001 low protein compared to control for both absolute and relative weights 
In 70 day old male rats the weights of all the organs studied were 
lower in the transgenic, low protein rats than in the wild type, controls (all 
p<0.01) (table 6.5J. When the organ weights were expressed relative to body 
weights (which were reduced by around 52 % in the transgenic, low 
protein rats) the weights of the brain and the testes were reduced 
proportionally less than the reduction in body weights (the spleen and 
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Table 6.3 Organ weights where the reduced weight in 70 day old low 
protein female rats was proportionally greater than the reduction in body 
weights. 
Transgenic, Transgenic, 
Control Low Protein, 
(n=8) (n=8) 
Kidneys (g) 2.317 (0.207) 1.109 (0.166) 
(% body 0.876 (0.067) 0.736 (0.091) 
weight)a, b 
MuscZel(g) 0.511 (0.038) 0.273 (0.065) 
(% body 0.193 (0.009) 0.177 (0.012) 
weight)a, b 
ap < 0.001 low protein compared to control for absolute weights 
bp < 0.05 low protein compared to control for relative weights 
Wild type, Wild type, 
Control, Low Protein, 
(n=8) (n=8) 
2.165 (0.141) 1.145 (0.208) 
0.875 (0.049) 0.724 (0.066) 
0.496 (0.062) 0.299 (0.065) 
0.200 (0.018) 0.188 (0.020) 
thymus showed a similar trend) . Like in the females, the kidneys appeared 
to be reduced proportionally greater than the reduction in body weight, 
although statistical significance was not quite reached (p=0.055). All other 
organs were reduced in weight proportionally to the reduction in body 
w eights. 
1 gastrocnemius muscle 
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Table 6.4 Organ weights where the reduced weight in 70 day old female 
low protein rats was proportional to the reduction in body weights. 
Transgenic, Transgenic, Wild type, 
Control Low Protein, Control, 
(n=8) (n=8) (n=8) 
Pancreas (g) 1.005 (0.185) 0.610 (0.191) 0.987 (0.178) 
(% body 0.379 (0.053) 0.395 (0.077) 0.401 (0.082) 
weight)a 
Liver (g) 11.255 (1.245) 6.246 (1.167) 10.831 (1.219) 
(% body 4.248 (0.301) 4.101 (0.359) 
weight)a 
Heart (g) 1.001 (0.092) 0.599 (0.105) 
(% body 0.378 (0.029) 0.394 (0.033) 
weight)a 
Spleen (g) 0.639 (0.064) 0.400 (0.058) 
(% body 0.242 (0.026) 0.266 (0.033) 
weight)a 
Lungs (g) 1.563 (0.234) 0.873 (0.138) 
(% body 0.592 (0.089) 0.579 (0.079) 
weight)a, b 
Ovaries (g) 0.143 (0.033) 0.090 (0.029) 
(% body 0.054 (0.009) 0.057 (0.009) 
weight)a 
ap < 0.001 low protein compared to control for absolute weights 
bp < 0.01 transgenic compared to wild type for absolute weights 
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4.373 (0.411) 
0.909 (0.064) 
0.368 (0.034) 
0.616 (0.073) 
0.249 (0.033) 
1.228 (0.096) 
0.497 (0.045) 
0.136 (0.018) 
0.055 (0.006) 
Wild type, 
Low Protein, 
(n=8) 
0.584 (0.119) 
0.371 (0.056) 
6.551 (1.166) 
4.135 (0.374) 
0.586 (0.088) 
0.372 (0.030) 
0.379 (0.067) 
0.,240 (0.025) 
0.890 (0.083) 
0.570 (0.072) 
0.092 (0.022) 
0.058 (0.010) 
Table 6.5 Organ weights (actual and relative) in 70 day old male rats. 
Wild type, Transgenic, 
Control, Low Protein, 
(n=8) (n=8) p 
Pancreas (g) 1.027 (0.123) 0.571 (0.077) <0.001 
(% body weight) 0.291 (0.050) 0.326 (0.077) 0.305 
Liver (g) 15.763 (4.054) 7.352 (1.282) <0.001 
(% body weight) 4.381 (0.712) 4.422 (0.595) 0.901 
Spleen (g) 0.783 (0.145) 0.406 (0.081) <0.001 (%bodyweight) 0.219 (0.024) 0.242 (0.023) 0.068 
Kidneys (g) 3.054 (0.398) 1.251 (0.146) <0.001 
(% body weight) 0.858 (0.064) 0.759 (0.117) 0.055 
Heart (g) 1.299 (0.232) 0.645 (0.149) <0.001 (%bodyweight) 0.363 (0.031) 0.384 (0.045) 0.289 
Thymus (g) 0.873 (0.178) 0.497 (0.143) <0.001 
(% body weight) 0.245 (0.041) 0.293 (0.056) 0.069 
Lungs (g) . 1.729 (0.406) 0.891 (0.149) <0.001 (%bodyweight) 0.485 (0.089) 0.537 (0.068) 0.210 
Brain (g) 1.882 (0.140) 1.585 (0.094) <0.001 (%bodyweight) _ 0.532 (0.051) 0.973 (0.184) <0.001 
Testes (g) 2.730 (0.554) 2.040 (0.258) 0.006 
(% body weight) 0.765 (0.131) 1.228 (0.133) <0.001 
Gastrocnemius 0.650 (0.135) 0.308 (0.109) 
.<0.001 
Muscle (g) 0215 (0.085) 0.180 (0.033) 0.293 
(% body weight) 
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In female rats at 140 days of age the low protein animals were 
lighter than controls and the cafeteria animals heavier than the pellet 
animals. The genetic status did not detectably alter any of the organ 
weights (all p>0.05). The pancreata were lighter in the low proteins than in 
the controls (p<0.0001) and heavier in the cafeteria-fed animals compared 
to those which were pellet-fed (p=0.022; all interactions p>0.05) (table 6.6). 
When expressed relative to body weights the pancreata were heavier in 
the low protein rats (p<0.0001) and lighter in the cafeteria-fed rats 
(p<0.0001; all interactions p>0.05). The livers were lighter in low protein 
animals (p<0.0001) and heavier in cafeteria-fed rats (p<0.0001; all 
interactions p>0.05). When expressed as relative weights all the alterations 
in liver weights were proportional to those in body weights (all factors 
p>0.05). Spleens were lighter in low protein rats than controls (p<0.0001) 
but weights were not detectably affected by other factors (all p>0.05). When 
expressed relative to body weights, spleens of cafeteria-fed rats were lighter 
than those of other rats (p<0.001; all other factors p>0.05). Kidneys were 
lighter in low protein animals (p<0.0001) and heavier in cafeteria-fed 
animals (p<0.0001), especially those that were controls (interaction 
between early and adult diets p=0.044; all other interactions p>0.05). When 
expressed relative to body weights both low protein rats (p<0.001) and 
cafeteria-fed rats had lighter kidneys (p<0.0001) than their comparable 
control groups. 
Hearts were lighter in low protein rats (p<0.0001) and heavier in 
cafeteria-fed rats (p<0.0001; all interactions p>0.05). When expressed 
relative to body weights hearts in cafeteria-fed rats were lighter (p<0.001), 
especially in controls (interaction between early and adult diets p=0.024; all 
other interactions p>0.05). The thymus glands were lighter in low protein 
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Table 6.6 Organ weights (actual and relative) in 140 day old female rats. 
Control, Control, 
pellet cafeteria 
(n=16) (n=16) 
Pancreas (g) 1.100 (0.170) 1.231 (0.143) 
(% body 0.354 (0.039) 0.294 (0.041) 
weight)a, b, d, e 
Liver (g) 11.008 (1.209) 14.671 (3.017) 
(% body 3.552 (0.226) 3.451 (0.400) 
weight)a, C 
Spleen (g) 0.653 (0.163) 0.664 (0.071) 
(% body 0.212 (0.053) 0.158 (0.019) 
weight)a,e 
Kidneys (g) 2.266 (0.174) 2.548 (0.211) 
(% body 0.734 (0.056) 0.607 (0.051) 
weight)a, b, C, e 
Heart (g) 1.025 (0.092) 1.225 (0.125) 
(% body 0.333 (0.040) 0.293 (0.021) 
weight)a,c, e 
Thymus (g) 0.342 (0.062) 0.589 (0.151) 
(% body 0.111 (0.022) 0.138 (0.022) 
weight)a, c, e 
Lungs (g) 1.459 (0.192) 1.416 (0.202) 
(% body 0.472 (0.061) 0.338 (0.051) 
weight)a,e 
Brain (g) 1.646 (0.111) 1.617 (0.097) 
(% body 0.534 (0.043) 0.387 (0.045) 
weight)a, b, e 
Musclel · (g) 0.602 (0.057) 0.631 (0.050) 
(% body 0.195 (0.013) 0.151 (0.022) 
weight)a,e 
Ovaries (g) 0.127 (0.027) 0.144 (0.020) 
(% body 0.041 (0.010) 0.053 (0.042) 
w eight)d 
ap < 0.01 low protein compared to control for absolute weights 
bp < 0.01 low protein compared to control for relative weights 
Low protein, 
pellet 
(n=16) 
0.986 (0.106) 
0.394 (0.030) 
8.851 (1.232) 
3.523 (0.272) 
0.536 (0.088) 
0.214 (0.032) 
1.665 (0.195) 
0.664 (0.050) 
0.771 (0.091) 
0.307 (0.019) 
0.317 (0.059) 
0.126 (0.019) 
1.128 (0.124) 
0.451 (0.045) 
1.542 (0.106) 
0.620 (0.071) 
0.479 (0.068) 
0.190 (0.009) 
0.129 (0.023) 
0.051 (0.008) 
cp < 0.01, dp < 0.05 cafeteria compared to pellet for absolute weights 
ep < 0.01 cafeteria compared to pellet for relative weights 
1 Gastrocnemius muscle 
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Low protein, 
cafeteria 
(n=16) 
1.015 (0.106) 
0.335 (0.026) 
10.715 (1.356) 
3.527 (0.219) 
0.549 (0.074) 
0.182 (0.025) 
1.748 (0.201) 
0.578 (0.066) 
0.903 (0.081) 
0.299 (0.023) 
0.413 (0.096) 
0.135 (0.023) 
1.153 (0.251) 
0.382 (0.089) 
1.556 (0.072) 
0.518 (0.062) 
0.487 (0.042) 
0.162 (0.017) 
0.136 (0.017) 
0.045 (0.007) 
1, 
I 
I I 
I I 
rats (p<0.001) and heavier in cafeteria-fed rats (p<0.0001), especially in 
controls (interaction between early and adult diets p =0.005; all other 
interactions p>0.05). When expressed relative to body weights the thymus 
weights were higher in the cafeteria-fed animals (p=0.002; all 
interactions p>0.05). Lungs were lighter in low protein rats (p<0.0001) but 
weights were apparently unaffected by the adult diet used (p=0.871; all 
interactions p>0.05). When expressed relative to body weights lung 
weights were lighter in cafeteria-fed rats (p<0.0001; all other factors p>0.05). 
Brains were lighter in low protein rats (p=0.002) but weights were 
apparently unaffected by the adult diet used (p=0.767; all interactions 
p>0.05). When expressed relative to body weights brain weights were 
higher in low protein rats (p<0.0001) and lower in cafeteria-fed rats 
(p<0.0001; all interactions p>0.05). Gastrocnemius muscles were lighter in 
low protein rats (p<0.0001) but weights were apparently unaffected by the 
adult diet used (p=0.193; all interactions p>0.05). When expressed relative 
to body weights gastrocnemius muscle weights were lower in cafeteria-fed 
rats (p<0.0001; all other factors p>0.05). Ovary weights were higher in 
cafeteria-fed rats (p<0.031) but not detectably affected by the early diet used 
(p=0.563; all interactions p>0.05). When expressed relative to body weights 
ovary weights were not detectably affected by the early (p=0.841) or adult 
(0.564) diets used. 
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Table 6.7 Organ weights (actual and relative) in 140 day old male rats. 
Wild type, Transgenic, 
Control, Low Protein, 
Pellet Cafeteria 
(n=8) (n=8) p 
Pancreas (g) 1.338 (0.119) 1.0961 (0.226) 0.018 (%bodyweight) 0.266 (0.026) 0.241 (0.024) 0.067 
Liver (g) 19.248 (2.651) 17.617 (4.283) 0.375 (% body weight) 3.791 (0.228) 3.852 (0.325) 0.672 
Spleen (g) 0.853 (0.100) 0.756 (0.097) 0.069 (% body weight) 0.169 (0.024) 0.168 (0.021) 0.929 
Kidneys (g) 3.661 (0.390) 2.892 (0.454) 0.003 (% body weight) 0.723 (0.026) 0.639 (0.042) <0.001 
Heart (g) 1.473 (0.151) 1.254 (0.151) 0.012 (% body weight) 0.291 (0.014) 0.279 (0.028) 0.298 
Thymus (g) 0.484 (0.068) 0.489 (0.181) 0.950 (% body weight) 0.096 (0.015) 0.106 (0.026) 0.387 
Lungs (g) 1.610 (0.325) 1.429 (0.268) 0.245 (%bodyweight) 0.319 (0.057) 0.315 (0.030) 0.864 
Brain (g) 1.869 (0.167) 1.713 (0.150) 0.070 (%bodyweight) 0.371 (0.045) 0.386 (0.068) 0.620 
Testes (g) 2.960 (0.460) 2.758 (0.205) 0.275 (%bodyweight) 0.583 (0.058) 0.617 (0.081) 0.343 
Gastrocnemius 0.936 (0.112) 0.744 (0.126) 0.006 
Muscle (g) 0.185 (0.013) 0.166 (0.029) 0.110 (% body weight) 
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At 140 days of age body weights of transgenic, low protein, cafeteria 
male rats was not significantly different from those which were wild type, 
control, pellet animals. Even though the body weights were not 
significantly different in the former group the pancreata, kidneys, heart and 
gastrocnemius muscles were significantly lighter than in the other group 
(all other organs having weights which were not detectably different 
between the groups) (table 6.7). Of those organs whose actual weights were 
lower only the kidney weights were still significantly lower when 
expressed relative to the body weights. 
6.4 DISCUSSION 
To try and model in the rat the changes in growth and form 
associated with the development of type 2 diabetes and the insulin 
resistance syndrome (i.e. intrauterine and early growth restriction followed 
by subsequent obesity), rats were exposed to maternal and early protein 
restriction followed by subsequent cafeteria-style feeding. The use of a low 
protein diet was chosen because of the numerous human and animal 
studies which have shown a detrimental effect of protein restriction on 
insulin biosynthesis and secretion as well as on glucose tolerance 
(reviewed by Hales & Barker, 1992). In addition protein restriction was 
chosen as protein tends to be either scarce or relatively expensive in 
communities where type 2 diabetes and impaired glucose tolerance are 
most prevalent (King & Rewers, 1993; Dahri et aZ:, 1995; Hales et al., 1997). 
Whilst feeding a diet that is low in protein after weaning obviously leads to 
reduced protein intake (unless there is a concomitant large increase in total 
food intakes), the. actual nutrient deficiency that the pups receive during 
fetal life and whilst suckling may have been more widespread than merely 
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protein deficiency alone (Desai et al., 1996). For example during pregnancy 
it is possible that the decrease in maternal protein intake may have reduced 
their placental function resulting in a relatively non-specific defect in 
nutrient transfer to the fetus. 
Feeding pregnant rats the low protein diet resulted in growth 
restriction which was apparent by at least two days of age (the earliest 
recorded weights) in the offspring. Until the final few days of pregnancy, 
body weights of pregnant rats fed the low protein diet were not detectably 
different from those fed the control diet. This has been reported previously 
in studies using pregnant Wistar rats fed these diets (Sugden & Holness, 
1995; Desai et al., 1996). The body weights of the rats fed the low protein diet 
failed to increase as much as those fed the control diet during the final few 
days of pregnancy, making the overall weight gains lower in the rats fed 
the low protein diet (as has also been reported for Wistar rats (Snoeck et al., 
1990)). 
The maintenance of body weights throughout early and mid 
pregnancy was achieved by increasing food intakes after two days 
adaptation. This increase was not enough to make the protein intakes the 
same as those rats fed the control diet. However because the two diets were 
isocaloric and the deficit in calories in the low protein diet were made up 
with carbohydrate, the dams fed the 'low protein' diet actually consumed 
significantly more carbohydrate than those fed the control diet. During the 
first few days of the final week of pregnancy· food intakes were not 
significantly different between those rats feeding on the two diets but 
during the final few days prior to parturition rats fed the low protein diet 
consumed less food than those fed the control diet (which coincided with 
those rats fed the low protein diet not being able to maintain the same 
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weight gain as the controls). These results are consistent with those from 
other studies using Wistar rats: total food intakes during pregnancy being 
raised in the low protein group (Snoeck et al., 1990), the food intakes being 
equivalent at day 19 of pregnancy (Sugden & Holness, 1995) and the food 
intakes being higher during the first two weeks of pregnancy and 
equivale11t in the third week (Desai et al., 1996). 
As reported previously the use of the different diets were not 
associated with differences in litter sizes (Snoeck et al., 1990; Sugden & 
Holness, 1995; Desai et al ., 1996). Neither were there detectable alterations 
in the penetrance of the transgene. The low protein pups remained lighter 
than the controls whilst suckling and the magnitude of the difference in 
body weights was magnified with time as the suckling continued. During 
this period the daily food intakes were generally lower in the low protein 
dams and overall they lost weight during this period of time whereas the 
dams fed the control diet maintained weight (as also reported by Dahri et 
al., 1995). 
Once weaned the reduced body weight of the low protein rats was 
permanent when compared with weights of comparably fed controls. 
Because of their growth restriction they also ate less than the equivalent 
controls. Before swapping onto the adult diets the low protein rats also had 
a slower rate of growth than the controls. Thus by restricting maternal and 
early protein intake it is possible to model a similar pattern of early growth 
restriction to that associated with human type i diabetes and the insulin 
resistance syndrome (Hales & Barker, 1992; Hales et al., 1997). Further 
evidence that this may be a suitable model for testing the thrifty phenotype 
hypothesis came from the fact that the low protein rats were shorter than 
the controls. This mirrors the human situation where people with 
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impaired glucose tolerance or type 2 diabetes have been found to be shorter 
than people in the general population with normal glucose tolerance 
(Brown et al., 1991). 
Feeding the rats the cafeteria diet caused a large increase in food 
intake so that it was well above that of equivalent rats fed the pellet diet, 
even when the relatively large water content of the diet was accounted for. 
This difference in food intakes between those rats fed the cafeteria and 
those fed the pellet diets was especially evident in control rats who were 
heavier and therefore eating more when they were swapped onto these 
particular diets. The fact that this increased food intake in cafeteria-fed rats 
was maintained even when the rats showed excessive weight gain suggests 
that this diet was indeed highly palatable as suggested by Wilding et al. 
(1992). The cafeteria diet caused excessive weight gain in both control and 
low protein rats which, although more sensitive indices such as fat pad 
weights and total body lipid contents were not measured, was certainly 
compatible with dietary-induced obesity. The excessive weight gain, like 
with the food intakes, was particularly apparent in control rats which when 
the adult diets were introduced were already substantially heavier than 
equivalent low protein rats. This reflects the human situation where those 
born with the highest birth weights often appear to have the highest body 
mass indices in adult life (Valdez et al., 1994; Fall et al., 1995; Curhan et al., 
1996a, 1996b). -
The overall effect of the diets when combined was to cause 
permanent growth restriction (maternal and early protein restriction) and 
subsequent obesity (cafeteria diet). Thus the changes in growth and form 
associated with the development of type 2 diabetes and the insulin 
resistance syndrome in humans were modelled using these diets . When 
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comparing the extreme groups (i.e. the control pellet-fed rat with those that 
were low protein and cafeteria-fed) the low protein cafeteria-fed rats, 
whether male or female, showed early growth restriction and subsequent 
excessive weight gain. In addition they were shorter and, given enough 
time on the adult diet, heavier. 
The presence of the transgene was only associated with one 
alteration in organ weight, that of lungs in 70 day old female rats. Here the 
lungs were heavier in transgenic than in wild type animals. Since amylin 
has no known function in lungs and in female rats at 140 days of age the 
effect was not present, this disparity may have no functional consequences. 
Indeed the significant difference may be a type I statistical error which 
would be improved by studying a larger number of animals. 
Both maternal and early and then adult dietary manipulations were 
associated with significant alterations in organ weights in the present 
study. The reduced body weights of the low protein rats reflected the 
reduction in weights of nearly all the organs studied. The majority of 
organs in the low protein rats, in both males and females, were reduced in 
weight in proportion to the reduction in body weights. Certain organs, 
however, appeared to be spared the full effects of the reduction in weight. 
The brain was reduced in weight proportionally less than the reduction in 
body weight in low protein rats of both sexes and at both time points 
studied (which suggests a degree of permanency). Similar occurrences of 
apparent brain sparing have been noted previously in animals (Winick & 
Noble, 1966; Widdowson, 1971), small for gestational age babies 
(Gruenwald, 1963; Ogata et al., 1985) and in malnourished children (Garrow 
et al., 1965; Winick et al., 1970). In the thrifty phenotype hypothesis (Hales 
& Barker, 1992) it was suggested that the malnourished fetus diverts 
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nutrients away from visceral organs to the brain to aid both short- and 
long-term survival in conditions of undernutrition. Whilst the organ 
weights of the offspring of protein restricted rat dams clearly mirrors this 
situation (Desai et al., 1996) crude organ weights provide no clues as to 
organ structure and function. Indeed the use of this same low protein diet 
during rat pregnancy alone has been shown to lead to reduced 
vascularisation of the brains of the offspring (Reusens et al ., 1997) and 
maternal protein restriction has been reported to lead to behavioural 
changes and learning incompetence in the rat offspring (Rider & 
Simonson, 1974; Smart, 1993). 
In male rats at 70 days of age the reduction in testes weights in low 
protein animals was proportionally less than the reduction in body 
weights. Thus, like the brain, the testes appeared to be somewhat spared the 
full effects of the protein restriction. In addition at 140 days of age, when 
the low protein male rats had been cafeteria-fed for ten weeks, the 
protection was such that actual testes weights were not detectably different 
from those of controls. If this relative preservation of brain and testes 
weights reflected a protection of function, reproductive ability would not be 
compromised despite the occurrence of metabolic abnormalities associated 
with the early protein restriction (see chapters 7 and 8). 
The kidneys were lower in weight, even when expressed relative to 
body weights, in low protein rats of both sexes and at both the time points 
studied. Kidney growth has previously been shown to be particularly 
compromised in rat models using maternal protein restriction (Zemen, 
1968). This large reduction in weight is clearly compatible with both data 
showing reduced glomerular number from human asymmetrically growth 
restricted stillbirths (Hinchliffe et al., 1992) and with the diversion of 
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nutrients away from visceral organs towards the brain in malnourished 
fetuses, as proposed in the thrifty phenotype hypothesis (Hales & Barker, 
1992). Reduced kidney weights may have disease implications as it has been 
hypothesised that fetal renal growth retardation causes a deficiency of 
nephron number at -birth, leading to an increased susceptibility to the 
development of hypertension (MacKenzie & Brenner, 1995; see Chapter 8). 
Further, it has been suggested that when kidney growth lags behind 
somatic growth, sodium retention is favoured predisposing an individual 
to the development of hypertension (Weder & Schork, 1994). 
Not all organ weights were permanently altered by the maternal and 
early protein deprivation. Ovary weights after the rats were given the adult 
diets appeared unaffected by the protein restriction. Thus, they were able to 
catch up their early growth retardation. Of particular interest in this respect 
is the partial recovery by 140 days of age in pancreas and gastrocnemius 
muscle weights. Both organs were still reduced in weight in animals with 
maternal and early protein restriction, but unlike at 70 days of age the 
pancreata were by now reduced in weight relatively less than the reduction 
in body weights and the muscles only in proportion to the reduction in 
body weights. This opens the possibility that different organs have different 
critical 'windows' at which period of time nutritional deprivation is able to 
permanently alter their future weights (Petry et al., 1997). In the present 
case the period of protein deprivation may only have partially covered the 
critical period for the long-term alteration of pancreas and muscle weights. 
Organs appear to grow in three phases: (i) where there is a proportional 
increase in organ weight, protein and DNA content (cellular hyperplasia), 
(ii) where there is an increase in DNA content that is slower than the 
increase in organ protein and weight ( cellular hyperplasia and concomitant 
hypertrophy) and then (iii) where there is no further increase in DNA 
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content but there is an increase in organ protein and weight (cellular 
hypertrophy) (Winick, 1971). The time-course of these phases are different 
for different organs. Thus it has been hypothesised that the exact timing of 
undernutrition during fetal and early life may affect organs differently (i.e. 
whether they are able to recover weight and possibly function in future 
life) and therefore may affect which features of the insulin resistance 
syndrome present in an individual and at what time (Hales & Barker, 
1992). 
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6.5 SUMMARY 
(1) A rat model was set up to try and model the growth characteristics 
pertaining to the thrifty phenotype hypothesis, namely intrauterine 
growth restriction and subsequent obesity. Low birth weight was 
achieved by feeding pregnant female rats a diet that contained a little 
under half the protein content of the control diet (but was isocaloric). 
The offspring were further growth restricted by feeding them the diet 
that their mothers had been given until they were 70 days of age. The 
low protein animals were always shorter and lighter than the 
equivalent controls. Obesity was achieved by feeding the rats a 
cafeteria-style highly palatable diet. Although they started lighter the 
low protein animals who were cafeteria-fed with time became 
heavier than the controls who were subsequently chow-fed. Growth 
characteristics pertaining to the thrifty phenotype hypothesis were 
therefore achieved in the rat. 
(2) Nearly all organ weights were lower in the low protein animals. 
Whilst most organs reduced in weight proportionally to the 
reduction in body weight, the brain weights appeared to be relatively 
spared in all animals. This contrasts with the kidneys which were 
reduced in weight in the low protein animals proportionally more 
than the reduction in body weights. This is consistent with the 
suggestion that in the malnourished fetus nutrients are diverted 
away from organs such as the kidneys towards the brain. 
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Chapter 7 
The Effects Of Maternal And Early Protein 
Restriction On Glucose And Lipid 
Metabolism In Young Adult Rats 
7.1 INTRODUCTION 
In some developing countries malnutrition-related diabetes has a 
relatively high prevalence (Ramachandran et al., 1988; Kiatsayompoo et 
al., 1993). Patients with this condition tend to be young but not ketosis-
prone, hence the World Health Organisation categorises it as a separate 
clinical class of diabetes (World Health Organisation, 1985). One variant of 
malnutrition-related diabetes is protein-deficient pancreatic diabetes 
(PDPD) (Bhatia et al., 1995) as people who are protein-calorie 
malnourished characteristically are glucose intolerant (Bowie, 1964; 
Becker, 1983; Rao, 1988). Of particular importance appear to be children 
who are severely protein malnourished who, even after periods of 
recovery lasting several weeks, show a prolonged impairment of insulin 
secretion and glucose intolerance (James & Coore, 1970; Milner, 1971). 
Milner (1971) suggested that if this deficit in insulin secretion was 
permanent then these previously malnourished children may be 
p redisposed to the development of diabetes. 
Whilst these early studies were performed on babies and young 
infants and their birth weights were not reported, it is likely that they were 
also fetally malnourished (Hales & Barker, 1992) . In humans around half 
the adult mass of pancreatic ls-cells are already present by one year of age 
(Rahier et al., 1981) and there is a gradually declining capacity for further fs-
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cell division. Malnourishment prior to this age during the time when ls-
cells are rapidly dividing may therefore cause a deficit of ls-cell number 
that is irrecoverable in later life. This may underlie the importance of the 
effects seen on insulin secretion from malnourishment in fetal/ early life 
and distinguish them from those due to poor nourishment in later life. 
These effects seen in humans have been modelled by feeding 
weanling rats a low protein diet for three weeks, prior to being fed a 
normal laboratory chow (Swenne et al., 1987). At six weeks of age 
(immediately prior to being fed the chow) the low protein rats were 
glucose intolerant and failed to mount an insulin secretory response to an 
intraperitoneal injection of glucose. By twelve weeks of age, after six weeks 
of chow feeding, the glucose tolerance had normalised but there was still a 
decreased insulin secretary response to glucose. As in the human study it 
was speculated that this poor insulin secretory response could predispose 
the rats to the development of diabetes. 
Maternal protein restriction in rats during pregnancy alone has 
been shown to lead to reduced islet cell proliferation in the endocrine 
pancreas of the neonatal offspring (Snoeck et al., 1990). In addition the low 
protein offspring have a 50 % reduction in islet vascularisation. When 
islets from these offspring were challenged in vitro with secretagogues 
there was a depressed insulin response (Dahri et al., 1991). The pups were 
growth restricted. Maternal protein restriction is likely to lead to either a 
reduced supply of amino acids alone to the fetus or a more generalised 
nutrient deficiency (Desai & Hales, 1997). Amino acids are essential for the 
growing fetus both to lay down protein and as a substr'ate for energy 
production (Battaglia & Meschia, 1978). Also the fetal ls-cell appears to 
secrete insulin in response to amino acids rather than glucose, at least 
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until late fetal life (De Gasparo et al., 1978), and insulin is a key growth 
factor in fetal life (Fowden, 1989). 
The combination of the factors described above and the fact that 
foods high in protein tend to be expensive for poor communities living in 
affluent societies suggests that maternal (and early) protein restriction may 
be a suitable dietary manipulation to test the thrifty phenotype hypothesis 
in animals (Hales & Barker, 1992; Hales et al., 1997). The work described in 
the following chapter was initiated to investigate what effects protein 
restricting a rat during pregnancy and lactation and then 
weaning her offspring onto a protein restricted diet has on glucose 
tolerance and circulating lipid concentrations in the young offspring. In 
humans it appears that the worst glucose tolerances are found in those 
individuals who were growth restricted in utero and in early infancy but 
who subsequently have high body mass indices in adult life (Hales et al., 
1991). The study was therefore then extended to look at the effects of later 
dietary induced obesity, especially in combination with early protein 
restriction. 
7.2METH0DS 
7.2.1 Animals And Diets Used 
Sprague Dawley transgenic and wild type rats were set up as detailed 
in chapter 6 (section 6.2.1). In one set of animals intra-peritoneal glucose 
tolerance tests were performed at 63 days of age after an overnight fast 
(section 5.2.5). Fasting blood samples were collected into lithium heparin 
for the measurement of plasma insulin (section 2.2.1), triacylglycerol 
(section 2.2.6), free glycerol (section 2.2.6), total cholesterol (section 2.2.7) 
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and creatinine (section 2.2.8). The animals from which these samples were 
taken were then killed at 70 days of age, had their pancreata removed and 
their islet hormones extracted and measured (section 4.2.2). Of the 
remaining rats half of them were given a laboratory chow (Porton 
Combined Diet ('pellet')) (table 2.3; section 2.1.2) at 70 days of age, whilst 
the remainder were fed the cafeteria diet (section 6.2.1). Both groups of rats 
had intra-peritoneal glucose tolerance tests performed on them at 133 days 
of age after an overnight fast. Fasting blood samples were collected for the 
measurement of the same analytes that were measured on the 63 day old 
animals. At 140 days of age the rats from which the samples were taken 
were killed and their pancreata removed. Islet hormones were then 
extracted and measured (section 4.2.2). 
7.2.2 Congo Red Staining Of Pancreatic Sections For Amyloid Detection 
In addition to having islet hormones extracted, small pieces of the 
pancreata (around 25 mm2 from the head and tail of each pancreas) from 
the 70 day old rats were removed and rapidly fixed in 4 % (v /v) neutral 
buffered formaldehyde. These were stored as wax blocks. Staining for 
pancreatic amyloid was performed according to Highman (1946) . Briefly 
the blocks were cut to 6 µm sections and dewaxed. After this they were 
rinsed in alcohol and then in water. The sections were then stained with 
0.5 % (w /v) Congo Red in 50 % (v /v) alcohol, for 5 mins. at room 
temperature. After this the slides were drained and flooded with 0.2 % 
(w /v) potassium hydroxide for 15-20 sees. at room 'temperature. Following 
this they were rinsed with tap water and counterstained with Mayer's 
haematoxylin for 15 sees. at room temperature. Finally the slides were 
dehydrated, cleared and mounted. 
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7.2.3 Statistical Analyses 
Results from 70 day animals were compared using two-way ANOV A 
with the genetic status and the early diet as independent variables. Results 
from 140 day animals were compared using three-way ANOVA with the 
genetic status, the early diet and the adult diets used as the independent 
variables. In each case if necessary the variables were log-transformed prior 
to analysis to allow the appropriate use of parametric statistical testing. All 
results shown are geometric means (95 % CI) unless otherwise stated. All 
data from male rats were compared using Student's unpaired t-test. 
7.3 RESULTS 
7.3.1 Glucose Tolerances 
The results of the glucose tolerance tests for 63 day old female and 
male rats are shown in fig. 7.1. In female rats the low protein animals had 
significantly better glucose tolerances than the controls (when judged by 
the area under the curves) (F=l7.016, p =0.0003). There was no detectable 
alteration in glucose tolerances associated with the presence of the 
transgene (F=0.215, p =0.647; interaction F=0.0009, p=0.977). In male rats at 
this age the transgenic, low protein rats had significantly better glucose 
tolerances than the wild type, control rats (mean (SD) 2750 (500) v. 3873 
(449) units (p=0.0003)). The results of the glucose tolerance tests for 133 day 
old female and male rats are shown in fig. 7.2. In female rats cafeteria-fed 
animals had significantly worse glucose tolerances than pellet-fed animals 
(F=l9.031, p<0.0001). There was no detectable alteration in glucose 
tolerance associated with either the presence of the transgene (F=l.519, 
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Figure 7.1 Intra-peritoneal glucose tolerance test results from (a) 63 day old 
female rats and (b) 63 day old male rats. The groups were as described in 
section 6.2.1. Data are means (error bars not shown for clarity). 
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Figure 7.1 Intra-peritoneal glucose tolerance test results from (a) 63 day old 
female rats and (b) 63 day old male rats. The groups were as described in 
section 6.2.1. Data are means (error bars not shown for clarity). 
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p=0.223) or the early diet used (F=l.592, p=0.212; interactions F=0.005-2.511, 
p=0.119-0.945). The difference in glucose tolerance between the transgenic, 
low protein, cafeteria male rats and those which were wild type, control, 
pellet did not reach significance (mean (SD) 4304 (197) v. 4013 (423) units, 
p =0.100). 
The areas under the glucose tolerance curves were similar for 
female controls at 63 days of age and controls that were fed the pellet diet 
at 133 days of age (mean (SD) values being 4126 (539) and 3992 (476) units, 
respectively). In contrast the low protein rats that were pellet fed appeared 
to have worse glucose tolerances at 133 days of age than the low protein 
rats at 63 days of age (mean (SD) values being 3396 (458) and 3845 (348) 
units, respectively), although they were different animals. 
7.3.2 Fasting Plasma Insulin Concentrations 
The fasting plasma insulin concentrations in 70 day old female rats 
are shown in fig. 7.3 (a). Low protein animals had significantly lower 
insulin concentrations than controls (F=5.933, p =0.022). There was no 
detectable alteration in fasting plasma insulin concentrations associated 
with the presence of the transgene (F=0.075, p =0.786; interaction F=0.614, 
p =0.441). In male rats at this age fasting plasma insulin concentrations 
were: wild type, control 51.7 (33.9-78.9) pmol/1 and transgenic, low protein 
46.0 (33.9-62.4) pmol/1 (p=0.641) . Figure 7.3 (b) shows the fasting plasma 
insulin concentrations in 133 day old female rats. Cafeteria-fed animals 
had significantly higher concentrations than pellet-fed animals (F=42.242, 
p<0.0001) . There was no detectable significant effect associated either w ith 
the presence of the transgene (F=0.578, p=0.451) or with the early diet used 
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Figure 7.3 Fasting plasma insulin concentrations in (a) 63 day old and (b) 133 day 
old female rats. Results are geometric means (95 % Cl). pel = pellet, caf = cafeteria. 
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(F=0.501, p =0.483; interaction F=0.000-0.758, p=0.389-0.985) . In male rats at 
this age fasting plasma insulin concentrations were: wild type, control, 
pellet 31.8 (21.1-48.0) pmol/1 and transgenic, low protein, cafeteria 115.0 
(54.5-242.7) pmol / 1 (p=0.002). 
7.3.3 Fasting Plasma Triacylglycerol Concentrations 
The fasting plasma triacylglycerol concentrations in 70 day old 
female rats are shown in fig. 7.4 (a). Low protein animals had significantly 
higher triacylglycerol concentrations than controls (F=8.568, p =0.007) . 
There was no detectable alteration in fasting plasma triacylglycerol 
concentrations associated with the presence of the transgene (F=0.960, 
p =0.336; interaction F=2.866, p =0.102). In male rats at this age fasting 
plasma triacylglycerol concentrations were: wild type, control 0.25 
(0.12-0.49) mmol/1 and transgenic, low protein 0.26 (0.16-0.41) mmol/1 
(p =0.873). Figure 7.4 (b) shows the fasting plasma triacylglycerol 
concentrations in 133 day old female rats. Cafeteria-fed animals had 
significantly higher concentrations than pellet-fed animals (F=21.863, 
p<0.0001). There was no detectable significant effect associated either with 
the presence of the transgene (F=0.658, p=0.423) or with the early diet used 
(F=0.014, p =0.906; interaction F=0.007-2.130, p=0.152-0.933). In male rats at 
this age fasting plasma triacylglycerol concentrations were: wild type, 
control, pellet ·0.10 (0.05-0.18) mmol/1 and transgenic, low protein, 
cafeteria 0.41 (0.20-1.11) mmol/1 (p=0.003). 
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7.3.4 Fasting Plasma Free Glycerol Concentrations 
The fasting plasma free glycerol concentrations in 70 day old female 
rats are shown in fig. 7.5 (a). There were no detectable significant effects 
associated with either the presence of the transgene (F=0.000, p=0.995) or 
with the diet used (F=2.355, p =0.137; interaction F=l.444, p=0.240). In male 
rats at this age fasting plasma free glycerol concentrations were: wild type, 
control 0.78 (0.67-0.91) mmol / 1 and transgenic, low protein 0.74 
(0.66- 0.84) mmol/1 (p=0.535). Figure 7.5 (b) shows the fasting plasma free 
glycerol concentrations in 133 day old female rats. Transgenic animals had 
significantly higher concentrations than wild type animals (F=7.311, 
p =0.010). Cafeteria-fed rats had significantly higher concentrations than 
pellet-fed rats (F=8.680, p=0.005). There was no detectable significant effect 
associated with the early diet used (F=2.129, p =0.152; interaction 
F=0.063-3.708, p =0.060-0.803). In male rats at this age fasting plasma free 
glycerol concentrations were: wild type, control, pellet 0.59 (0.54 
-0.65) mmol/1 and transgenic, low protein, cafeteria 0.67 (0.60 
-0.75) mmol/1 (p=0.053). 
7.3.5 Plasma Total Cholesterol Concentrations 
The plasma total cholesterol concentrations in 70 day old female 
rats are shown ·in fig. 7.6 (a). There were no detectable significant effects 
associated with either the presence of the transgene (F=0.764, p=0.390) or 
with the diet used (F=0.884, p=0.356; interaction F,;2.310, p=0.141). In male 
rats at this age plasma cholesterol concentrations were: wild type, control 
2.3 (2.0-2.7) mmol/1 and transgenic, low protein 2.9 (2.2-3.9) mmol/1 
(p=0.150). Figure 7,6 (b) shows the plasma cholesterol concentrations in 133 
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Figure 7.5 Fasting plasma free glycerol concentrations in (a) 63 day old and 
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day old female rats. There were no detectable significant effects associated 
with the presence of the transgene (F=0.138, p=0.712), with the early diet 
used (F=0.209, p =0.650) or with the adult diet used (F=2.813, p =0.100). 
However there was a significant interaction between the early and adult 
diets so that in low protein rats the cafeteria diet was associated with the 
rats having a raised cholesterol concentration (an observation not seen in 
control rats) (F=9.019, p =0.004; other interactions F=0.014- 0.648, 
p =0.425-0.907). In male rats at this age plasma cholesterol concentrations 
were: wild type, control, pellet 2.2 (1.7- 2.8) mmol / 1 and transgenic, low 
protein, cafeteria 1.8 (1.5-2.1) mmol/1 (p=0.134). 
7.3.6 Plasma Creatinine Concentrations 
The plasma creatinine concentrations in 70 day old female rats are 
shown in fig. 7.7 (a). Low protein rats had significantly higher plasma 
creatinine concentrations than controls (F=l0.883, p=0.005). There was no 
detectable significant difference that was associated with the presence of 
the transgene (F=l.362, p=0.261; interaction F=0.829, p =0.377). In male rats 
at this age there was insufficient plasma to measure creatinine 
concentrations. Figure 7.7 (b) shows the plasma creatinine concentrations 
in 133 day old female rats. There were no detectable significant effects 
associated with the presence of the transgene (F=2.737, p =0.106), with the 
early diet used (F=l.777, p=0.190) or with the adult diet used (F=l.003, 
p =0.323; interactions F=0.072-1.155, p=0.289-0.789). In male rats at this age 
plasma creatinine concentrations were: wild type, control, pellet 38 
(29-49) µmol/1 and transgenic, low protein, cafeteria 43 (39-46) µmol/1 
(p=0.333). 
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Figure 7.7 Plasma creatinine concentrations in (a) 63 day old and 
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7.3.7 Pancreatic Amylin Contents 
The pancreatic amylin contents (measured using a DELFIA that 
cross reacts 100 % with rat amylin and 30 % with human amylin (section 
3.3.3)) in 70 day old female rats are shown in fig. 7.8 (a). The transgenic rats 
had significantly more amylin in their pancreata than the wild type 
animals (F=l2.599, p =0.001). The control rats had significantly more 
amylin in their pancreata than the low protein animals (F=ll.085, p=0.002; 
interaction F=l.341, p =0.257). When expressed per unit pancreas weight 
(fig. 7.8 (b)) the transgenic rats still had greater pancreatic amylin contents 
than the wild type animals (F=8.150, p =0.008). However the pancreatic 
amylin contents of the control animals were not detectably different from 
those of the low proteins (F=2.761, p =0.108; interaction F=l.028, p =0.319). 
When expressed relative to the body weights (fig. 7.8 (c)) again the 
transgenic rats had greater pancreatic amylin contents than the wild type 
animals (F=8.985, p =0.006). The pancreatic amylin contents of the control 
animals did not appear to be different from those of the low protein 
animals (F=2.400, p=0.108; interaction F=l.028, p=0.319). 
The pancreatic amylin contents in 140 day old female rats are shown 
in fig. 7.9 (a). At this age the difference between the pancreatic amylin 
contents of the transgenic and wild type rats did not reach significance 
(F=2.423, p =0.125). Low protein rats had lower pancreatic amylin contents 
than controls (F=4.231, p =0.044) and cafeteria rats had higher pancreatic 
amylin contents than pellet-fed animals (F=l3.388, p =0.0006; interactions: 
F=0.000-0.828, p=0.367-0.998). When expressed relative to pancreatic 
weights (fig. 7.9 (b )) the transgenic rats did have greater pancreatic amylin 
contents than the wild type animals (F=4.791, p=0.033). The cafeteria 
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animals still had greater pancreatic amylin contents (F=6.066, p=0.017) than 
pellet fed rats, but the pancreatic amylin contents did not appear to be 
different between control and low protein animals (F=0.000, p =0.984; 
interactions F=0.005-0.692, p=0.409-0.945). When expressed relative to 
body weights (fig. 7.9 (c)) transgenic animals tended to have greater 
pancreatic amylin contents than wild type rats (F=3.245, p=0.077) as did low 
protein rats in comparison to controls (F=3.518, p =0.066). There were no 
detectable differences in pancreatic amylin contents between cafeteria- and 
pellet-fed rats (F=0.000, p=0.996; interactions: F=0.016-0.871, p =0.355-0.899). 
At 70 days of age pancreatic amylin contents of male, transgenic, low 
protein rats appeared not to be different from those of wild type, control 
rats: 350.9 (274.2- 449.2) v. 341.0 (278.6-417.5) pmol (p=0.839), respectively. 
When the results were expressed relative to pancreas weights the 
transgenic, low protein animals had greater pancreatic amylin contents: 
620.4 (541.8-710.4) v. 334.2 (273.4-408.6) pmol / g pancreas (p<0.0001), 
respectively. This difference was also apparent when the results were 
expressed relative to body weights: 2.12 (1.73-2.60) v. 0.99 (0.83- 1.18) 
pmol/ g body weight (p<0.0001), respectively. At 140 days of age male, 
transgenic, low protein, cafeteria animals had significantly greater 
pancreatic amylin contents than wild type, control, pellet animals: 798.8 
(674.3-946.3) v. 615.7 (519.8-729.3) pmol (p=0.025), respectively. When 
expressed relative to pancreatic weights the difference was even more 
pronounced: 742.9 (608.0-907.0) v. 462.0 (390.0-546.0) pmol/g pancreas 
(p=0.0009). This relationship also held when the · results were expressed 
relative to body weights: 1.78 (1.48-2.14) v. 1.22 (1.04-1.43) pmol/ g body 
weight (p=0.003). 
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7.3.8 Pancreatic Insulin Contents 
The pancreatic insulin contents in 70 day old female rats are shown 
in fig. 7.10 (a). Control animals had significantly greater pancreatic insulin 
contents than low protein rnts (F=l0.329, p =0.003). There was no detectable 
effect associated with the presence of the transgene (F=0.009, p =0.924; 
interaction F=l.215, p=0.280). When expressed relative to the pancreas 
weights (fig. 7.10 (b)) neither the early diet used (F=2.324, p =0.139) nor the 
genetic status of the rats (F=0.004, p =0.953; interaction F=l.655, p =0.209) 
was, associated with detectable alterations in pancreatic insulin contents. 
This was also true if the results were expressed relative to the body weights 
(fig. 7.10 (c)) (early diet F=l.580, p =0.219; genetic status F=0.000, p=0.996; 
interaction F=0.541, p=0.468). 
The pancreatic insulin contents in 140 day old female rats are 
shown in fig. 7.11 (a). At this age the low protein rats still had lower 
pancreatic insulin contents than controls (F=S.818, p=0.019). Cafeteria-fed 
rats had significantly greater pancreatic insulin contents than pellet-fed 
animals (F=l3.307, p =0.001). The presence of the transgene was not 
associated with a detectable alteration in pancreatic insulin contents 
(F=l.002, p =0.321; interactions F=0.002-1.730, p =0.194- 0.961) . When 
expressed relative to pancreas weights (fig. 7.11 (b)) the cafeteria rats still 
had greater pancreatic insulin contents (F=S.378, p=0.024). There was no 
detectable alteration in the pancreatic insulin contents associated either 
with the presence of the transgene (F=0.063, p=0.802) or with the use of the 
low protein diet (F=0.006, p=0.938; interactions: F=0.006-1.501, 
p=0.226-0.936). When expressed relative to body weights (fig. 7.11 (c)) there 
was no significant alteration in pancreatic insulin content that could be 
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per pancreas and relative to pancreas and body weights. Results shown are 
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attributed to the presence of the transgene (F=l.547, p=0.219), the use of the 
low protein diet (F=0.270, p=0.606) or the use of the cafeteria diet (F=0.170, 
p=0.681; interactions: F=0.002-1.994, p=0.164-0.968). 
In male rats at 70 days of age there were no detectable differences in 
pancreatic insulin contents between transgenic, low protein animals and 
those which were wild type, control: 11.8 (9.6-14.7) v. 14.6 (12.3-17.5) nmol 
(p=0.102). However when the results were expressed relative to the 
pancreas weights the transgenic, low protein animals had greater 
pancreatic insulin contents: 20.9 (17.3-25.3) v. 14.3 (11.8-17.5) nmol/ g 
pancreas (p=0.007). The difference became even more apparent when the 
results were expressed relative to body weights: 71.6 (61.5-83.4) v. 42.2 
(35.6-50.1) pmol/ g body weight (p=0.0001). At 140 days of age there was a 
tendency for male, transgenic, low protein, cafeteria rats to have greater 
pancreatic insulin contents than wild type, control, pellet rats: 30.4 
(26.4-35.1) v. 25.2 (20.8-30.7) nmol (p=0.096). This difference became 
statistically significant when the results were expressed relative to the 
pancreas weights: 28.3 (22.6-35.5) v. 18.9 (15.8-22.7) nmol/ g pancreas 
(p=0.007), respectively. The difference was still statistically significant 
when expressed relative to the body weights: 67.8 (56.2-81.8) v. 50.1 
(41.2-60.9) pmol/ g body weight (p=0.022), respectively. 
7.3.9 Pancreatic Glucagon Contents 
The pancreatic glucagon contents in 70 day old female rats are 
shown in fig. 7.12 (a). Neither the early diet used (F=0.000, p=0.985) nor the 
genetic status of the rats (F=0.162, p=0.690; interaction F=l.043, p =0.316) 
was associated with significant alterations in pancreatic glucagon 
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contents. When expressed relative to the pancreas weights (fig. 7.12 (b )) 
low protein rats had significantly greater pancreatic glucagon contents 
than controls (F=36.188, p<0.0001). There was no detectable effect associated 
with the presence of the transgene (F=0.278, p =0.602; interaction F=0.790, 
p =0.382). Similar differences were found if the results were expressed 
relative to the body weights (fig. 7.12 (c)) (early diet F=36.447, p<0.0001; 
genetic status F=0.237, p=0.630; interaction F=2.292, p=0.141). 
The pancreatic glucagon contents in 140 day old female rats are 
shown in fig. 7.13 (a). At this age the low protein rats had greater 
pancreatic glucagon contents than the controls (F=4.927, p =0.031). There 
was no detectable alteration in pancreatic glucagon content that was 
associated with the presence of the transgene (F=0.076, p=0.783) or with the 
use of the cafeteria diet (F=0.203, p=0.654; interactions: F=0.001-2.506, 
p =0.119-0.972). Similar results were found when the pancreatic glucagon 
contents were expressed relative to the pancreatic weights (fig. 7.13 (b)): 
association with the early use of the low protein diet (F=ll.036, p =0.002), 
association with the presence of the transgene (F=0.528, p =0.471), 
association with the use of the cafeteria diet (F=0.063, p =0.803; interactions 
F=0.157- 0.843, p =0.362- 0.693). When the results were expressed relative to 
the body weights (fig. 7.13 (c)) the low protein rats again had greater 
pancreatic glucagon results in comparison to the controls (F=38.863, 
p<0.0001) . The cafeteria rats had significantly lower pancreatic glucagon 
contents than the pellet-fed animals (F=l0.962, p =0.002). There was no 
significant alteration associated with the presence of the transgene 
(F=0.007, p=0.932; interactions: F=0.047-1.901, p=0.174-0.829). 
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Figure 7.13 Pancreatic glucagon contents of 140 day old female rats expressed per 
pancreas and relative to pancreas and body weights. Results shown are geometric 
means (95 % CI) of the number of rats indicated. pel = pellet, caf = cafeteria. 
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In male rats at 70 days of age there were no detectable differences in 
pancreatic glucagon contents between transgenic, low protein animals and 
those which were wild type, control: 2.40 (1.90-3.03) v. 2.23 (1.95- 2.55) µg 
(p=0.551). However when the results were expressed relative to the 
pancreas weights the transgenic, low · protein animals had greater 
pancreatic glucagon contents: 4.24 (3.38-5.31) v. 2.19 (1.88- 2.54) µg / g 
pancreas (p=0.0001). The difference became even more apparent when the 
results were expressed relative to body weights: 14.48 (11.51-18.22) v. 6.44 
(5.69-7.29) ng/ g body weight (p<0.0001). At 140 days of age male transgenic, 
low protein, cafeteria rats had significantly lower pancreatic glucagon 
contents than wild type, control, pellet rats: 2.95 (2.49-3.48) v. 3.76 
(3.18-4.44) µg (p=0.032). When expressed relative to pancreatic weights this 
difference in pancreatic glucagon content was no longer statistically 
significant: 2.74 (2.41-3.11) v. 2.82 (2.38-3.35) µg / g pancreas (p=0.760), 
respectively. There was also no detectable difference when the results were 
expressed relative to the body weights: 6.56 (5.91 - 7.29) v. 7.45 (6.31-8.81) 
ng/ g body weight (p=0.159), respectively. 
7.3.10 Pancreatic Somatostatin Contents 
The pancreatic somatostatin contents in 70 day old female rats are 
shown in fig. 7.14 (a). Neither the early diet used (F=0.401, p =0.532) nor the 
genetic status of the rats (F=0.075, p =0.786; interaction F=0.159, p=0.693) 
was associated with detectable alterations in pancreatic somatostatin 
contents. When expressed relative to the pancreas weights (fig. 7.14 (b)) the 
low protein rats had significantly greater pancreatic somatostatin contents 
than controls (F=9.600, p=0.004). Again there was no detectable effect 
associated with the presence of the transgene (F=0.147, p=0.705; interaction 
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Figure 7.14 Pancreatic somatostatin contents of 70 day old female rats 
expressed per pancreas and relative to pancreas and body weights. Results 
shown are geometric means (95 % Cl) of the number of rats indicated. 
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F=0.168, p=0.685). When expressed relative to the body weights (fig. 7.14 (c)) 
the low protein rats had significantly greater pancreatic somatostatin 
contents than controls (F=9.441, p=0.005). There was no detectable effect 
associated with the presence of the transgene (F=0.128, p=0.723; interaction 
F=0.619, p=0.438). 
The pancreatic somatostatin contents in 140 day old female rats are 
shown in fig. 7.15 (a) . None of the experimental factors was associated 
with significant alterations in pancreatic somatostatin contents: 
association with the presence of the transgene (F=0.037, p=0.848), with the 
use of the low protein diet (F=0.089, p=0.767), with the use of the cafeteria 
diet (F=0.242, p=0.625). There was, however, a significant interaction 
between all three factors (F=4.878, p=0.031; other interactions: 
F=0.034-0.536, p=0.467-0.853). Similarly when the results were expressed 
relative to pancreas weights (fig. 7.15 (b)) there were no detectable 
significant differences associated with: (a) the presence of the transgene 
(F=0.423, p=0.518), (b) the use of the low protein diet (F=l.341, p=0.252) or 
(c) the use of the cafeteria diet (F=0.122, p=0.728). Again there was, 
however, a significant interaction between the three factors (F=4.547, 
p=0.037; other interactions: F=0.030-0.157, p=0.694-0.863). When expressed 
relative to body weights there were no detectable significant alterations in 
pancreatic somatostatin contents (fig. 7.15 (c)) associated with: the presence 
of the transgene (F=0-.529, p=0.470), the use of the low protein diet early in 
life (although there was a tendency for it to be higher) (F=3.664, p=0.061) or 
the use of the cafeteria diet (F=2.516, p=0.118; interactions F=0.001-2.266, 
p=0.138- 0.975). 
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In male rats at 70 days of age there were no detectable differences in 
pancreatic somatostatin contents between transgenic, low protein animals 
and those which were wild type, control (although there was a tendency 
for the former to be greater): 357.4 (281.1-454.6) v. 273.3 (224.1-333.0) ng 
(p=0.066), respectively. However when the results were expressed relative 
to the pancreas weights the transgenic, low protein animals had greater 
pancreatic somatostatin contents: 632.1 (520.7-767.2) v. 267.8 (212.9-336.9) 
ng/ g pancreas (p<0.0001). The difference became even more apparent 
when the results were expressed relative to body weights: 2160.3 
(1802.0-2589.8) v. 789.3 (674.4-923.7) pg/ g body weight (p<0.0001). At 140 
days of age male, transgenic, low protein, cafeteria rats had pancreatic 
somatostatin contents that were not detectably different from those of the 
wild type, control, pellet animals: 558.2 (374.2-832.6) v. 486.0 (367.6-642.7) 
ng (p=0.523), respectively. When the results were expressed relative to the 
pancreas weights there was to a tendency for the former group to have 
higher pancreatic somatostatin contents: 519.1 (362.1-744.3) v . 364.6 
(282.6-470.5) ng/ g pancreas (p=0.086), respectively. There was no 
statistically significant difference between the groups when the results 
were expressed relative to the body weights: 1243.3 (886.5-1743.6) v. 963.9 
(764.9-1214.8) pg/ g body weight (p=0.174), respectively. 
7.3.11 Pancreatic Polypeptide Contents 
The pancreatic polypeptide contents in 70 day old female rats are 
shown in fig. 7.16 (a). Neither the early diet used (F=l.963, p=0.172) nor the 
genetic status of the rats (F=l.214, p=0.299; interaction F=3.930, p=0.057) 
was associated with detectable changes in pancreatic polypeptide contents. 
When expressed relative to the pancreas weights (fig. 7.16 (b)) the low 
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Figure 7.16 Pancreatic polypeptide contents of 70 day old female rats 
expressed per pancreas and relative to pancreas and body weights. Results 
shown are geometric means (95 % Cl) of the number of rats indicated. 
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I 
I 
protein rats had significantly greater pancreatic polypeptide contents than 
controls (F=31.583, p<0.0001). Again there was no detectable effect 
associated with the presence of the transgene (F=0.170, p =0.683; interaction 
F=l.263, p=0.271). When expressed relative to the body weights (fig. 7.16 (c)) 
the low protein rats had significantly greater pancreatic polypeptide 
contents than controls (F=57.336, p<0.0001). There was no detectable effect 
associated with the presence of the transgene (F=0.455, p=0.506; interaction 
F=0.521, p=0.477). 
The pancreatic polypeptide contents in 140 day old female rats are 
shown in fig. 7.17 (a). None of the experimental factors appeared to be 
associated with significant alterations in pancreatic polypeptide contents: 
association with the presence of the transgene (F=l.165, p =0.285), with the 
use of the low protein diet (F=0.139, p=0.710), with the use of the cafeteria 
diet (F=0.783, p =0.380; interactions F=0.050-0.824, p =0.368- 0.824). When 
expressed relative to the pancreatic weights (fig. 7.17 (b)) the low protein 
animals had greater pancreatic polypeptide contents than the controls 
(F=6.866, p=0.011). There was no detectable difference associated with the 
presence of the transgene (F=3.164, p=0.081) or with the use of the cafeteria 
diet (F=0.844, p =0.362; interactions F=0.061-1.598, p =0.212- 0.805). When 
expressed relative to body weights (fig. 7.17 (c)) low protein rats had greater 
pancreatic polypeptide contents than controls (F=30.276, p<0.0001). 
Cafeteria-fed animals had lower pancreatic polypeptide contents than 
those animals that were pellet-fed (F=22.556, p=0.0002). There was no 
significant alteration associated with the presence of the transgene 
(F=l.414, p=0.240; interactions F=0.033-2.549, p =0.116-0.856). 
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In male rats at 70 days of age there were no detectable differences in 
pancreatic polypeptide contents between transgenic, low protein animals 
and those which were wild type, control: 24.7 (20.6-29.6) v. 21.3 (18.4-24.6) 
ng (p=0.161), respectively. However when the results were expressed 
relative to the pancreas weights the transgenic, low protein animals had 
greater pancreatic polypeptide contents: 43.7 (34.1-55.9) v. 20.9 (17.2-25.3) 
ng/ g pancreas (p<0.0001), respectively. The difference became even more 
apparent when the results were expressed relative to body weights: 149.3 
(113.6-196.2) v. 61.5 (53.8-70.3) pg/ g body weight (p<0.0001). At 140 days of 
age there were no significant differences in pancreatic polypeptide contents 
between male transgenic, low protein, cafeteria animals and those which 
were wild type, control, pellet: 24.0 (21.3-26.9) v. 23.8 (20.2-28.1) ng 
(p=0.944), respectively. When expressed relative to pancreas weights the 
former group had greater pancreatic polypeptide contents: 22.3 (19.6-25.4) 
v . 17.9 (15.1-21.2) ng/ g pancreas (p=0.033), respectively. This difference was 
not detectable when the results were expressed relative to body weights: 
53.4 (46.3-61.5) v. 47.2 (38.3-58.2) pg/ g body weight (p=0.282), respectively. 
7.3.12 Pancreatic Congo Red Staining 
Congo Red staining of pancreatic sections from male and female 
rats at 63 and 133 days of age failed to show any evidence of pancreatic 
amyloid deposition . 
7.4 DISCUSSION 
The results described in the present study showed that young rats 
w ho w ere growth restricted by maternal and early protein restriction 
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(section 6.3) had better glucose tolerance than control animals. It has been 
suggested that the minimum protein requirement for a rat diet is 9 % 
(w / w) under ordinary circumstances and 12 % (w / w) if the rat is pregnant 
(National Research Council, 1978). Thus the low protein diet used in the 
current series of experiments, containing 8 % (w / w) protein, represented 
only a mild protein restriction but was still able to cause an alteration in 
glucose tolerance. Swapping the rats onto either normal laboratory chow 
or a highly palatable cafeteria-style diet for a period of 9 weeks caused a 
greater deterioration in the -glucose tolerance of the low protein animals 
than in the controls (so that at the end of this period the two pellet-fed 
groups did not show any significant difference in glucose tolerance; 
likewise for the two cafeteria-fed groups). Thus changing the diets may 
have revealed subtle abnormalities in overall glucose handling that 
would predispose the rat to more severe changes in later life. 
Cafeteria-fed rats had worse glucose tolerances than those that were 
pellet-fed irrespective of whether or not they had previously been protein 
restricted. The cafeteria diet is of the sort that is likely to lead to a degree of 
whole body insulin resistance (Storlien et al., 1986). The rises in fasting 
plasma insulin concentrations in the cafeteria-fed rats are consistent with 
this. In contrast to the alterations in glucose tolerance caused by both the 
early and late dietary manipulations, the presence of the human amylin 
transgene was rrot associated with significant alterations in glucose 
tolerance. If any amylin had been deposited as pancreatic amyloid it would 
only have been present in very small (submicroscopic) amounts as the 
Congo Red pancreatic h istological staining was negative. Also whereas in 
humans amylin may have metabolic roles which could alter glucose 
tolerance (section 1.2.1.2) human amylin may not be able to elicit a 
biological response in the rat (Rodriguez-Gallardo et al ., 1995) even if it is 
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formed, processed and secreted correctly from the rat pancreatic is-cells 
(Van Hulst et al., 1997). 
Previous studies looking at the effects of low protein feeding on 
glucose tolerance in weanling rats have shown a worsening of (Weinkove 
et al., 1976; Swenne et al ., 1987), an improvement in (Okitolonda et al., 
1987; Escriva et al., 1991) or no alteration (Younoszai & Dixit, 1980; Levine 
et al., 1983; Okitolonda et al., 1987; Swenne et al., 1987; Claeyssens et al., 
1990; Harel & Tannenbaum, 1995) in glucose tolerance in the low protein 
rats. These contrasting results are likely to be accounted for by such factors 
as alterations in the protein contents and source in the different diets used, 
whether the diet produces a pure protein deficiency or one which also 
causes a deficit in energy intake, other differences in the dietary 
compositions (e.g. fat composition and content), the length of time that 
the rats were fed the protein deficient diet and whether there was a period 
of time after the protein restriction when the rats were fed a normal diet 
prior to the assessment of glucose tolerance. 
Reported results are also somewhat varied from studies where the 
protein restriction was applied to the pregnant dam (as well as to the 
offspring in some cases). Young offspring from dams fed a low protein diet 
during pregnancy and/ or lactation have been reported to have better 
(Langley et al., 1994; Hales et al., 1996b; Holness, 1996b; Shepherd et al., 
1997), worse (Dahri et al., 1991) or not significantly altered (Holness & 
Sugden, 1996; Holness 1996a; Wilson & Hughes 1997) glucose tolerances. 
This discrepancy in results is likely to be at least partially due to the factors 
described earlier. Dahri et al. (1991) found a worsening of glucose tolerance 
in rats using the same low protein diet as that used in the present study, 
both for rat dams and their offspring. In the present study, however, the 
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glucose tolerances were better in low protein animals than in controls at 
63 days of age and not significantly different at 133 days of age after 63 days 
of normal protein intake. The results of the present study are therefore 
more consistent with other studies where the dam has been protein 
restricted than with those of Dahri et al. (1991) even though the other 
studies used either different protein diets (Langley et al., 1994; Wilson & 
Hughes 1997) from that described for the present study or they restricted 
maternal protein intake alone (Hales et al., 1996b; Holness, 1996a and 
1996b; Holness & Sugden, 1996; Shepherd et al., 1997). 
The improvement in glucose tolerances in the 63 day old low 
protein rats is likely to have been caused by an increased whole-body 
insulin sensitivity. Consistent with this in the post-absorptive state the 
female low protein rats had lower blood glucoses and yet also had lower 
plasma insulin concentrations. Previously reported studies have also 
shown improvements in whole-body insulin sensitivity in young low 
protein rats . Holness (1996a) using the same diets as those used in the 
present study, protein restricted rat dams during pregnancy and lactation 
and found that at 18 weeks of age the low protein offspring required a 
greater glucose infusion rate to maintain glycaemia in euglycaemic 
hyperinsulinaemic clamp studies. Weanling rats fed a low protein diet 
also appear to have improved whole-body insulin sensitivity. Escriva et al. 
(1991) found that· feeding weanling rats a diet containing 5 % (w /w) 
protein for just four weeks led to an increased glucose disappearance rate 
during intravenous glucose tolerance tests. Weinkove et al. (1976) found 
that feeding weanling rats a diet containing 4 % (w /w) protein for just 
three weeks led to an improvement in whole-body insulin sensitivity that 
was so great that one third of their low protein rats died from 
hypoglycaemia during insulin tolerance tests. 
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This improvement of whole-body insulin sensitivity allowed the 
circulating plasma insulins in the low protein female rats to be lower than 
those of controls. From these studies in young adult rats it can not be 
concluded that this alteration was permanent (i.e. 'programmed' (section 
4.1)) as results did not show significant differences at 133 days of age. The 
mean fasting insulin concentrations of several of the low protein groups 
were lower than those of equivalent controls, however. There was still 
some flexibility as shown by the rise in fasting insulin concentrations in 
the low protein rats that were fed the cafeteria diet. These results may 
reflect the situation reported in a human study where malnourished 
children had lower circulating insulin concentrations during intravenous 
glucose tolerance tests than controls even after a period of rehabilitation 
(James & Coore, 1970). As in the rats there was some flexibility as the 
insulin concentrations, which whilst not quite reaching those seen in 
controls, after the recovery period were higher than those seen whilst the 
children were still malnourished. 
The fasting plasma lipid concentrations generally appeared not to be 
programmed by the early protein restriction. The only factor that was 
significantly affected by the early protein restriction was the fasting 
triacylglycerol concentration in 63 day old female rats. It has previously 
been shown that feeding weanling rats a diet containing 6 % (w /w) protein 
for three weeks produces a massively triacylglycerol-rich liver (Claeyssens 
et al., 1990). Thus the high fasting plasma triacylglycerol concentrations in 
the low protein rats may reflect greater triacylglycerol production by the 
liver. The circulating concentration is clearly not programmed to be 
different from that of the controls, however, as the difference disappears 
when the rats have been given the adult diets for 63 days. This contrasts 
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with the results of Lucas et al. (1996) who restricted maternal protein only. 
This was done during pregnancy and/ or lactation and any period of 
maternal protein restriction was found to be associated with a reduction in 
plasma cholesterol and triacylglycerol concentrations in the offspring. 
The cafeteria diet provided 16 % of its energy as fat, as opposed to 
9 % in the pellet diet. The rats that were fed the cafeteria diet had much 
higher food intakes than those that were pellet-fed (section 6.3.3) because it 
was highly palatable. Therefore these rats ate considerably more fat-
calories. In contrast to maternal and early protein restriction, eating this 
diet caused significant rises in circulating concentrations of triacylglycerol 
and free glycerol that were presumably related to dietary intake rather than 
any effect of programming. 
The circulating creatinine concentrations were higher in 63 day old 
protein restricted female rats than in the controls. Given that the source of 
protein in the diets was of vegetable origin (casein) the factors most likely 
to contribute to the plasma creatinine concentration were the muscle mass 
(creatinine being a metabolite of muscle creatine) and the glomerular 
filtration rate (creatinine being cleared from the blood by the kidneys into 
the urine). Both the weights of the gastrocnemius muscles and the kidneys 
were severely reduced in the protein restricted animals (section 6.3.4). If 
the weights of the other muscles were similarly reduced it seems likely 
that the raised creatinine concentrations would largely have been due to 
the small kidneys having reduced numbers of nephrons and a lower 
glomerular filtration rate. Further studies needed to clarify this would 
include an assessment of the clearance of a non-metabolisable agent such 
as inulin. Blood pressures were not measured at this age but in humans at 
least, small kidneys with low nephron numbers (and therefore 
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presumably causing low glomerular filtration rates) have been associated 
with the development of hypertension (MacKenzie & Brenner, 1995). The 
alteration in creatinine concentration associated with the early protein 
restriction was not present in the female rats at 133 days of age probably 
due to a greater part of the circulating c·reatinine concentration being 
affected by creatine breakdown in muscles (values being higher at 133 days 
than at 63 days of age). 
The pancreatic hormone contents in the present study show a 
number of relative differences from those seen in the previous study 
(chapter 4). There are several differences between the designs of the two 
studies, however, the major ones being that in the present study: (i) half 
the rats were transgenic for human amylin, (ii) the litter sizes were not 
standardised, (iii) the pups whose mothers had been fed the low protein 
diet were weaned onto the diet themselves until they reached 70 days of 
age and (iv) the cafeteria and pellet diets were given continuously for ten 
weeks instead of six. The differences in results between the present and the 
previous studies particularly appear to emphasise the effects of low 
protein feeding immediately post weaning. 
At both 70 and 140 days of age the low protein female rats had 
lighter pancreata than the controls (section 6.3.4). At 70 days of age the 
reduction in pancreas weights was proportional to the reduction in body 
weights. The reduction was proportionally less than the reduction in body 
weights at 140 days of age, however (section 6.3.4). At this age the cafeteria-
fed rats had heavier pancreata than pellet-fed animals (although relative 
to the body weights the cafeteria-fed rats had lighter pancreata). In males 
the transgenic, low protein rats had lighter pancreata than the wild type, 
control animals at both ages studied (section 6.3.4). 
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Not surprisingly the pancreatic amylin contents were increased in 
the transgenic female rats at 70 days of age, despite the total pancreatic 
amylin being measured with a rat amylin assay that only cross reacted 
around 30 % with human amylin (section 3.3.3). This low cross reactivity 
probably explains why statistical significance was not reached in 140 day 
old transgenic female rats when the pancreatic amylin contents were 
expressed per pancreas (significance only being reached when the values 
were standardised per unit pancreas weight or body weight). The presence 
of the human amylin transgene was not associated with detectable 
alterations in the contents of any of the other pancreatic hormones 
measured. This is different from one human amylin transgenic mouse 
line which has been reported to have increased pancreatic insulin storage 
(Verchere et al., 1994). 
Aside from the effect associated with the presence of the transgene, 
the pancreatic amylin contents appeared to be programmed in a very 
similar manner to that seen in the previous study (i.e. lower in the low 
protein female rats at both 70 and 140 days of age, but with the increase in 
cafeteria-fed rats showing some flexibility around the lowered set-point; 
section 4.3.2). The lowering of the pancreatic amylin contents of the low 
protein rats appeared to be proportional to their reduction in pancreas 
weights as the difference in amylin contents disappeared when the results 
were expressed relative to pancreas weights. 
The pancreatic insulin contents of the female rats showed a very 
different pattern from that seen in the previous study (section 4.3.3). 
Firstly the low protein rats had lower pancreatic insulin contents than 
controls. In the previous study there was no significant difference in 
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pancreatic insulin contents between the control and low protein rats, 
when the only protein restriction was maternal during pregnancy and 
lactation. Previously it has been shown that in the rat the volume of 
pancreatic .ls-cells increases with increasing age, at least up to 210 days of 
age (McEvoy & Madson, 1980a). Thus by extending the period of protein 
restriction from weaning to 70 days of age (a period of time when B-cell 
volume in the rat has been shown to increase around four-fold and the 
pancreatic insulin contents more than double (McEvoy & Madson, 1980b)) 
it is likely that this increase in .ls-cell volume was inhibited (amino acids 
having been shown to potently stimulate islet cell proliferation in adult 
mouse islets (Dunger et al., 1990)). The programming of pancreatic insulin 
contents in the protein restricted animals could then become apparent. In 
the previous study all the maternal protein restricted offspring were 
weaned onto a laboratory chow and therefore, because of the rapid 
expansion of .ls-cell volume during the immediate post-weaning period, a 
recuperation may have taken place to mask any effects of maternal protein 
restriction on pancreatic insulin contents in the offspring (Snoeck et al., 
1990; Dahri et al., 1991). 
In the present study the cafeteria diet was also associated with large 
increases in pancreatic insulin contents in female rats, presumably to 
compensate for any whole body insulin resistance that developed as a 
result of the cafeteria feeding and the ensuing obesity. This meant that 
insulin appeared to programmed in a similar manner to amylin, so that 
there was flexibility around the lowered set-point of the maternal and 
early protein restricted rats. This suggests that at the ages studied the 
lowering of plasma insulins in the female low protein rats would 
· only 
predispose the rats to the development of diabetes,i f there was a change in 
the ability of the .ls-cells to respond to nutrient challenges in adult life. 
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The pancreatic glucagon contents also appeared to be affected 
differently from those seen in the previous study (section 4.3.4). At 70 days 
of age in the female rats there was no detectable difference in pancreatic 
glucagon contents between the controls and those rats that underwent 
maternal and early protein restriction. By 140 days of age, however, the 
previously protein restricted rats had greater pancreatic glucagon contents 
than controls, independent of which adult diet they had been given from 
70 days of age. Without further studies looking at older rats it is impossible 
to describe this increase as permanent programming. It is difficult to 
explain why the previously protein restricted animals should increase 
their pancreatic glucagon contents after being fed the adult diets for ten 
weeks. One possibility, however, is that the animals were glucagon 
resistant as Ozanne et al. (1996a) previously have shown that offspring of 
protein restricted mothers have reduced numbers of hepatic glucagon 
receptors. Clearly if these pancreatic changes were permanent from this 
age onwards and reflected secretion rates, the combination of increased 
glucagon and decreased insulin could contribute towards a future diabetic 
state. 
Neither somatostatin nor pancreatic polypeptide contents appeared 
to be programmed to be different to that of controls by maternal and early 
protein restriction in- the present study. In light of the alterations in 
pancreatic insulin and glucagon contents in female rats, these results 
suggest that the protein restriction may somehow have caused a change in 
islet architecture with a reduced volume of fs-cells, possibly an increased 
volume of a-cells and standard volumes of 8- and PP-cells. 
Immunocytochemistry would be necessary to confirm these suggestions 
but they are certainly consistent with the reduction in fs-cell numbers seen 
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with maternal protein restriction alone in the pancreata of the rat 
offspring (Berney et al., 1997). When the results were expressed relative to 
the pancreas weights the low protein rats had raised glucagon and 
pancreatic polypeptide contents, suggesting that the cells in which these 
hormones were made may have been relatively less affected by the 
reduction in pancreas weights than was the exocrine tissue. Relative to 
body weights the low protein rats had raised glucagon, pancreatic 
polypeptide and possibly somatostatin contents, suggesting that there were 
increased potentially available amounts of these hormones for whole body 
control purposes. 
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7.5 SUMMARY 
(1) In an attempt to model and test the thrifty phenotype hypothesis in 
the rat, pregnant dams were protein restricted throughout 
pregnancy and lactation. Their offspring were weaned onto the 
same diet until 70 days of age. Rats were then given either a pelleted 
laboratory chow or a highly palatable cafeteria-style diet for a further 
10 weeks. Measures of glucose tolerance, circulating lipid 
concentrations and pancreatic hormone contents were taken. 
(2) At 63 days of age both male and female low protein rats had better 
glucose tolerances than the controls. In the females the fasting 
plasma insulins were lower suggesting an improved whole body 
insulin sensitivity. At 133 days of age, after being fed the adult diets 
for 63 days, the previously protein restricted rats had similar glucose 
tolerances to controls and cafeteria-fed rats had worse tolerances 
than those that were chow fed. Thus the glucose tolerances of the 
formerly protein restricted animals had deteriorated more than that 
of the controls. Cafeteria feeding was associated with an increase in 
fasting plasma insulins suggesting a degree of whole body insulin 
resistance. The presence of the human amylin transgene was not 
associated with an alteration in glucose tolerance. 
(3) Circulating lipid concentrations in previously protein restricted 
animals appeared not to be programmed to be different from that of 
controls but cafeteria-fed rats had higher fasting triacylglycerols. 
(4) Pancreatic amylin and insulin concentrations were programmed to 
be lower in the protein restricted females than in the controls. At 
140 days of age these animals also had higher pancreatic glucagon 
contents. If these changes were permanent and reflected secretion 
rates they could have contributed to a future diabetic state. Neither 
somatostatin nor pancreatic polypeptide contents appeared to be 
programmed to be different in protein restricted rats. 
(5) See tables 7.1 and 7.2 for summaries of effects of maternal and early 
protein restriction on plasma concentrations and pancreatic 
hormone contents in young adult female rats. 
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Table 7.1 Main plasma effects associated with maternal and early protein 
restriction in 70 and 140 day old female rats. 
70 days of age 140 days of age 
Glucose tolerance improved no detectable difference 
Fasting plasma insulin lower no detectable difference 
Fasting plasma higher no detectable difference 
triacylglycerol 
Fasting plasma free no detectable difference no detectable difference 
glycerol 
Plasma total no detectable difference no detectable difference 
cholesterol 
Plasma crea tinine higher no detectable difference 
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Table 7.2 Main pancreatic hormone content effects associated with 
maternal and early protein restriction in 70 and 140 day old female rats. 
70 days of age 140 days of age 
Pancreatic amylin 
(/pancreas) lower lower 
(/ g pancreas) no detectable difference no detectable difference 
(/ g body weight) no detectable difference ? higher 
Pancreatic insulin 
(/ pancreas) lower lower 
(/ g pancreas) no detectable difference no detectable difference 
(/ g body weight) no detectable difference no detectable difference 
Pancreatic glucagon 
(/pancreas) no detectable difference higher 
(/ g pancreas) higher higher 
(/ g body weight) higher higher 
Pancreatic somatostatin 
(/pancreas) no detectable difference no detectable difference 
(/ g pancreas) higher no detectable difference 
(/ g body weight) higher ? higher 
Pancreatic polypeptide 
(/pancreas) no detectable difference no detectable difference 
(/ g pancreas) higher higher 
(/ g body weight) higher higher 
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Chapter 8 
The Effects Of Maternal And Early Protein 
Restriction On Glucose And Lipid 
Metabolism In Old Rats 
8.1 INTRODUCTION 
In the maiden study that linked low birth weight with subsequent 
impaired glucose tolerance and type 2 diabetes (Hales et al., 1991), those 
individuals who were glucose intolerant had raised blood pressures as 
well as lower birth weights. These links found in Hertfordshire men were 
also found in follow up studies in men and women in Preston (Barker et 
al., 1990; Phipps et al., 1993). Measurement of plasma lipids in these 
individuals combined with the glucose tolerance and blood pressure data 
allowed the classification of the individuals as to whether or not they 
showed characteristics of having the insulin resistance syndrome. For both 
cohorts (when adjusted for current BMI) those included in the lowest birth 
weight categories (less than 2.5 kg) were greater than ten times more likely 
to have the insulin resistance syndrome than those in the highest birth 
weight category (>4.31 kg in Hertfordshire or >3.41 kg in Preston) (Barker et 
al., 1993a). This association with low birth weight was found to be 
independent of possible confounding factors such as duration of gestation, 
smoking history, alcohol consumption and social class, either currently or 
at birth. From these results it was suggested that the origins of the insulin 
resistance syndrome are sub-optimal development in utero. 
In the San Antonio Heart Study 562 subjects were split into tertiles 
for both birth weight and current BMI (Valdez et al., 1994). The p revalence 
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of the insulin resistance syndrome fell with increasing birth weight in 
each of the BMI tertiles and with rising current BMis in each of the birth 
weight tertiles. None of the 61 subjects with the highest birth weights and 
the lowest BMis were classified as having the insulin resistance syndrome. 
This contrasts with 25 out of 64 subjects having the insulin resistance 
syndrome in the category containing those people with the lowest birth 
weights and the highest current BMis. The authors stated that for each 
tertile decrease in birth weight (a decrease of 535 g on average) the odds of 
developing conditions related to insulin resistance increased by 72 %. It 
would appear that factors associated with low birth weight and factors 
associated with current obesity are both able to influence glucose tolerance 
and blood pressure. 
A number of studies have investigated the effects of protein 
restriction on glucose tolerance in rats (outlined in section 7.4). Several of 
these have tried to model and test the thrifty phenotype hypothesis (Hales 
& Barker, 1992) by restricting the protein intake of pregnant female rats 
and then subsequently testing the glucose tolerance of the offspring. Even 
though these studies have used fetal and neonatal malnutrition to try and 
model the development of type 2 diabetes, which in Western countries 
develops in middle age or beyond, only two studies have tested the 
glucose tolerance of the rat offspring when they reached middle and / or 
old age (Langley et al ., 1994; Hales et al., 1996b). None of the studies that 
investigated the effects of dietary induced obesity on rats whose mothers 
were protein restricted, tested glucose tolerance in middle and later life. 
Maternal protein restriction has also been used to investigate effects 
on blood pressure of the rat offspring. Thus feeding a diet containing 6 or 
9 % protein to rats during pregnancy resulted in raised blood pressure in 
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the offspring that was detectable by nine weeks of age and was still evident 
at twenty-one weeks of age (Langley & Jackson, 1994). It was later shown 
that fetal exposure to maternal low protein diets during any single 
trimester of the pregnancy is associated with subsequent hypertension 
(although of a lesser magnitude than when the protein restriction was 
throughout the whole gestational period) (Langley-Evans et al., 1996b). 
The studies in humans show that factors associated with low birth 
weight and obesity are able to worsen both glucose tolerance and blood 
pressure (to cause the adult degenerative diseases diabetes and 
hypertension) . The work described in the following chapter was initiated 
to investigate whether early growth restriction (caused by maternal and 
early low protein) and subsequent obesity (caused by feeding a cafeteria-
style diet) are able to precipitate the features of the insulin resistance 
syndrome. 
8.2METH0DS 
8.2.1 Animals And Diets Used 
Sprague Dawley transgenic and wild type rats were set up exactly as 
for the rats studied at 140 days of age (section 6.2.1). Once they had been 
swapped from their weaning diets (control or low protein) onto either the 
pellet or cafeteria diets (at 70 days of age) they were allowed to continue 
feeding on these diets for the remainder of the study.' At twelve months of 
age the rats had their blood pressures measured by an indirect tail cuff 
procedure (section 8.2.2). They also had intra-peritoneal glucose tolerance 
tests performed on them after an overnight fast (section 5.2.5). These 
glucose tolerance tests w ere repeated on the same an imals at sixteen 
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months of age. The body weights of the rats were still being monitored 
weekly at this age (section 6.3.3) and once they started to lose weight 
(generally between 16 and 22 months) glucose tolerance tests were repeated 
on these animals for the final time. Upon death pancreas samples were 
removed for thioflavin S histology (section 5.2.6). 
At 12 months of age the following analytes were measured in 
plasma: insulin (section 2.2.1), rat amylin (section 3.2.3), human amylin-
like peptides (section 3.2.4), corticosterone (section 2.2.5), triacylglycerol 
(section 2.2.6), free glycerol (section 2.2.6) and cholesterol (section 2.2.7). At 
16 months of age plasma insulin, corticosterone, triacylglycerol, free 
glycerol and cholesterol were measured. 
8.2.2 Blood Pressure Measurements 
At twelve months of age each of the rats described in section 6.2.1 
had its blood pressure measured. These were determined by recording tail 
vein pulses at 29 + 1 °C with the rats being conscious (Blood Pressure 
Monitor; Linton Instrumentation, Diss, Norfolk, U.K.) (Langley & Jackson, 
1994). Prior to measurement and in order to minimise stress, the rats were 
trained to enter the perspex restraining tubes ( each rat entering the tube 
three times on three separate occasions was found generally to be 
sufficient). All measurements were taken in the early evening after 
animal house staff had left so that extraneous noise was minimised. The 
cuffs were placed over the tails of the rats who were restrained in the tubes 
and then inflated so that there was an absence of detectable tail vein 
pulses. After this the pressure was slowly released and the systolic blood 
pressures taken by comparing the point at which tail vein pulses 
reappeared with a blood pressure scale that had been pre-calibrated against 
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a mercury sphygmomanometer (a typical trace is shown in fig. 8.1). Due to 
the reading of the blood pressure traces being somewhat subjective, each 
blood pressure trace was coded and read by an independent investigator 
(Dr. S.E. Ozanne) not involved in obtaining the traces. Each of the rats had 
five blood pressure traces recorded in a single session. The highest and 
lowest systolic blood pressure results were discarded ( on the 
recommendation of a Linton Instrumentation technical advisor) and the 
systolic pressure recorded as the mean of the three remaining results. One 
rat had its systolic pressure measured at each of the evening sessions, the 
recordings having a CV of 3.2 % (n=7). 
The diastolic blood pressure was also estimated using the following 
equation which is adapted from the pulse pressure formula (according to 
the supplier's instructions: Linton Instrumentation, Diss, Norfolk, U.K.): 
Diastolic blood pressure = (3 x mean blood pressure) - systolic blood pressure 
2 
The mean blood pressure was taken as the point on the blood pressure 
scale corresponding to the point where the tail vein pulse trace reaches its 
'first maximum' after reappearing. In each case the diastolic pressures were 
measured on the three traces that were used to gain the systolic pressure 
and recorded as the mean of these results. One rat had its diastolic pressure 
measured at each of the evening sessions, the recordings having a CV of 
10.6 % (n=7). 
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Figure 8.1 A typical blood pressure trace. 
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8.2.3 Statistical Analyses 
All glucose tolerances were assessed using the areas under the 
glucose tolerance test curves. Results from all animals were compared 
using three-way ANOVA with the genetic status, the early diet and the 
adult diets used as the independent variables. If necessary results from 
solely wild type female rats were compared using two-way ANOV A, the 
early diet and the adult diets used as the independent variables. Post-hoe 
comparisons were made using Duncan's multiple range test. In each case if 
necessary the variables were log-transformed prior to analysis to allow the 
appropriate use of parametric statistical testing. All results shown are 
geometric means (95 % CI) unless otherwise stated. All data from male rats 
were compared using Student's unpaired t-test, apart from lipid results 
which were compared using the Mann Whitney U test. 
8.3 RESULTS 
8.3.1 Glucose Tolerance Tests 
The results of the glucose tolerance tests for 12 month old female 
and male rats are shown in fig. 8.2. In female rats cafeteria-fed animals had 
significantly worse glucose tolerances than pellet-fed animals (F=9.164, 
p=0.004) . There was no detectable alteration in glucose tolerance associated 
with either the presence of the transgene (F=l.030, p=0.315) or the early 
diet used (F=0.771, p=0.384; interactions F=0.185-2.SOi, p=0.120-0.668). The 
d ifference in glucose tolerances in male rats between transgenic, low 
protein, cafeteria animals and those that were wild type, control, pellet did 
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Figure 8.2 Intra-peritoneal glucose tolerance test results from (a) 12 month old 
female rats and (b) 12 month old male rats. The groups were as described in 
section 6.2.1. 
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not quite reach significance at this age (mean (SD) 3798 (233) v. 3521 (272) 
area under curve units, p =0.055). 
The results of the glucose tolerance tests for 16 month old female 
and male rats are shown in fig. 8.3. As at 12 months of age the cafeteria-fed 
female rats had significantly worse glucose tolerances than those that were 
pellet-fed (F=l6.145; p =0.0002). Again there were no detectable effects 
associated with either the presence of the transgene (F=0.931, p=0.339) or 
with the early diet used (F=0.968, p =0.330). The interaction between the 
early and late diets used almost reached significance (F=3.345, p =0.073; 
other interactions F=0.001-1.112, p =0.297-0.981). Individual comparisons 
between the groups showed that low protein, pellet rats had worse glucose 
tolerances than control, pellet animals (p=0.041) but glucose tolerances of 
low protein, cafeteria rats were not significantly different from those of 
control, cafeteria animals (p=0.532). Mean (SD) deteriorations in glucose 
tolerances in the female rats over the four months were as follows (n.b. a 
negative sign denotes a relative improvement in glucose tolerance): 
control, pellet -468 (616) area under the glucose tolerance curve units; 
control, cafeteria -216 (600); low protein, pellet 82 (469); low protein, 
cafeteria -18 (522). Thus over these four months the relative deterioration 
in glucose tolerance was greater in the low protein rats than in the 
controls (p=0.014). There was no difference in the relative deterioration in 
glucose tolerance ·associated with the use of the different adult diets 
(p=0.603; interaction p =0.236). As at 12 months of age the difference in 
glucose tolerances in male rats between transgenic, low protein, cafeteria 
animals and those that were wild type, control, pellet did not quite reach 
significance at 16 months of age (mean (SD) 3940 (572) v. 3411 (270) units, 
p=0.063). 
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section 6.2.1. 
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The results of the glucose tolerance tests for 16-22 month old 
female and male rats are shown in fig. 8.4. As in the other ages studied 
female rats that were cafeteria-fed had worse glucose tolerances than those 
that were pellet-fed (F=4.950, p=0.032). There were no detectable alterations 
in glucose tolerance associated with the presence of the transgene (F=0.896, 
p=0.349) or with the early diet used (F=0.054, p=0.817) . Like the case at 16 
months of age the interaction between the early and late diets used almost 
reached significance (F=3.263, p=0.078) . In male rats over these ages the 
glucose tolerances of those that were transgenic, low protein, cafeteria 
were significantly worse than those that were wild type, control, pellet 
(mean (SD) 3808 (334) v. 3222 (288) units, p=0.018). 
8.3.2 Fasting Plasma Insulin Concentrations 
The fasting plasma insulin concentrations in 12 month old female 
rats are shown in fig. 8.5 (a). Low protein rats had lower plasma insulins 
than the controls (F=4.636, p=0.036) and cafeteria-fed rats had higher 
insulins than those that were pellet-fed (F=41.773, p<0.0001). There was no 
detectable effect on fasting plasma insulins associated with the presence of 
the transgene (F=0.121, p=0.730; interactions F=0.051-0.692, p=0.409-0.822). 
The fasting plasma insulins of male transgenic, low protein, cafeteria rats 
were not significantly different from those of wild type, control, pellet rats 
(geometric mean (95 % CI) 292.6 (145.2-589.5) v. 188.3 (102.6-345.7) pmol/1, 
p=0.292). 
The fasting plasma insulin concentrations in 16 month old female 
rats are shown in fig. 8.5 (b).Like at 12 months of age, low protein rats had 
lower plasma insulins than the controls (F=7.749, p=0.008) and cafeteria-
-218 -
(a) 8 
' 7 , ... 
.... 
.... 
.... 
.... 
-
6 ...__ ~ -
-..... - -
.. 0 
s 5 s 
-(I) 
rr, 
0 4 
u 
= ..... 
c., 3 8 Control, Pellet (n=ll ) 
"!j 
0 
• - Control, Cafeteria (n=9) 0 ..... 
i:;Q 2 e- - Low Protein, Pellet (n=17) 
• Low Protein, Cafe
teria (n=13) 
1 
0 
0 30 60 90 120 150 180 
Time (mins.) 
8 (b) 
7 
-
..... 6 
-
..... 
0 
s 
s 5 
-(I) 
rr, 
0 
u 4 
= ..... 
c., 
"!j 
0 
3 D Control, Pellet (n=S) 
0 
..... 
• Low Protein, Cafeter
ia (n=S) 
i:;Q 
2 
1 
0 
0 30 60 90 120 150 180 
Time (mins.) 
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fed rats had higher insulins than those that were pellet-fed (F=62.691, 
p<0.0001). Similarly there was no detectable effect on fasting plasma 
insulins associated with the presence of the transgene (F=0.053, p=0.818; 
interactions F=0.002-0.895, p=0.349-0.964). In males, like at 12 months of 
age, the fasting plasma insulins of transgenic, low protein, cafeteria rats 
were not significantly different from those of wild type, control, pellet rats 
(geometric mean (95 % CI) 242.3 (107.7-545.1) v. 194.6 (111.9-338.2) pmol/1, 
p=0.578). 
8.3.3 Fasting Plasma Amylin Concentrations 
The fasting plasma amylin concentrations in 12 month old female 
rats are shown in fig. 8.6 (a). The transgenic rats had higher amylin 
concentrations than the wild type animals (F=l2.538, p=0.001). The 
cafeteria-fed rats had higher fasting amylin concentrations than those that 
were pellet-fed (F=5.109, p=0.029). The difference in fasting plasma amylin 
concentrations between low protein and control animals did not quite 
reach statistical significance, although they tended to be lower in the low 
protein rats (F=3.796, p=0.058; interactions F=0.000-1.485, p=0.230-0.992). In 
males transgenic, low protein, cafeteria rats had higher fasting plasma 
amylin concentrations than those that were wild type, control, pellet 
(geometric mean (95 % CI) 10.3 (3.9-27.2) v. 2.4 (0.9-6.6), p=0.028). 
The fasting plasma human amylin-like peptides concentrations in 
12 month old female rats are shown in fig. 8.6 (b ). The transgenic animals 
had higher concentrations than wild type animals (F=73.506, p<0.0001). 
Cafeteria-fed animals showed a tendency to have higher concentrations 
than pellet-fed animals (F=3.483, p=0.068) which only reached statistical 
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Figure 8.6 Fasting plasma (a) amylin and (b) human amylin-like peptides 
concentrations in 12 month old female rats. Results shown as median 
(interquartile range). pell= pellet-fed, caf = cafeteria-fed. 
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significance when interacting with the presence of the transgene (F=4.634, 
p=0.036) . The early diet did not result in detectable changes in human 
amylin-like peptides concentrations (F=0.215, p=0.645) even when 
interacting with the presence of the transgene (F=l.110, p=0.297). Human 
amylin-like peptide concentrations were not measured in male rats 
because of the two groups only one was transgenic for human amylin. 
8.3.4 10°0 Plasma Corticosterone Concentrations 
The 1000 plasma corticosterone concentrations of 12 month old 
female rats are shown in fig. 8.7 (a). There were no statistically significant 
alterations in female rats associated with the presence of the transgene 
(F=l.816, p=0.183), the early diet used (F=0.510, p=0.478) or the adult diet 
used (F=2.933, p=0.092; interactions F=0.000-0.674, p=0.415-0.993). In male 
rats there were no detectable difference in corticosterone concentrations 
between transgenic, low protein, cafeteria animals and those that were 
wild type, control, pellet (geometric mean (95 % Cl) 182 (127-263) v. 205 
(123-342) ng/ml, p=0.624). 
The 10°0 plasma corticosterone concentrations of 16 month old 
female rats are shown in fig. 8.7 (b ). Generally cafeteria-fed rats had lower 
concentrations than those that were pellet-fed (F=4.817, p=0.034). There 
were no statistically significant alterations in female rats associated with 
the presence of the transgene (F=0.282, p=0.580) or with the early diet used 
(F=2.517, p =0.120). In male rats, like at 12 months of age, there were no 
detectable difference in corticosterone concentrations between transgenic, 
low protein, cafeteria animals and those that were wild type, control, pellet 
(geometric mean (95 % Cl) 530 (145-1939) v. 671 (466-967) ng/ml, p=0.661). 
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Figure 8.7 Plasma 1000 corticosterone concentrations in (a) 12 month old 
and (b) 16 month old female rats. Results shown are geometric means 
(95 % Cl). The groups were as described in section 6.2.1. pell = pellet-fed, 
caf = cafeteria-fed. 
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8.3.5 Fasting Plasma Triacylglycerol Concentrations 
The fasting plasma triacylglycerol concentrations in 12 month old 
female rats are shown in fig. 8.8 (a). Cafeteria-fed rats had higher 
triacylglycerol concentrations than pellet-fed rats (F=35.339, p<0.0001). 
There were no significant alterations in triacylglycerol concentrations 
associated with the presence of the transgene (F=0.133, p =0.717) or with the 
early diet used (F=0.958, p=0.332; interaction F=0.035- 0.254, p=0.616-0.852). 
In male rats the difference in fasting plasma triacylglycerol concentrations 
between transgenic, low protein, cafeteria animals and those that were 
wild type, control, pellet did not reach statistical significance (median 
(interquartile range) 1.6 (1.2-2.6) v. 0.9 (0.4-1.4) mmol/1, p =0.093). 
The fasting plasma triacylglycerol concentrations in 16 month old 
female rats are shown in fig. 8.8 (b ). Low protein rats had lower fasting 
triacylglycerol concentrations than controls at this age (F=4.933, p =0.032). 
Cafeteria-rats had triacylglycerol concentrations that in comparison to 
pellet-fed animals were almost statistically significantly higher (F=3.880, 
p =0.055), also when interacting with the effects caused by differences in the 
maternal and early diets (F=3.115, p =0.085). There was no detectable 
significant effect associated with the presence of the transgene (F=0.622, 
p =0.434; other interactions F=0.007-0.188, p =0.667-0.935) . In male rats there 
was no detectable difference in fasting plasma triacylglycerol 
concentrations between transgenic, low protein, cafeteria animals and 
those that were wild type, control, pellet (median (interquartile range) 1.8 
(1.2-3.2) v . 1.4 (0.5-3.1) mmol/1, p=0.475). 
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Figure 8.8 Fasting plasma triacylglycerol concentrations in (a) 12 month 
old and (b) 16 month old female rats. Results shown are geometric means 
(95 % Cl). The groups were as described in section 6.2.1. pell = pellet-fed, 
caf = cafeteria-fed. 
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8.3.6 Fasting Plasma Free Glycerol Concentrations 
The fasting plasma free glycerol concentrations in 12 month old 
female rats are shown in fig. 8.9 (a). Cafeteria-fed animals had higher 
fasting glycerols than those that were pellet-fed (F=l6.193, p=0.0.002). There 
were no detectable significant effects associated with either the presence of 
the transgene (F=0.081, p=0.777) or with the early diets used (F=0.035, 
p=0.851; interactions F=0.083-2.017, p=0.161-0.774). In male rats there was 
no detectable difference in fasting plasma free glycerol concentrations 
between transgenic, low protein, cafeteria animals and those that were 
wild type, control, pellet (median (interquartile range) 0.26 (0.14-0.45) v. 
0.29 (0.14-0.38) mmol/1, p=l.000). 
The fasting plasma free glycerol concentrations in 16 month old 
female rats are shown in fig. 8.9 (b). Again the cafeteria-fed rats had higher 
fasting plasma glycerols than those that were pellet-fed (F=4.725, p=0.035). 
There were no detectable significant effects associated with either the 
presence of the transgene (F=0.457, p=0.503) or with the early diet used 
(F=0.111, p=0.741; interactions F=0.002-0.533, p=0.469-0.964). In male rats 
there was no detectable difference in fasting plasma free glycerol 
concentrations between transgenic, low protein, cafeteria animals and 
those that were wild type, control, pellet (median (interquartile range) 0.87 
(0.65-0.98) v. 0.82 (0.77-0-.89) mmol/1, p=0.721). 
8.3.7 Plasma Total Cholesterol Concentrations 
The plasma cholesterol concentrations in 12 month old female rats 
are shown in fig. 8.10 (a). Cafeteria-fed animals had higher plasma 
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Figure 8.9 Fasting plasma free glycerol concentrations in (a) 12 month old 
and (b) 16 month old female rats. Results shown are geometric means 
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old and (b) 16 month old female rats. Results shown are geometric means 
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cholesterols than those that were pellet-fed (F=4.133, p =0.047). There were 
no detectable significant effects associated with either the presence of the 
transgene (F=l.683, p=0.200) or with the early diet used (F=l.101, p=0.299; 
interactions F=0.004-0.422, p =0.519- 0.947). In male rats there was no 
detectable difference in plasma cholesterol concentrations between 
transgenic, low protein, cafeteria animals and those that were wild type, 
control, pellet (median (interquartile range) 3.0 (2.5-4.6) v . 3.9 (2.9-5.6) 
mmol/1, p=0.699). 
The plasma cholesterol concentrations in 16 month old female rats 
are shown in fig. 8.10 (b ). At this age there were no detectable differences in 
plasma cholesterols associated with the presence of the transgene (F=0.000, 
p =0.992), the early diet used (F=l.623, p=0.209) or with the adult diet used 
(F=0.057, p =0.813; interactions F=0.126- 1.740, p=0.194- 0.724) . In male rats 
there was no detectable difference in plasma cholesterol concentrations 
between transgenic, low protein, cafeteria animals and those that were 
wild type, control, pellet (median (interquartile range) 6.1 (5.4-6.8) v. 6.3 
(5.6-9.2) mmol/1, p =0.886). 
8.3.8 Blood Pressures 
The systolic blood pressures of the 12 month old female rats are 
shown in fig. 8.11 (a).- There were no detectable significant effects on 
systolic blood pressure independently associated with the presence of the 
transgene (F=2.711, p=0.106), the early diet used (F=0.194; p=0.661) or the 
adult diet used (F=l.287, p=0.262). However there was a complicated 
pattern of interactions. The genetic status of the rats (i.e. whether they 
were transgenic or not) had statistically significant interactions with both 
- 230 -
[ 1! 
N 
w 
I-' 
(a) 
bi:) 
::i::: 
250 
e 200 e 
-(lj 
'"" ~ 150 
r.lJ (lj 
'"" ~
] 100 
0 
~ 
I.I 
::.= 50 
0 
.... 
r.lJ 
>. 
en 
0 
pellet cafeteria pellet cafeteria pellet cafeteria pellet cafeteria 
Control Low Protein Control Low Protein 
Wild Type Transgenic 
(b) 
bi) 
::c: 
e 
e 
-~ 
= r.lJ 
rJ) 
Cl) 
'"" ~
"O 
0 
0 
-i:Q 
u 
.... 
-0 
.... 
~ 
Cl) 
250 
200 
150 
100 
50 
CID 
Cl 
Cl 
Cl 
Cl 
Cl 
• 
• 
• 
• 
• 
• 
0 
0 
0 
0 
00 
0 
0 
0 
• 
• 
• 
•• 
• 
• 
• 
• 
0 -t-----.-----.-------r-----r-
Control, 
Pellet 
Control, 
Cafeteria 
Low Protein, Low Protein, 
Pellet Cafeteria 
Figure 8.11 Systolic blood pressures in 12 month old female rats. (a) Mean (SD) blood pressures in the eight 
groups. (b) Systolic blood pressure raw data from the wild type female rats. 
the early diet used (F=4.664, p =0.036) and the adult diet used (F=4.291, 
p =0.043). There was also an interaction between the genetic status of the 
rats, the early diet used and the diet used in adult life which also nearly 
reached statistical significance (F=3.733, p=0.059). The interaction between 
the early and late diets used was not statistically significant (F=l.598, 
p=0.212). 
To clarify this confusing picture the systolic blood pressures of just 
the wild type female rats were analysed (shown in fig. 8.11 (b)). Here both 
the use of the early low protein diet (F=S.655, p=0.025) and the cafeteria diet 
in adult life (F=S.518, p =0.026) were associated with raised systolic blood 
pressures. These rises were independent and additive (interaction F=0.056, 
p =0.815) so that in the wild type rats the highest blood pressures were 
generally seen in the low protein, cafeteria rats. 
The diastolic blood pressures of the 12 month old female rats also 
showed a somewhat complicated pattern (fig. 8.12). The transgenic animals 
had diastolic blood pressures that were almost statistically significantly 
higher than those of the wild type animals (F=3.041, p =0.087). A similar 
pattern was seen comparing the diastolic blood pressures of cafeteria-fed 
with those that were pellet-fed (F=3.300, p=0.075). The early diet used was 
not associated with a statistically significant difference in diastolic blood 
pressures (F=2.243, · p=0.141) . Two sets of interactions almost reached 
statistical significance: genetic status and early diet (F=3.342, p =0.074) and 
genetic status, early and adult diets (F=3.742, p =0.059;· other interactions 
F=0.529-1.457, p=0.233-0.470). When analysing the diastolic blood 
pressures of just the wild type rats, the cafeteria-fed rats had higher 
pressures than those that were pellet-fed (F=4.818, p=0.037). There was no 
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significant difference attributable to differences in the early diets used 
(F=0.011, p=0.917; interaction F=0.077, p=0.783). 
In male rats at 12 months of age there was not a detectable difference 
in systolic blood pressures between transgenic, low protein, cafeteria rats 
(n=7) and those that were wild type, control, pellet (n=6) (mean (SD) 166 
(29) v. 153 (38) mm Hg, p =0.473). Neither was there a detectable difference 
in diastolic blood pressures (mean (SD) 113 (17) v. 94 (45) mm Hg, p=0.324). 
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Figure 8.12 Diastolic blood pressures of 12 month old female rats. Results 
shown are mean (SD). The groups were as described in section 6.2.1. caf = 
cafeteria-fed. 
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8.3.9 Pancreatic Thioflavin S Staining 
Thioflavin S staining of pancreatic sections from male and female 
old rats failed to show any evidence of pancreatic amyloid deposition. 
8.4 DISCUSSION 
The results described in this chapter showed that early growth 
restriction in female rats, caused by maternal and early protein restriction, 
did not . appear to greatly influence glucose tolerance by 12 months of age. 
Obese rats that had been cafeteria-fed had worse glucose tolerances than 
the non-obese pellet-fed rats; thus the over all pattern at this age was the 
same as that seen at 133 days of age (section 7.3.1). During the subsequent 
four months, however, this pattern altered. Generally there was an 
improvement in glucose tolerances (as assessed by reduced areas under the 
glucose tolerance curves), as has previously been reported (Langley et al., 
1994). In the control rats there was an improvement in glucose tolerances 
independent of which diet the rats had been fed in adult life. In contrast 
the low protein rats that were pellet-fed showed no improvement in 
glucose tolerance at all and those that were cafeteria-fed only showed a 
very mild improvement. Thus the low protein rats showed a 
deterioration in gluco·s·e tolerance relative to controls (independent of 
which adult diet was used). This impairment of glucose tolerance was 
mild but statistically significant and was achieved in females, which in 
rodents show a lower prevalence of diabetes than in males in several 
different strains and transgenic lines (Efrat et al., 1990; Allison et al:, 1991; 
Gill et al., 1994). 
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The over all pattern of glucose tolerance at 16 months of age 
showed that, as at all the other ages studied, cafeteria-fed rats had worse 
glucose tolerances than pellet-fed rats independent of the maternal and 
early diet used. However a significant effect associated with the maternal 
and early diet used was observed in the pellet-fed rats. Here the low 
protein rats had significantly worse glucose tolerances than the equivalent 
controls that were pellet-fed. This pattern appeared to be established as it 
was observed to a similar extent when the same rats had their glucose 
tolerances tested between 16 and 22 months of age. Further investigations 
are required to examine the molecular cause of the deterioration in 
glucose tolerance in the low protein rats between 12 and 16 months of age, 
especially since this has previously been noted in offspring of protein 
restricted mothers between 11 and 15 months of age (although statistical 
significance was not reached in female rats) (Crowther, personal 
communication; Hales et al., 1996b). What is certain is that the cause is not 
associated with a large weight gain as there was barely any change in the 
relative difference in body weights between control and low protein rats 
that were pellet-fed between 12 and 16 months of age (section 6.3.3). 
In the present study only two 'extreme' groups of male rats were 
investigated, thus alterations in glucose tolerance could not with certainty 
be attributed to the presence of the transgene, the maternal and early 
protein restriction or the cafeteria-feeding. However between 12 and 16 
months of age the difference in the glucose tolerance between the 
transgenic, low protein, cafeteria rats and the wild type, control, pellet rats 
widened. Previously it has been shown that maternal protein restriction 
alone is able to lead to a shift in glucose tolerance in the male offspring 
between 11 and 15 months of age, so that the peak plasma glucose in the 
glucose tolerance tests were higher in the low protein offspring than in the 
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controls (Hales et al., 1996b ). Thus the widening of the gap in the glucose 
tolerances of the two male groups in the present study between 12 and 16 
months of age is consistent with the effect being associated with the 
maternal and early protein restriction. Further there was neither a large 
increase in relative body weights between 12 and 16 months of age (section 
6.3.3) nor was there any substantial amyloid deposition in their pancreata. 
This suggests that the change in glucose tolerance was not associated with 
either cafeteria feeding or with the presence of the transgene. 
As was previously observed in 63 and 133 day old female rats 
(section 7.3.2) the fasting plasma insulin concentrations in the female rats 
were lower in low proteins than controls and higher in cafeteria- than 
pellet-fed animals at both 12 and 16 months of age. When the low protein 
rats were younger the lower circulating insulin concentrations appeared to 
be due to an enhanced whole body insulin sensitivity (which would be 
consistent with previously reported results showing that maternal protein 
restriction in rats leads to increases in numbers of insulin receptors in 
skeletal muscle (Ozanne et al., 1996b) and increased adipocyte glucose 
uptake (Ozanne et al., 1997) in 3 month old offspring). However the 
deterioration in glucose tolerances of 16 month old female rats occurred 
without an apparent rise in circulating insulin concentrations. Thus for 
the first time the lower circulating concentrations were consistent with a 
partial insulin deficiency. 
Early studies using the same diets in rats showed that maternal 
protein restriction during pregnancy alone leads to reduced islet cell 
proliferation in the endocrine pancreas of the offspring (Snoeck et al., 
1990) and that when challenged with secretagogues in vitro these islets 
give a depressed insulin response (Dahri et al., 1991). It appears that these 
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alterations in islet function may well persist into adult life but be balanced 
by alterations in insulin sensitive organs such as skeletal muscle (Ozanne 
et al., 1996b) and adipocytes (Ozanne et al., 1997) to produce a whole body 
insulin sensitivity that is so good that the pancreatic :ls-cells are able to 
produce sufficient insulin for bodily requirements (with a little in reserve, 
as observed in the cafeteria-fed rats). Some age-associated factor in later 
life, however, is able to reveal the deficiency in islet function. This would 
have the advantage to the rat in that the deficiency in islet function would 
only be revealed after peak reproductive performance had passed, as 
essentially prior to this time the rat would have 'normal' glucose 
tolerance. This timing of onset of the deficiency of islet function would be 
consistent with the presentation of impaired glucose tolerance and type 2 
diabetes in humans, which is generally in middle age and beyond at least 
in the Western world (King & Rewers, 1993). The male rats in the present 
study never showed any detectable significant differences in plasma 
insulins, possibly because the extreme experimental group might tend to 
have lower insulins associated with the maternal and early protein 
restriction but higher insulins associated with the cafeteria-feeding. 
Alternatively the male low protein rats may be more insulin resistant 
than females relative to respective controls. 
The circulating fasting amylin concentrations were measured in 12 
month old rats to check that the presence of the transgene was associated 
with hyperamylinaemia. This proved to be the only factor in the present 
study that was consistently raised in the transgenic animals. Using the 
assay that cross-reacted 100 % with rat amylin but only 30 % with the 
human peptide, the factor most strongly associated with a raised amylin 
concentration was the presence of the transgene. By taking the wild type 
values away from the equivalent transgenic circulating amylin 
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concentrations and then multiplying this difference by 10/3 (to take into 
account the low cross-reactivity that this assay had for human amylin) it 
appeared that in the female rats the fasting human amylin concentration 
ranged between about 7 and 40 pmol/1, values that are consistent with 
those seen in humans with impaired glucose tolerance or early-stage type 
2 diabetes (Percy et al., 1996). The various dietary manipulations produced 
variations in amylin concentrations that were consistent with the 
variations observed in insulin concentrations. Thus the cafeteria-fed rats 
had higher concentrations than those that were pellet-fed and the low 
protein rats had concentrations that were lower than those of the controls. 
In male rats the transgenic, low protein, cafeteria rats had higher 
concentrations than those of the wild type, control, pellet animals probably 
because two of their manipulations (i.e. being transgenic and cafeteria-fed 
in adult life) would tend to raise its concentration whilst only one 
manipulation (i.e. the maternal and early protein restriction) may tend to 
lower it. 
The antibodies used in the human amylin-like peptides assay are 
not thought to cross-react with rat amylin (Percy, personal 
communication). However there was clearly some 'noise' in the present 
study as median values in all the wild type groups were above O pmol/1. 
The noise may not be causa::lby rat amylin, however, as in the wild type 
animals the cafeteria-fed rats did not have higher concentrations than 
those that were pellet-fed and the low protein rats did not appear to have 
lower concentrations than controls. All the transgenic groups had 
circulating human amylin-like peptide concentrations which were 
substantially higher than this noise level. Again the values seen in this 
assay are consistent with those seen in humans with impaired glucose 
tolerance or early-stage type 2 diabetes (Percy et al., 1996). Cafeteria-fed rats 
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had higher concentrations than pellet-fed animals but there was no 
detectable effect associated with variations in the maternal and early diets 
used. The latter point may perhaps be most readily explained by the 
relative insensitivity of the assay (section 3. 3.4). 
Unfortunately none of the various manipulations used in the 
present study caused pancreatic amyloid deposition, at least enough to be 
detected by light microscopy. The vasculature of the pancreatic islets is 
reduced by protein restricting the rat mother during pregnancy (Snoeck et 
al., 1990), thus the clearance of the secreted amylin from the external 
regions of the pancreatic fs-cells may be reduced. The amount of human 
amylin secreted was increased with cafeteria-feeding, yet even in the low 
protein rats that were subsequently cafeteria-fed there was no pancreatic 
amyloid deposition detectable by light microscopy. This does not mean 
that the proposal that amyloid deposition may be enhanced by reduced 
amylin clearance due to an altered islet vasculature secondary to fetal 
malnutrition (Hales & Barker, 1992) may not be true, just that higher 
concentrations of human amylin may need to be secreted before this 
becomes evident. Consistent with this theory in the one transgenic mouse 
line where amyloid deposited without either dietary or hormonal 
manipulation circulating amylin concentrations were almost one 
thousand times higher than those seen in these rats (Janson et al., 1996). 
Plasma corticosterone concentrations were measured in the present 
study because of a previous report that suggested that protein restricting a 
pregnant rat leads to a reduced placental llfs-hydroxysteroid 
dehydrogenase activity and therefore a greater concentration of active 
glucocorticoids being able to cross the placenta and alter the hypothalamic-
pituitary-adrenal axis in the offspring (Langley-Evans et al., 1996a). In the 
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-present study differences in the maternal and early diets used were not 
associated with detectable alterations in plasma corticosterone 
concentrations. Thus any changes in apparent glucocorticoid activity 
would have had to have been mediated by changes in glucocorticoid 
sensitivity rather than amount. At 16 months of age, but not at 12 months 
of age, the female rats that were cafeteria-fed had lower plasma 
corticosterone concentrations than pellet-fed animals. This lowering in 
concentration was clearly not caused by early programming and would 
tend to argue against a major role for glucocorticoids in causing the 
cafeteria-feeding-associated impaired glucose tolerance. 
The fasting plasma lipid concentrations appeared not to be 
programmed by the maternal and early diets used. This appears to be 
entirely compatible with the situation observed in humans. Even though 
those born light have a much increased risk of developing the insulin 
resistance syndrome in later life (Barker et al., 1993a; Valdez et al., 1994), in 
studies of 50 year old men in Sweden low birth weight was associated with 
an increased prevalence of both type 2 diabetes (Lithell et al., 1996) and 
hypertension (Leon et al., 1996) but in no way with plasma lipid 
concentrations. Only one study has found a statistical link between plasma 
lipids and fetal malnutrition, where serum cholesterol concentrations 
were found to be inversely related to abdominal circumference at birth but 
not with birth weight in people aged a little over 50 in Sheffield, England 
(Barker et al., 1993b ). The only lipids that were consistently altered in the 
present study were the raised fasting triacylglycerols and free glycerols in 
the cafeteria-fed rats. Given that compared with the pellet diet there was a 
greater percentage of its energy provided by fat and that the diet was highly 
and obesity f 
palatable, increased fat intake~would be the most likely explanation for 
these results. 
- 240 -
The systolic blood pressures of the female rats at 12 months of age 
show a wide variation between the different groups. The various 
comparisons between the groups present a somewhat puzzling picture. 
Close inspection of the results, however, reveals that the results in the 
groups are relatively interpretable with one exception. The transgenic, 
control, pellet group appears to have much higher blood pressures than 
would be expected from looking at the effects of the various 
manipulations in the other groups. Largely because of the results from this 
one group the presence of the transgene was associated with raised systolic 
blood pressures that were not far from reaching statistical significance. The 
role of amylin in the regulation of blood pressure is somewhat confused as 
it may lower blood pressure by causing vasodilation in a CGRP-like 
manner (Brain et al., 1990) and it may raise blood pressure by stimulating 
renin secretion (Cooper, M.E. et al., 1995). One recent study found that it 
could either raise or lower blood pressure in anaesthetised rats depending 
on the dose given (Haynes et al., 1997). None of these studies have 
investigated the effects of long-term hyperamylinaemia on blood pressure 
' regulation. Any authentic role that such exposure has on blood pressure 
only 
regulation can -· be clarifiedl\with further studies. 
A clearer pattern can be gained from looking at the systolic blood 
pressures of just the wild type female rats . Here both the maternal and 
early low protein and the cafeteria-feeding were associated with raised 
blood pressures at 12 months of age. These rises were independent and 
additive so that the highest blood pressures were generally seen in the low 
protein rats that were subsequently cafeteria-fed. This reflects the human 
situation where low birth weight and current weight have been shown to 
independently be associated with raised blood pressures in individuals 
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aged 10 and 36 (Barker et al., 1989a). In the two male groups of rats there 
were no detectable differences in systolic blood pressures, possibly due to 
the low numbers that were studied. 
The mechanism by which early low protein may lead to 
hypertension is not clearly understood. Previously it has been shown that 
protein restricting a female rat during pregnancy alone is sufficient to 
cause hypertension in the offspring (Langley & Jackson, 1994). Maternal 
low protein has been shown to reduce islet vascularisation of the pancreas 
in rats (Snoeck et al., 1990) and it may be that maternal low protein is 
associated with a generalised alteration in vascularisation which 
predisposes her offspring to hypertension. In a recent study of 210 subjects 
aged 8 to 24 years, systolic blood pressures were inversely related to birth 
weight and left ventricular masses were inversely related to body weights 
at 9 months and 2 years (Zureik et al., 1996). This increase in left 
ventricular mass may have been necessary to overcome the resistance to 
blood flow caused by an altered vascular tone in growth retarded 
individuals. Hypertension would then be the result of a relative over-
compensation. In the present study an increase in left ventricular mass of 
the rat hearts may have been expected to cause an increase in the heart 
weights (Hangartner et al., 1985). However the 140 day old low protein rats 
did not have increased heart weights, even when expressed relative to 
body weights (section 6.3.4). This suggests that this may not be the 
mechanism by which early protein restriction led to the increase in blood 
pressure. 
, An alternative explanation for early protein restriction leading to 
hypertension involves growth retardation of the kidneys. Kidney growth 
has been shown to be particularly compromised in rat models using 
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maternal protein restriction (Zemen, 1968). It has been hypothesised that 
fetal renal growth retardation causes a deficiency of nephrons at birth 
leading to an increased susceptibility to hypertension (MacKenzie & 
Brenner, 1995). Further it has been suggested that when kidney growth 
lags behind somatic growth sodium retention is favoured, predisposing an 
individual to hypertension (Weder & Schork, 1994). Data from the present 
study are consistent with these theories. The kidney weights of the low 
protein rats, at least up to 140 days of age, were substantially reduced in 
relation to those of control rats (section 6.3.4). The low protein rats also 
had lower body weights (section 6.3.3), but when their kidney weights were 
expressed relative to their body weights they were still lower than those of 
the controls. If the mechanism of the early protein restriction-associated 
hypertension involves a sodium-retentive renal mechanism, then it is 
predicted that further studies involving salt loading the rats would result 
in blood pressure differences being exaggerated. 
The measurement of diastolic blood pressure by tail 
plethysmography is considerably less precise than the measurement of 
systolic blood pressure by this method. In the present study the pattern of 
diastolic pressures largely reflects the pattern of systolic pressures, with the 
exception of the lack of detectable effect on diastolic blood pressures by the 
maternal and early diets used. The inconsistencies in the results found in 
the other groups make ·it difficult to suggest whether this apparent lack of 
effect is physiological or merely due to method insensitivity and 
imprecision. 
In summary, by 12 months of age the early growth retarded 
(maternal and early low protein) rats had higher systolic blood pressures 
but no apparent alteration in glucose tolerance. Nevertheless such an 
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alteration did become apparent by 16 months of age. Interestingly, in a 
study of individuals where hypertension and type 2 diabetes co-existed, the 
diagnosis of hypertension preceded the diagnosis of diabetes eight times 
more often than in the opposite direction (Lundgren et al., 1988). Thus the 
regime a~opted in the present study may be a good model of the situation 
found in humans. 
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8.5 SUMMARY 
(1) In an attempt to model and test the thrifty phenotype hypothesis in the 
rat, pregnant dams were protein restricted throughout pregnancy and 
lactation. Their offspring were weaned onto the same diet until they 
were 70 days old. They were then fed either a pelleted laboratory chow 
or a highly palatable cafeteria-style diet for the remainder of the study. 
(2) At 12 months of age the female cafeteria-fed rats had worse glucose 
tolerances than those that were pellet-fed, but there was no detectable 
effect associated with the early diet used. The systolic blood pressures at 
this age showed a complicated series of significant interactions. The 
picture was clearer in wild type rats alone. Here both early low protein 
and adult obesity (caused by cafeteria-feeding) were associated with 
hypertension. These associations were independent and additive so 
that generally the highest systolic blood pressures were found in the 
obese group that had received maternal and early protein restriction. 
The transgenic rats were shown to have circulating concentrations of 
human amylin which were similar to those seen in humans with 
impaired glucose tolerance or early stage type 2 diabetes. 
(3) By sixteen months of age the glucose tolerance of the control animals 
generally improved. No improvement was seen in the low protein rats 
that were pellet-fed and only a small improvement was seen in low 
protein rats that were cafeteria-fed. The low protein rats that were 
pellet fed now had worse glucose tolerances than equivalent controls. 
Cafeteria-fed rats still had worse glucose tolerances than those that 
were pellet-fed. This shift in glucose tolerance appeared fixed as it was 
similarly seen when the rats underwent a final glucose tolerance test 
between 16 and 22 months of age. The effect in the low protein rats may 
have revealed a partial insulin deficiency. No amyloid deposition was 
detectable by light microscopy in the pancreata of any of the rats 
studied. 
(4) Early protein restriction appeared to have no consistent detectable 
effects on plasma lipid concentrations. It is concluded that maternal 
and early protein restriction in the rat produces a number of metabolic 
changes that are consistent with the situation found in humans in 
general and with the thrifty phenotype hypothesis in particular. 
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Table 8.1 Main findings associated with maternal and early protein 
restriction in 12 and 16 month old female rats. 
12 months of age 16 months of age 
Glucose tolerance no detectable difference impaired Y 
l 
Fasting plasma insulin lower lower 
Fasting plasma amylin ? lower 
Fasting plasma human no detectable difference 
amylin-like peptides 
Plasma 10°0 no detectable difference no detectable difference 
corticosterone 
Fasting plasma no detectable difference lower 
triacylglycerol 
Fasting plasma free no detectable difference no detectable difference 
glycerol 
Plasma total no detectable difference no detectable difference 
cholesterol 
Systolic blood pressure higher 
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Chapter 9 
General Discussion And Future Prospects 
The studies outlined in this thesis raise a number of important 
issues, potential criticisms and pointers that require further investigation. 
In these studies, the rat line that was transgenic for human amylin was 
linked with a modification of the previously used low protein rat model 
(reviewed in Dahri et al., 1995; Hales et al., 1997). The rats were shown to 
have human amylin largely located in their pancreata. They secreted it 
such that its circulating concentration was broadly equivalent to the 
concentrations observed in the plasma of human individuals with 
impaired glucose tolerance or early-stage type 2 diabetes (Percy et al., 1996). 
Yet, unlike in humans, the amylin did not precipitate as pancreatic 
amyloid in and around their is-cells. Neither did the stresses of altered 
islet vasculature due to maternal low protein exposure during fetal life 
(Snoeck et al., 1990) nor the increased human a;mylin secretion due to 
cafeteria-feeding prove sufficient to enhance the precipitation. Therefore 
there was no evidence to support the hypothesis that early growth 
restriction may be associated with an enhanced tendency to deposit 
pancreatic amyloid. In the present studies the pancreatic histological 
staining used may not have been sensitive enough to reveal any small 
bundles of amyloid fibrils that may have been present (Couce et al., 1996a). 
If such bundles of amyloid were present, however, they clearly were not 
associated with the degree of glucose intolerance observed in pr~vious 
· studies with mouse transgenic lines in which amyloid was deposited 
(Janson et al., 1996; Verchere et al. , 1996; Couce et al., 1996a). 
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Amylin concentration appears to be an important factor involved 
m pancreatic amyloid formation (outlined in section 1.2.1.3). Future 
studies which increase amylin production in this transgenic rat line might 
therefore be able to produce amyloid deposition in the pancreatic islets. 
One group achieved this . and successfully deposited amyloid in a 
transgenic mouse line by either making the mice very insulin resistant 
(Couce et al., 1996a) or by cross-breeding to make homozygotes (Janson et 
al., 1996). In contrast, another group that obtained amyloid deposition in a 
transgenic mouse line (Verchere et al., 1996) suggested that neither 
making the mice homozygous nor raising the circulating human amylin 
concentration by causing insulin resistance (Verchere et al., 1997) is 
sufficient on its own to cause the human amylin to deposit as amyloid. 
They attribute their amyloid deposition to a change in the fat content of 
the laboratory chow fed to the animals. This contrasts with results from 
the present studies, where high fat intake with the highly palatable 
cafeteria-style diet was not associated with the deposition of pancreatic 
amyloid. It is possible that a high intake of either a particular specific fatty 
acid or a particular series of fatty acids may be necessary for amyloid 
deposition. These possibilities could be addressed in future studies which 
combine maternal and early protein restriction with alteration of dietary 
fatty acid composition in adult life in the transgenic rats. Such studies 
would be very relevant in light of recent investigations which suggest that 
certain fatty acids are particularly important in causing insulin resistance 
' (Storlien et al., 1996). Greater sensitivity in looking for amyloid deposition 
in these experiments could be gained by using electron microscopy. 
At none of the ages tested was the early protein restriction 
independently associated with detectable alterations in glucose tolerance. 
In contrast, the dietary-induced obesity was associated with a worsening in 
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glucose tolerance at every age tested. An unexpected finding, however, at 
the two oldest ages studied was that whilst cafeteria-fed rats still had worse 
glucose tolerances than pellet-fed animals, there appeared to be a shift in 
the glucose tolerances so that low · protein-pellet rats became worse than 
equivalent controls. Analysis of the interaction between the effects 
associated with the early and adult diets used on glucose tolerance yielded 
p-values of 0.073 and 0.078 for the two ages respectively, values above 5 % 
but below 10 %, suggesting that further studies would be useful. On the 
other . hand, these studies do not provide evidence to support the 
hypothesis that early growth restriction is associated with effects that 
exacerbate impaired glucose tolerance caused by adult obesity (Hales & 
Barker, 1992). Th~ possibility remains that other nutritional deficiencies 
encountered early in life in rats may be able to provide such support 
(Hales et al., 1997). 
There appeared to be a relative shift in glucose tolerances between 
low protein rats and controls between twelve and sixteen months of age. 
This was mainly due to an improvement in glucose tolerance in control-
pellet rats that was not observeci in equivalent low protein rats. A similar 
(though smaller in magnitude) shift has been observed previously in rats 
exp.osed to maternal protein restriction alone (Hales et al., 1996b) making 
this finding less likely to have occurred by chance. Pellet-fed rats of all . 
groups seemed to put on weight at a similar rate during the period of time 
during which this shift occurred (section 6.3.3), thus the relative difference 
in glucose tolerance was not associated with a reduction in body weight 
only in the control animals. The mechanism of this shift therefore 
remains unknown. 
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-That the model used in this series of studies failed to support the 
thrifty phenotype hypothesis, in terms of producing diabetes, may be due 
to deficiencies in the model itself, rather than to deficiencies in the 
hypothesis. This could be a problem associated with trying to model and 
test the thrifty phenotype hypothesis in a rat strain that is not prone to the 
development of diabetes. In adult life around 3 % of rat pancreatic fs-cells 
are capable of undergoing mitosis (Swenne, 1983) unlike the virtually 
quiescent adult human fs-cells (Sjoholm, 1996). In addition, rats show a 
remarkable regenerative capacity after partial pancreatectomy (Lee et al., 
1989). Thus models of diabetes in rats usually depend upon either 
pharmacological destruction of fs-cells or the use of inbreeding to create 
strains genetically susceptible to either autoimmune destruction of fs-cells 
or severe insulin resistance (Shafrir, 1992). In trying to model and test the 
thrifty phenotype hypothesis and generate diabetes, there would appear to 
be two strategies available to overcome the fs-cell regenerative capacity of 
the rat. The first of these requires the killing of fs-cells by amyloid 
deposition (Lorenzo et al., 1994) in the transgenic rats (perhaps using one 
of the strategies outlined earlier) to curtail the ability of the cells to divide. 
If the deposition was enhanced by fetal exposure to maternal low protein 
the model would conceivably be more reflective of the human situation. 
Alternatively the modelling may be more suited to the use of a different 
species which has fs-cells with a regenerative capacity similar to that of 
humans (and which exhibits diabetes-associated amyloid deposition). 
The pattern of significant interactions when , analysing the 
measured systolic blood pressures, between the genetic status of the rats 
and the various dietary manipulations, would suggest that (at least in 
wild type rats) both early protein restriction and subsequent obesity can 
contribute to raised pressures . As maternal protein restriction has 
- 250-
previously been reported to lead to hypertension in the offspring (Langley 
& Jackson, 1994) it is unlikely that this observation was due to chance 
alone. Further studies are necessary to confirm and clarify these findings 
but blood pressure measurements may provide the one piece of evidence 
from this study to support the. hypothesis that early growth restriction and 
subsequent obesity are both linked to the development of components of 
the insulin resistance syndrome. 
In humans significant effects appear to be associated with restricted 
growth in utero and possibly early infancy (Hales et al., 1997). Thus 
another potential criticism of this series of studies is that the significant 
effects observed with this rat model used protein restriction covering a 
much longer equivalent period of time and therefore the effects could not 
solely be attributed to fetal malnutrition. Indeed when considering the rat 
in isolation this assertion is legitimate. However in trying to model the 
scenario found in humans account has to be taken of the different relative 
stages of development reached by the time of birth in the human and the 
rat. Several organs appear to be much less developed in the rat at birth 
than in humans. One example is the kidney, where in humans 
glomerular number reaches a plateau by about 36 weeks of gestation 
(Hinchliffe et al., 1991), yet in the rat the number of mature glomeruli is 
able to increase by almost 40 % at some point between 5 and 540 days of 
age (Nyengaard, 1993). The second organ that is relevant to this discussion 
is the pancreatic islet: in particular pancreatic is-cells. In humans around 
13 % of the adult mass of pancreatic is-cells are already present by very 
early neonatal life and around 50 % by one year of age (Rahier et al., 1981). 
The corresponding values in the rat, at broadly equivalent times, are less 
than 4 % and 10 % (McEvoy & Madson, 1980a & 1980b). 
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The fact that the period immediately after weaning is a period of 
rapid is-cell growth in the rat is suggested by the differences in pancreatic 
insulin contents observed in the present series of studies (i.e. female low 
protein rats having lower pancreatic insulin contents than controls when 
the protein restriction continued after weaning (section 7.3.8) and not 
when it was not (section 4.3.3)). Other studies would appear to suggest that 
protein restriction may inhibit is-cell growth and proliferation both when 
given maternally during pregnancy (Snoeck et al., 1990) and when given 
after weaning (Swenne et al., 1987). If in humans malnutrition during a 
period of time when there is rapid is-cell growth and proliferation 
subsequently leads to the development of diabetes, it would appear 
perfectly justifiable to cover the same period in rat models. 
In summary the low protein rat model described in this series of 
studies does show a number of apparent similarities with conditions 
described in humans (outlined in table 9.1). Particularly if a modification 
could be found that really would produce diabetes in the rats, the model 
should prove useful to elucidate the molecular mechanisms behind the 
link between fetal growth restriction and the subsequent development of · 
diabetes and the insulin resistance syndrome. Once such mechanisms 
have been established and shown to replicate the human situation, 
strategies can be developed to try and reduce the health burden that they 
create. In a bid to speed this process up at a recent symposium addressing 
this subject (Hales~ 1997) a call was made to start a study in a developing 
country whereby pregnant women could be freely gl.ven adequate 
nutrition to see whether the burden of type 2 diabetes could be reduced in 
their offspring. Whilst this has immense cost implications, faced with a 
future epidemic of type 2 diabetes (Zimmet & McCarty, 1995) the benefits 
to health are likely to be enormous. 
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Table 9.1 Apparent similarities between results gained using the low 
protein rat model in the present series of studies and results pertaining to 
the thrifty phenotype hypothesis in humans. 
Characteristics Of The Low Protein Human Equivalent (Reference} 
Rat 
Low weight at 2 days of age Low birth and neonatal weight 
(section 6.3.2) 
Short (section 6.3.3) Newly diagnosed patients with 
impaired glucose tolerance or type 2 
diabetes being shorter than those 
with normal glucose tolerance 
(Brown et al ., 1991) 
Reduced pancreatic insulin Reduced numbers of pancreatic 
contents (in female rats) B-cells in type 2 diabetics 
(section 7.3.8) (Kloppel et al., 1985) 
Similarly to what was observed Low birth weight not being 
previously (Hales et al., 1996b ), associated with worse glucose 
between 12 and 16 months of age tolerance in children (Whincup 
little change in glucose tolerance, et al., 1997) but being linked with 
unlike the improvement that was increased risk of developing 
observed in controls (i.e. a relative impaired glucose tolerance or 
deterioration compared with type 2 diabetes in later life 
controls) (section 8.3.1) (Hales et al., 1991) 
Lack of raised fasting plasma Birth weight not significantly 
triacylglycerol concentrations inversely correlated with fasting 
(section 8.3.5) plasma triacylglycerol 
concentration (Lithell et al ., 1996) 
Hypertension (in wild type female Low birth weight linked with 
rats relative to wild type controls) increased risk of developing 
(section 8.3.8) hypertension (Barker et al., 1989a) 
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Early and late nutritional windows for diabetes susceptibility 
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Our epidemiological studies have led us to propose that events in early (fetal and infant) 
life are major factors determining susceptibility to non-insulin-dependent diabetes 
(NIDDM) in adult life (Brown et al. 1991; Hales et al. 1991; Robinson et al. 1992; Barker 
et al. 1993; Phillips et al. 1994; Law et al. 1995; Yajnik et al. 1995). It has been 
suggested that fetal growth restriction due to poor nutrition (either maternal or fetal or 
both) is environmentally determined and has at least two major consequences: (1) 
selective growth of major organs such as the brain at the expense of others such as the 
liver and kidney, (2) a permanent change in the endocrine and/ or metabolic setting of the 
offspring in a direction likely to aid survival in a nutrient-deficient environment. The 
conflict between this setting and exposure to good or supra-normal nutrition was 
envisaged as a major route leading to NIDDM (Hales & Barker, 1992). It has been 
objected that whilst it is conceivable that nutritional deprivation might have an impact in 
populations with clear problems of obtaining adequate nutrition, such as the under-
developed countries (and which also have severe problems with NIDDM emerging in 
'epidemic' proportions; Zimmet & McCarty, 1995), such a mechanism is very unlikely to 
be of any importance in the developed Western world. It has also been thought highly 
improbable that processes occurring so early in life could determine aspects of health 50-
70 years later. Therefore, in addressing the issue of what life-time 'windows' are 
important in producing NIDDM we shall first consider whether nutrition during 
pregnancy could be an issue in the Western world and whether processes at this early 
stage could be of long-term importance. 
IS NUTRITION DURING PREGNANCY A MATTER OF ANY CONCERN IN 
THE WESTERN WORLD? 
There is abundant evidence that a substantial proportion of the populations of countries 
such as the USA and the UK suffer from inadequate nutrition during pregnancy. This 
problem has been most dramatically highlighted in recent years by the recognition of the 
role of folate deficiency in the aetiology of neural-tube defects in the newborn. In a review 
of the subject, Rosenberg (1992) concluded, 'The observations on the efficacy of folic acid 
in preventing birth defects establish nutritional needs at a new moment in the life cycle, the 
periconceptional period. Our concept of nutritional requirements, obstetrical practice, and 
public health targeting may never be the same.' One may wonder, therefore, why, if it is so 
manifest that a nutritional deficiency during pregnancy in susceptible women can lead to a 
gross visible physical defect at birth, it is so hard to accept that more subtle nutritional 
deficiencies during pregnancy can determine the emergence of disease 50 years later. 
There are many well-documented examples of poor or borderline nutrition in the USA 
and the UK during -pregnancy. A recent international conference on maternal nutrition and 
*For reprints. 
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the outcome of pregnancy concluded that in addition to folate deficiency, deficiencies of 
Fe, Zn, Se, vitamins E and B6, protein and iodine were matters of concern during 
pregnancy in different populations in developed countries worldwide (Keen et al. 1993). 
For example, the officially recommended adequate intake of Zn in pregnancy is 15 mg in 
Sweden. However, the calculated mean dietary Zn intake in young first-time pregnant 
women in Sweden was 9-4 mg. Zn supplementation during pregnancy has been reported to 
have beneficial effects on the outcome, such as a reduction in premature births, intrauterine 
growth retardation and neonatal morbidity. When diets are low in protein the Zn intake is 
also considerably reduced. Protein deficiency in the diet of poor pregnant women is 
widespread (Gonzalez-Cossio & Delgado, 1991). It was a consensus view of the 
conference that pre-pregnancy nutritional status significantly affects pregnancy outcome. 
The problem of adequate nutrition before and during pregnancy is, therefore, by no means 
restricted to the underdeveloped countries. In 1972 the US Congress initiated a Special 
Supplemental Food Program for Women, Infants and Children (WIC) following the finding 
that (amongst others) pregnant women were at special risk by reason of inadequate 
nutrition. In the fiscal year 1992 funding for this programme was $2·6 billion. In 1990, 
WIC served 612 OOO pregnant women. It was generally concluded that WIC improved 
pregnancy outcome with respect to a reduction in the incidence of low birth weight, very-
low birth weight and preterm delivery. It appears that the earlier in pregnancy a woman 
received WIC benefits the greater the positive effects. It was also apparent that even if only 
the immediate short-term benefits of the outcome of pregnancy were considered, the 
programme was highly cost efficient. It was estimated that for every dollar spent on WIC 
there was an associated overall average saving of $2-91 (Abrams, 1993). 
In Britain, steps are at last being taken to address the issue of diet and low-income and 
related health consequences. The government has set up a Nutrition Task Force which 
recently issued a final report (Department of Health, 1996a). Also the Low Income Project 
Team set up by the Task Force has reported and highlighted (amongst other problems) the 
existence of poor nutrition during · pregnancy as being of concern. It concludes that, 
'substantial improvements in the diet of low income families throughout Britain will only 
be achieved through a nationally co-ordinated strategy.' (Department of Health, 1996b). 
WHAT ARE THE CRITICAL WINDOWS FOR PERMANENT CHANGES ('PROGRAMMING')? 
Pregnancy and lactation 
It has been known for more than a decade that permanent changes in behaviour can be 
induced by the administration of a sex hormone in a narrow early time window. Exposure 
of female rats to a single exogenous dose of testosterone in fetal life permanently 
reoriented their sexual behaviour. A similar dose of testosterone in 20-day-old females had 
no effect (Angelbeck & Du Brul, 1983). Similarly, exposure of animals to an excess of 
thyroxine in the neonatal period changed the pituitary- hypothalamic responses linked to 
the secretion of thyroid-stimulating hormone in later life (Besa & Pascula-Leone, 1984). 
Extensive_ studies by Mccance & Widdowson (1966, 1974) and Winick & Nobel (1966) 
and Winick et al. (1968) have demonstrated that interference with the animal's growth 
during critical stages of development could have lasting effects. Essentially, malnutrition 
during early fetal and neonatal life would affect cell division, organ growth and 
differentiation which may be irrecoverable. Later in life, it would lead to changes in cell 
composition and cell size. · 
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It is also beginning to be recognized that inter-generational effects due to nutrition can 
occur, thereby giving the false impression that they are genetic effects. Females in the 
uterus in the first two trimesters of pregnancy during the Dutch Famine, when they 
subsequently gave birth to their children, produced newborns with significantly lower birth 
weights than females not so exposed during fetal life (Lumey, 1992). Thus, the nutrition of 
the grandmother can affect the growth of the grandchild and, hence, we would suggest the 
susceptibility of the latter to certain diseases. 
More recent studies have shown that pregnant rats fed on a diet containing a little 
under half the normal protein content produced pups with reduced neonatal /J-cell 
proliferation, islet size and vascularization (Snoeck et al. 1990). Other studies have shown 
that prenatal exposure to maternal low protein diet induced hypertension in the young adult 
offspring (Langley & Jackson, 1994). 
We have studied growth and hepatic metabolism in the offspring of protein-restricted 
rats during pregnancy and/ or lactation. If the offspring of mothers fed on an adequate-
protein (200 g/ kg) diet during pregnancy were nursed by mothers fed on a low-protein 
(80 g/ kg) diet, permanent growth retardation was observed. This was despite the fact that 
these animals were weaned onto a normal 200 g protein/ kg diet. Conversely, the offspring 
of mothers fed on a low-protein diet during pregnancy when nursed by mothers fed on a 
200 g protein/ kg diet, demonstrated a complete catch-up in growth (Desai et al. 1996). 
Therefore, when a rat dam was fed on a low-protein diet, the critical window for the overall 
growth of the offspring appeared to be the nursing period. Growth retardation was also 
accompanied by sex-dependent, selective and permanent changes in organ weights. For 
example, compared with the body weights, organs such as the brain and lung experienced a 
smaller decrease in weight, the heart, kidney and thymus decreased proportionately, 
whereas the pancreas, spleen, muscle and liver showed a greater reduction in weight in 
these offspring at 21 d of age (i.e. foUowing exposure to maternal protein-restricted diet 
during pregnancy and lactation). As adults, the muscle weight in relation to the body 
weight was significantly lower in the male rats, whereas the weight of pancreas in relation 
to the body weight was significantly increased in the female rats (Desai et al. 1996). 
Changes in liver enzyme activities associated with glucose metabolism were seen in 
the . offspring exposed to maternal low-protein diet . during pregnancy. Glucokinase (EC · 
2. 7.1.1) was decreased by about 50 % and phosphoenolpyruvate carboxykinase (EC 
4.1.1.32) was increased by about 100 % in the offspring. These changes were still apparent 
in the adult offspring despite the fact that they had been nursed by mothers fed on an 
adequate-protein diet and had remained on a 200 g protein/ kg diet for almost 10 months 
(Desai et al. 1995). This indicates that the maternal protein diet during pregnancy can 
permanently alter the enzyme activities in the offspring in a direction where glucose 
production rather than utilization would be expected to be predominant. These results are 
quite striking given that neither glucokinase nor phosphoenolpyruvate carboxykinase are 
expressed until after birth. Thus, events during fetal life can programme what will happen 
during postnatal life. 
In recent studies, we have also looked at the effects of a low-protein diet during 
pregnancy and lactation on hormonal regulation of hepatic glucose output in the offspring. 
These experiments revealed that at 3 months of age the male offspring of protein-
malnourished rats had significar,.tly glucagon-resistant livers. In addition, these livers had 
an altered response to insulin. In control animals, insulin rapidly inhibited glucagon-
stimulated hepatic glucose output (HGO). In contrast, in the low-protein offspring, insulin 
caused an initial increase in HGO before inhibition occurred (Ozanne et al. 1996). These 
experiments reveal that poor nutrition during fetal and early postnatal life can have long-
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term effects on the control of hepatic glucose output. A striking parallel exists between 
these findings and studies of HOO following the administration of oral glucose in 
Australian Aborigines, many 0f whom were destined to develop NIDDM (O'Dea, 1991). 
We have also investigated the influence of maternal low-protein diet on the longevity 
of the offspring. The combined effect of maternal low-protein diet during pregnancy and 
lactation did not alter longevity in the offspring. However, a beneficial effect in terms of 
increasing the lifespan, particularly of the male offspring, was seen when the exposure to 
maternal protein restriction was limited to the nursing period only. Conversely, when the 
exposure to maternal protein restriction occurred during gestation alone, it had a 
detrimental effect and the lifespan of the male offspring was significantly shorter. A similar 
trend was observed in the female offspring, although it was not statistically significant. 
Thus, longevity can be permanently altered by events in early life in the rat, with reduced 
longevity being associated with 'catch-up' growth (Hales et al. 1996). It is possible that 
similar patterns may arise in the human male. Men who were light at birth but are of above 
median adult height have been found to have particularly high blood pressure (Leon et al. 
1996). 
Early post-weaning 
We extended the studies described previously to determine the effect of lengthening the 
period of protein restriction to 10 weeks of age. Offspring of female rats fed on the 80 g 
protein/ kg diet during pregnancy and lactation, were weaned onto the sa,me reduced 111 
protein diet and compared with rats fed on the 200 g protein/ kg diet. By 70 d of age female , II! 
rats given the low-protein diet had reduced indices of growth: body weights (reduced 39 % 
compared with that of similar rats given the 200 g protein/ kg diet), body lengths (15 % 
reduced) and BMI (15 % reduced; Fig. 1). This was mirrored by reductions in weights of 
individual organs. Pancreas, liver, spleen, heart, lungs and. ovaries were reduced in 
proportion to total body weight. The tibialis anterior muscles and kidneys were so affected 1111 
as to be reduced in weight relatively more than the reduction in total body weight. In 
contrast, the brain appeared to be somewhat preserved, in that although the protein 
reduction appeared to reduce its overall weight, this was proportionally less than the 
reduction in total body weight (only being 15 % reduced compared with the 39 % reduction 
in body weight). 
Adulthood 
Recently we have investigated the effect of a nutritionally-rich diet on adult rats who had 
been growth retarded by early protein restriction. For this study rats given the 80 g /JI 
protein/ kg diet until 10 weeks of age and rats who had been fed on a control (200 g I 
protein/ kg) diet during an equivalent period were given one of two different adult diets: 
some of them being fed on a standard laboratory chow in pellet form ('pellet' diet) and 
other rats being fed on a cafeteria-style diet containing a mixture of the laboratory chow 
with condensed milk and sugar ('cafeteria' diet; adapted from Wilding et al. 1992). These 
diets · were continued until the rats reached 20 weeks of age. Whilst the postweaning rats 
were fed on the 80 or 200 g protein/ kg diets, the energy intakes of female rats given the 
low-protein diet were significantly lower than those of the control rats (Fig. 2(a)). When the 
rats were transferred onto their adult diets, this difference in energy intake was preserved 
between the low-protein and control animals given the pelleted diet and between those 
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Fig. 1. The body lengths, body weights and BMI of 70-d-old female rats. Their mothers had received either a 200 g 
protein/kg (control) or an 80 g protein/kg (low-protein) diet throughout pregnancy and lactation, and then these rats 
were weaned onto the same diets. Values are means and standard deviations represented by vertical bars for sixteen rats 
per group (from at least eight different litters). The low-protein diet was associated with significant reductions in body 
lengths, body weights and BMI (all P < 0-001; Student's t test). 
animals given the cafeteria diet. However, those rats given the cafeteria diet had 
considerably higher energy intakes than equivalent rats given the pelleted diet (Fig. 2(a)). 
This meant that between 10 and 20 weeks of age low-protein rats subsequently given the 
cafeteria diet had higher energy intakes than control rats given the pelleted diet. 
The body weights of the female rats given these diets largely reflect their energy 
intakes (Fig. 2(b) ). · At 10 weeks of age, when the diets were changed the low-protein rats 
weighed considerably less than the controls. This difference in body weight between 
control and low-protein rats was still evident at 20 weeks of age in both pelleted-diet and 
cafeteria-diet groups. However, those rats given the cafeteria diet put on considerably more 
weight than those rats given the pelleted diet. Overall, this had the effect that the rats 
growth retarded by early protein restriction, who were subsequently fed on the cafeteria 
diet, caught up in terms of body weight with control rats subsequently given the pelleted 
diet. Indeed, by 17 weeks of age there was no statistically significant difference.in the body 
weights of these two groups (P > 0-05; Student's t test). However, whilst their weights 
were not significantly different, the rats who were initially protein deprived were shorter 
than the control rats at 140 d of age (mean length 225 (so 6) mm v. 228 (SD 7) mm; 
P < 0-01). A trend for shorter, fatter rats was also seen with BMI, although statistical 
significance was not reached (mean BMI 6-23 (SD 0-39) kg/m2 v. 5.97 (SD 0-48) kg/m2; 
P = 0-11; Fig. 3). It is thus apparent that a low-protein diet during fetal and early life can 
have permanent effects on body mass, body length and BMI irrespective of the adult diet. 
Weight gain as a measure of growth of organs and tissues could be misleading in these 
animals since the body weight may also increase as a result of fat storage. For instance, 
unlike the body weight, most of the organs did not exhibit a corresponding increase in 
weight (brain, spl~en, lungs and tibialis anterior muscles). Some organs showed a relative 
decrease in weight (pancreas, kidneys and heart), which could be interpreted as those 
organs showing no change in weight as a result of the cafeteria diet. The organs that 
increased proportionally with body weight were the liver and ovaries. 
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Fig. 2. (a) Energy intakes and (b) body weights of female rats. The mothers of these rats had been given either a 200 g 'II 
protein/kg (control) or an 80 g protein/kg (low protein) diet throughout pregnancy and lactation. These rats were then 1 
weaned, at 4 weeks of age, onto the same diet as their mothers. They continued on these diets until they w
ere 10 weeks 
old and then were transferred either onto a Porton combined (pelleted) diet or a highly-palatable (cafeteria) diet 111 
consisting of a mixture of the Porton combined diet, condensed milk, sugar and water. Values are means f
or sixteen rats 
(from at least eight different litters). Two-way ANOVA of energy intakes: association with early diet (control or low- ''I 
protein) P < 0-05 (at all ages), association with adult diet (pelleted or cafeteria) P > 0-05 (before week 11) and 
P < 0-001 (after week 10), statistical interactions between these two variables P < 0-05 (weeks 12-14 and 20) and i
1
, 
P > 0-05 (all other weeks). Two-way AN OVA of body weights: association with early diet (control or low-protein) 
P < 0-001 (at all ages), association with adult diet (pelleted or cafeteria) P > 0-05 (before week 12) and P < 0-002 (after 
week 11), statistical interaction between these two variables P > 0-05 (before week 13) and P < 0-001 (after week 12) . 
(0), Control, pelleted; (e), control, cafeteria; (L',), low-protein, pelleted; (.A.), low-protein, cafeteria. 
I,/ ... 
I 
., 
1 given either a 200 g 
These rats were then 
l they were 10 weeks 
table ( cafeteria) diet 
neans for sixteen rats 
diet (control or low-
efore week 11) and 
12-14 and 20) and 
1trol or low-protein) 
and P < 0-002 (after 
001 (after week 12). 
ria. 
N 
E 
Ol 
.:,< 
10 
DIABETES TOW ARDS THE YEAR 2000 
Control, Control, 
pelleted cafeteria 
Low-protein, Low-protein, 
pelleted cafeteria 
239 
Fig. 3. BMI of 140-d-old female rats. The mothers of these rats were given either a 200 g protein/kg (control) or an 80 g 
protein/kg (low-protein) diet throughout pregnancy and lactation. These rats were then weaned, at 4 weeks of age, onto 
the same diet as their mothers. They continued on these diets until they were 10 weeks of age and were then transferred 
onto a Porton combined (pelleted) diet or a highly-palatable ( cafeteria) diet consisting of a mixture of the Porton 
combined diet, condensed milk, sugar and water. Values are means and standard deviations represented by vertical bars 
for sixteen rats per group (from at least eight different litters). Two-way ANOVA: association with early diet (control or 
low-protein) P < 0-001, association with adult diet (pelleted or cafeteria) P < 0-001, statistical interaction between these 
two variables P=0-002. The rats given the early low-protein diet followed by the cafeteria diet caught up in weight 
with those rats given the early control diet followed by the pelleted diet (see p. 237). The former group were 
significantly shorter than the latter group (P < 0-01; Student's t test) but the differences in BMI did not reach statistical 
significance (P = 0-11; Student's t test; see p. 237). · 
COMBINATION OF EARLY AND LATE DIETARY MANIPULATION 
The test of early nutritional programming is whether the effects of early diets, i.e. protein 
deprivation in this case, hold true even after a period of nutritional recuperation, i.e. the use 
of the cafeteria diet in this case. In this respect a number of organ weights were shown to be 
permanently altered by the protein deprivation in early life. The kidneys were still reduced 
in weight in the rats which were protein restricted early in life and the reduction in organ 
weight was still greater than the reduction in total body weight attributable to protein 
deprivation. The liver, lungs, spleen and heart were still reduced in weight in proportion to 
the reduction in body weight. The brain, although reduced in weight, was still increased in 
relation to the reduction in body weight. These results demonstrate that early protein 
deprivation causes selective preservation of some organs, such as the brain, at the expense 
of others such as the kidneys. Observations such as these are the basis of the Thrifty 
Phenotype hypothesis (Hales & Barker, 1992) in which it is proposed that during times of 
nutritional thrift, the developing organism diverts essential nutrients to selected organs. 
Not all organ weights were permanently altered by the early protein deprivation. Ovary 
weights after the cafeteria or pelleted diets were unaffected by early protein restriction. 
Thus, they were able to catch up their early growth restriction. Of interest is the partial 
recovery of organ weights seen in the pancreas and anterior tibialis muscles. Both organs 
were still reduced in weight by the early protein restriction, but the pancreas was now 
reduced relatively less than the reduction in total body weight and the muscles only in 
proportion to that of body weight. This opens the possibility that different organs have 
different critical 'windows' at which period of time nutritional deprivation is able to 
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permanently alter their future weights. In this case the period of protein deprivation may ,,\:l 
',l l,~ 
only have partially covered the critical period for the long-term alteration of pancreas and ,.\1
. 
muscle weights. A more extended period of protein deprivation may well have permanently : :)\; 
altered the weights of these organs. A change in organ weights is of course a very crude , t( 
'·'.\ 
and incomplete index of the programming of the structure and function of an organ. Organs · :( 
such as the liver may exhibit no change in adult organ weight after an earlier period of , ? 
protein restriction (during pregnancy alone) and yet exhibit clear changes in enzyme )r 
composition (Desai et al. 1995). '{ j 
CONCLUSIONS 
We have reviewed the evidence that there are a number of critical periods ('windows') in 
which the growth of the whole organism or individual organs can be determined 
('programmed'). The effect of poor nutrition on organ growth is also gender specific. 
Epidemiological evidence strongly suggests that changes in organ growth consequent upon 
poor nutrition can have a major impact on disease susceptibility, particularly in the so-
called 'degenerative' diseases which include NIDDM and the insulin-resistance syndrome. 
The precise outcome of poor nutrition is likely to depend on the critical window(s) and the 
particular nutrient involved. A summary of some of the windows is given in Table 1. 
Nutritional effects can be transmitted over more than one generation. Thus, it is likely that 
reversal of adverse consequences of poor nutrition will require improved nutrition over 
several generations. Furthermore, 'improved' nutrition in terms of increased energy intake 
leading to obesity can, at least within one generation, have detrimental effects. Obesity 
during pregnancy may lead to gestational diabetes which has been shown to predispose to 
diabetes in the offspring of Pima Indians (McCance et al. 1993). There is no doubt, 
therefore, that in attempting to disentangle the effects of nutrition to increase susceptibility 
Table 1. Some critical windows of nutrition 
Window · Consequence 
Pregnant grandmother 
Grandmother starved during first two trimesters of pregnancy Decreased birth weight of grandchild (Lumey, 
1992) 
Pre-pregnancy 
Mother's pre-pregnancy nutrition 
Pregnant mother 
High carbohydrate and/or energy intake in early pregnancy 
Low protein intake in late pregnancy 
Lactation 
Offspring of adequate-protein-fed dams nursed by protein-
restricted dams 
Offspring of low-protein-fed pregnant dams nursed by 
adequate-protein-fed dams 
Adult 
Overnutrition 
Outcome of pregnancy (e.g. poor nutrition leading 
to a low birth weight, prematurity; Keen et al. 
1993) 
Small placenta, adult hypertension (Campbell et al. 
1996) 
?Reduced islet P-cell growth (Godfrey et al. 1996) 
Permanent growth retardation; increased lifespan 
(in males; Hales et al. 1996) 
Catch-up growth; reduced lifespan (in males; Hales 
et al. 1996) 
Obesity, IGT or NIDDM depending on early-life 
events 
NIDDM, non-insulin-dependent diabetes mellitus; IyT, impaired glucose tolerance. 
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to diseases such as NIDDM a great deal of painstaking research both in different 
populations and different animal models is required. Ho~ever'. in view of ~e pote~tial 
rewards in terms of long-term health benefits to be gamed m understanding optimal 
nutrition before, during and after pregnancy, a high priority should be given to this 
research. 
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Early protein restriction and obesity independently induce 
hypertension in I -year-old rats 
Clive. J. PETRY*, Susan E. OZANNE, Chun Li WANG and C. Nicholas HALES 
Clinical Biochemistry Department, University of Cambridge, Addenbrooke 's Hospital, Cambridge CB2 2QR. U.K. 
(Received 10 February/16 April 1997; accepted 29 April 1997) 
1. Recent studies have revealed a link between fetal 
and early post-natal growth retardation and the development of features of the insulin resistance 
syndrome in later life. Obesity is also a strong risk factor for this syndrome. The aim of this study was 
to assess whether maternal and early protein 
restriction, which causes growth retardation, and 
obesity are risk factors that are independent for the development of certain features of the insulin resist-
ance syndrome, especially hypertension. 
2. Pregnant Sprague-Dawley rats were given either 20% or 8% protein isocaloric diets throughout preg-
nancy and lactation. Female offspring were weaned 
onto the same diets as their mothers and they 
remained on these diets until 70 days of age. Half 
the rats were then given standard laboratory chow, 
whilst · the remainder were fed a highly palatable 
. cafeteria-style diet. Rats were maintained on these diets for the remainder of the study. 
3. Rats given the 8% protein diet remained physic-
ally lighter than comparable animals fed the 20% protein diet· throughout the study. In contrast; cafe-
teria-fed rats showed excessive weight gain. At 1 year of age the rats had their systolic blood pres-
sures and fasting lipids measured, as well as under-going an intraperitoneal glucose-tolerance test. 
4. Cafeteria-fed rats had worse glucose tolerances 
than controls and hypertriacylglycerolaemia. The 
early 8% protein rats had significantly increased blood pressures, as did the cafeteria-fed rats. These increases were additive, suggesting that early pro-
tein restriction, and later obesity, are indeed inde-
pendent risk factors for the development of hypertension. 
INTRODUCTION 
Results from a number of studies have established 
an association between low birth weight and the 
subsequent development of adult degenerative dis-
eases. Firstly, it was found that growth retardation during fetal life and infancy was linked to death 
rates from cardiovascular disease in adult life [l]. 
Key words: diabetes mellitus, feta! physiology, hypertension, insulin resistance syndrome. Abbreviation: NIDDM, non-insulin-dependent diabetes mellitus. 
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The processes involved in this association may involve hypertension, as it was subsequently found 
that low birth weight predicts adult hypertension [2, 3]. This alteration in blood pressure appears to be detectable in childhood and is amplified with age [4]. Impaired glucose tolerance and type 2 (non-insulin-dependent) diabetes mellitus (NIDDM) are 
also risk factors for cardiovascular disease and a 
strong link was found between their development 
and reduced weight at birth and at age 1 year [5]. The strongest association of all between low birth 
weight and adult degenerative disease, however, was found to be with the insulin resistance syndrome [ 6]. Thus in a study of 64-year-old men in Hertfordshire, U .K. the odds ratio of those born lightest for the presence of the insulin resistance syndrome was 18 in comparison with a value of 1 for those born heav~ iest [6]. 
Low birth-weight is a proxy for a variety of intra-
uterine influences. The 'thrifty phenotype hypothe-
sis' [7) suggests that nutritionally induced fetal growth retardation can lead to changes in cellular 
structure and function in a developing fetus, · thus 
rendering it more susceptible to the features of the insulin resistance syndrome in later life. The timing 
of the onset of these features is suggested as depending upon later factors, such as adult obesity, 
aging and physical inactivity. Obesity itself is 
strongly associated with the insulin resistance syn-drome [8]. Thus in the San Antonio Heart Study, by 
the fifth decade of life four-fifths of the obese sub-jects had hypertension and impaired glucose toler-
ance and more than four-fifths of the subjects with NIDDM were hypertensive and obese [9). Of those 
subjects who were hypertensive around three-quarters were obese and one half had abnormal glucose tolerance [10). 
Growth-retarded new born infants have been 
shown to have reduced numbers of pancreatic /J-cells and a reduction in insulin secretion [11 ). This has been modelled in experimental rats by a mater-
nal or early protein calorie malnutrition [12) and by 
maternal protein deficiency alone [13]. It was hypothesized that the impairment in insulin secre-
tion may predispose a rat to the development of dia-
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betes (12]. Subsequent studies in rats have modelled 
the findings in humans by showing that maternal 
protein restriction can lead to feta! growth retarda-
tion (13, 14], hypertension (14] and impaired glucose 
tolerance (15] in the offspring. The aim of the 
present study was to test the 'thrifty phenotype 
hypothesis' [7], which suggests that intrauterine and 
early post-natal growth retardation (modelled in this 
study by maternal and early protein restriction) and 
adult obesity (modelled by feeding rats a highly 
palatable cafeteria-style diet) are independent risk 
factors for the development of features of the 
insulin resistance syndrome. 
METHODS 
Virgin female Sprague- Dawley rats, weighing 
240- 255 g, were caged individually and maintained 
on a 12: 12 h light- dark cycle at 22°C. After mating, 
on the first day of pregnancy (taken as when a vagi-
nal plug was expelled), rats were fed either a 20% 
('control') protein diet (n = 13) or an isocaloric 8% 
('low protein') diet (n = 18) (Hope Farms BV, Hoge 
Rijndijk 14, 3440 HD Woerden, The Netherlands) 
(Table 1). The rats were maintained on these diets 
throughout the gestational and suckling periods. 
When the female offspring reached 28 days of age 
they were weaned onto the same diets as their 
mothers. At 70 days of age half of the rats were 
given Parton Combined Diet ('pellet') (Special Diet 
Services, Witham, Essex, U.K.); this diet contains 
17.9% protein, 55.0% carbohydrate and 2.7% fat by 
weight. The remaining rats were fed a high-fat cafe-
teria-style diet ('cafeteria'). This was a modified ver-
sion of the diet described by Wilding et al. (16] and 
was designed to be highly palatable so that the rats 
ate relatively large amounts of it. It contained 
330 g/kg ground Parton Combined Diet, 330 g/kg 
Nestles full fat sweetened condensed milk, 70 g/kg 
sucrose and 270 g/kg water. This cafeteria diet pro-
vided 16.7% of its energy content as protein, 67.3% 
Table I. Composition of the diets fed to pregnant female rats 
throughout their gestational and suckling periods (g/ I 00 g dry weight 
of diet) 
Diet 
. Control Low protein 
Mineral and vitamin mixture 5.05 5.45 
Casein (88 g of protein/ I 00 g) 22.00 9.00 
D,L-Methionine 0.20 0.08 
Maize starch 8.00 8.00 
Cellulose 5.00 5.00 
Soyabean oil 4.30 4.30 
Cerelose (glucose) 55.15 68.17 
Overall composition 
Protein (g/ I 00 g dry weight) 20.0 8.0 
Carbohydrate (g/ I 00 g dry weight) 63.2 76.2 
Fat (g/ I 00 g dry weight) 4.3 4.3 
Energy (kJ/ I 00 g dry weight) 1537 1528 
as carbohydrate and 16.0% as fat. In comparison, 
the pellet diet provided 28.7% of its energy content 
as protein, 61.7% as carbohydrate and 9.6% as fat. 
The rats remained on these diets until the study 
time points and throughout the study were allowed 
to eat ad libitum. All rats had free access to drinking 
water throughout. Animal maintenance and experi-
mentation was performed according to the Animals 
Scientific Procedures Act (1986). 
At 140 days of age, eight rats from each of the 
four dietary combination groups (and from different 
litters) were killed by carbon dioxide inhalation. 
Body weights and lengths were measured and then 
the kidneys and hearts were removed and their 
weights recorded. The remainder of the rats (31 in 
total) underwent intraperitoneal glucose tolerance 
tests and had their systolic blood pressures mea-
sured at 1 year of age. 
Systolic blood pressures were determined by 
recording tail vein pulses at 29°C in conscious rats . 
(Blood pressure monitor; Linton Instrumentation, 
Diss, Norfolk, U.K.) (14]. Before measurement, in 
order to minimize stress, the rats were trained to 
enter the Perspex restraining tube ( each rat entering 
the tube three times on three separate occasions was 
generally found to be sufficient). All measurements 
were taken in the early evening after staff had left 
so that extraneous noise was minimized. Due to the 
reading of the blood pressure traces being somewhat 
subjective, each blood pressure trace was coded and 
read by an independent investigator not involved in 
obtaining the traces. Each of the rats had five blood 
pressure traces recordep in a single session. The 
highest · and lowest results were discarded and the 
blood pressure recorded as the mean of the three 
remaining results. One rat had its blood pressure 
measured at each of the evening sessions, the 
recordings having a coefficient of variation of 3.2% 
(n = 7). 
Intraperitoneal glucose-tolerance tests were per-
formed after a 14 h fast. Conscious rats were 
injected intraperitoneally with 1 ml/100 g of body 
weight of a solution of 10% (w/v) glucose in 0.9% 
(w/v) saline. Blood was collected from the tail vein 
and blood glucose was measured using a Hemocue 
glucose analyzer (Hemocue, Sheffield, U.K.) 0, 15, 
30, 60, 120 and 180 min after the glucose injection. 
Fasting blood samples were also collected into hep-
arinized tubes for the measurement of plasma 
insulin, corticosterone (samples being collected 
around 10.00 hours), total cholesterol, free glycerol 
and triacylglycerols. Insulin and corticosterone were 
measured by RIA according to the manufacturer's 
instructions (using a Linea rat insulin kit purchased 
from Biogenesis Ltd., Poole, Dorset, U.K. and a rat 
corticosterone kit purchased from Amersham Inter-
national pie, Little Chalfant, Bucks., U .K.). Plasma 
total cholesterol (17], free glycerol and triacyl-
glycerol concentrations (18] were measured using 
standard laboratory techniques with kits purchased 
from Sigma Chemical Co., Poole, Dorset, U.K. 
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Statistical analysis 
All statistical analyses were performed using the 
Statistica for Mac (version 4.1) software package 
(Statsoft, Letchworth, Herts., U.K.). Two-way analy-
sis of variance was used to analyse the data, with 
early and adult diets being used as the independent 
variables. If appropriate, the data were log-trans-
formed before analysis to enable the appropriate 
use of parametric statistical tests. Litter sizes, body 
weights and food intakes are expressed · as means 
(SD) and data from the different groups are com-
pared using either Student's t-test or two-way analy-
sis of variance. 
RESULTS 
Litter sizes from dams given the control or low-
protein diets were not significantly different: control 
14.2 (2.4) pups and low-protein 14.7 (2.7) pups 
(P = 0.640). Two days after birth, however, the low-
protein pups had significantly lower body weights 
than the control pups: 5.41 (0.45) g compared with 
6.50 (0.95) g (P<0.001). At weaning (28 days of 
age) this difference in body weights was more pro-
nounced: low protein 35.84 (7.39) g compared with 
control 53.87 (14.19) g (P<0.0001). 
Body and organ weight data for the 140 day old 
animals is shown in Table 2. Be.tween weaning . and 
being given the pellet or cafeteria diets the total 
. food intakes .of these low-protein rats were signifi-
cantly lower than those of the controls: low protein 
520.7 (89.3) g compared with control 682.9 (49.4) g 
(P<0.0001; both n == 16). Immediately before the 
pellet or cafeteria diets were given· (70 days of age), 
body weights were: low protein 164.7 (24.8) g and 
control 255.3 (21.7) g (P<0.0001; both n = 16). 
During the period between 70 and 140 days of age 
the total food intakes of the different groups were: 
control rats given the pellet diet 1553.8 (88.3) g, 
control rats given the cafeteria diet 2813.8 (248.9) g, 
low-protein rats given the pellet diet 1365.5 (128.9) g 
and low-protein rats given the cafeteria diet 2283.2 
(160.9) g (all groups n = 8 from eight different lit-
ters). Control animals ate significantly more pellet 
or cafeteria diet than low-protein animals 
(P<0.0001). Cafeteria-fed animals ate significantly 
more than pellet-fed animals (P < 0.0001 ). This 
increased food intake in cafeteria-fed rats was signi-
ficantly greater in the control than in the low-pro-
tein animals (interaction P = 0.007). The early 
low-protein rats were still significantly lighter than 
tpe controls at 140 days of age (P<0.001) (Table 2). 
In contrast, the cafeteria-fed rats were significantly 
heavier than the pellet-fed rats (P<0.001). This 
increase in body weight due to the cafeteria feeding 
was greater in the control animals than in the low-
protein animals (interaction between early and later 
diets P = 0.009). These changes were similar to 
changes in body length ( early low-protein animals 
being shorter than controls P<0.0001; cafeteria-fed 
animals being longer than pellet-fed animals 
P < 0.001; interaction P = 0.299). Overall body mass 
indices were therefore significantly higher in the 
cafeteria-fed rats than in the pellet-fed rats 
(P<0.0001). In contrast, the early low-protein rats 
had significantly lower body mass indices than the 
control rats (P<0.0001). The association of cafeteria 
feeding with higher body mass indices was more 
pronounced in the control rats than in the low-pro-
tein rats (interaction P = 0.014). 
Kidney weights were lower in the animals given 
the early low-protein diet (P < 0.0001 ). The reduc-
tion in kidney weights was still significant when 
expressed relative to body weights (P = 0.017). Early 
low-protein rats had significantly smaller heart 
weights (P<0.0001), whereas there was a significant 
increase in heart weights associated with the use of 
the cafeteria diet (P <0.001; interaction P = 0.150). 
Relative to body weights, the heart weights signifi-
cantly decreased with the use . of the cafeteria diet 
(P < 0.001 ). A similar trend was seen in low-protein 
animals (P = 0.055; interaction P = 0.151). 
Body weights of the rats at 1 year of age were: 
control pellet 421.7 (31.5) g (n = 7), control cafeteria 
799.9 (131.3) g (n = 6), low-protein pellet 333.7 
(23.6) g (n = 9) and low-protein cafeteria 594.1 
(127.1) g (n = 9) (early low-protein animals being 
Table 2. Body and organ weight data of 140 day old female rats in the four dietary groups, Data are means (SD). Control or 
low-protein diets were fed to the mothers of these rats during their pregnancy and lactation, and then to these rats until they were 
70 days of age. After this the rats were fed either the pellet or cafeteria diets. Each group contained eight animals from eight different 
litters. *P<0.05, **P< 0:001 associated with the e'll'ly diet used (control/low protein). t tP<0.001 associated with the adult diet used 
(pellet/cafeteria). 
Dietary groups Control pellet Control cafeteria Low-protein pellet Low-protein cafeteria 
Body weight (g)**tt 305.7 (24.9) 428.3 (39.0) 254.6 (34.3) 309.6 (35.9) 
Body length (cm)**tt 22.7 (0.6) 23.8 (0.5) 21.4 (0.7) 22.0 (0.7) 
Body mass index (kg/m2)**tt 5.9 (0.4) 7.6 (0.4) 5.5 (0.4) 6.4 (0.5) 
Kidney weight (g)** 2.22 (0.21) 2.49 (0.19) 1.71 (0.23) 1.67 (0. 15) 
Kidney weight 
(as % of body weight)*tt 0.726 (0.047) 0.585 (0.051) 0.672 (0.054) · 0.544 (0.057) 
Heart weight (g)**tt L03 (0.07) 1.23 (0.1 1) 0.78 (0.10) 0.88 (0.09) 
Heart weight 
(as % of body weight)tt 0.338 (0.038) 0.291 (0.020) 0.307 (0.015) 0.286 (0.019) 
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Fig. I. Systolic blood pressures of I-year-old female rats in the four 
dietary groups 
significantly lighter than controls P<0.0001; cafe-
teria-fed animals being significantly heavier than 
pellet-fed animals P < 0.0001; interaction P = 0.110). 
The systolic blood pressures of these rats is shown in 
Figure 1. Mean (SD) systolic blood pressures were: 
control pellet 128 (25) mmHg, control cafeteria 157 
(29) mmHg, low-protein pellet 158 (28) mmHg and 
low-protein cafeteria 182 ( 40) mmHg. Early low-pro-
tein rats had significantly raised systolic blood pres-
sures (P = 0.025), as did rats given the cafeteria diet 
(P = 0.026; interaction P = 0.815). These rises were 
independent and additive, so that the highest systo- · 
lie blood pressures were generally in the group of 
early low-protein rats who were subsequently given 
the cafeteria diet. 
The mean blood glucose results from the glucose-
tolerance tests is shown in Figure 2. The area under 
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(n = 9). 
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the curves of the different groups [geometric mean 
(95% confidence interval)] were: control pellet 3257 
(3024- 3508) units, control cafeteria 3848 (3222-
4586) units, low-protein pellet 3505 (3235- 3798) 
units and low-protein cafeteria 3738 (3240- 4313) 
units. The cafeteria-fed rats had significantly worse 
glucose tolerances than pellet-fed rats (P = 0.027), 
but there was no significant alteration in glucose 
tolerance in early low-protein rats in comparison 
witfr controls (P = 0.645; interaction P = 0.310). 
Fasting plasma hormone and lipid concentrations 
from the 1-year-old female rats are shown in Table 
3. The use of the cafeteria diet was associated with a 
significant increase in fasting plasma insulin concen-
tration (P = 0.003). Early low-protein animals 
showed a tendency to have lower fasting plasma 
insulins (P = 0.061; interaction P = 0.957). Cafeteria-
fed rats tended to have lower 10.00 hours plasma 
corticosterone concentrations than pellet-fed ani-
mals, but there was no detectable difference associ-
ated with the different early diets used (association 
with use of the low-protein diet P = 0.543; associa-
tion with the use of the cafeteria diet P = 0.146; 
interaction P = 0.527). There was a tendency for 
cafeteria-fed animals to have higher plasma total 
cholesterol concentrations than pellet-fed animals 
(P = 0.157), but no change could be attributed to 
alterations in the early diet used (P = 0.871; inter-
action P = 0.844). The use of the cafeteria diet was 
associated with a significant increase in fasting ·· 
plasma free-glycerol concentrations (P < 0.0001 ). No 
such detectable alteration was observed with the use 
of the low-protein diet (P = 0.404; interaction 
P = 0.108). Cafeteria-fed animals al~o had signifi-
cantly increased fasting plasma triacylglycerol con-
centrations (P < 0.001 ), but no significant changes 
could be attributed to the early use of the low-pro-
tein diet (P = 0.490; interaction P = 0.330). 
DISCUSSION 
The 'thrifty phenotype hypothesis' [7] suggests 
that intrauterine growth retardation renders a grow-
ing fetus more susceptible to the development of the 
insulin resistance syndrome, and that the time of 
onset and severity of the condition depends upon 
factors encountered in adult life, such as obesity. 
The present study was performed to model these 
changes and to investigate whether any of the 
features of the insulin resistance syndrome could be 
detected in the middle-aged (1-year-old) rat. Intra-
uterine growth retardation of the rat pups was pro-
duced by feeding pregnant rats a diet containing a 
little under half the protein content of, but iso-
caloric with, the control diet. The use of the diet 
· does not affect the fertility of the rats, but the 
resulting offspring are significantly lighter than off-
spring from dams fed the control diet [19]. In the 
present study, obesity was produced by feeding the 
rats a cafeteria-style diet, such that by 140 days of 
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Table 3. Plasma measurements of fasted I year old female rats in the four dietary groups. Data are geometric means (95% 
confidence interval). Control or low-protein diets were fed to the mothers of these rats during their pregnancy and lactation, and then 
to these rats until they were 70days of age. After this the rats were fed either the pellet or cafeteria diets. *P<0.05, .. P<0.001 
associated with the early diet used (control/low protein). tP< 0.05, ttP<0.001 associated with the adult diet used (pellet/cafeteria). 
Dietary groups Control pellet Control cafeteria Low-protein pellet Low-protein cafeteria 
(n = 7) (n = 6) (n= 9) (n = 9) 
Insulin (pmol/l)t 129.8 385.8 69.8 200.3 
(67.8- 248.8) (111.4-1 335.6) (45.6-1 06.7) (75.3- 532.6) Corticosterone ( ng/ml) 663 406 
(34 1-1 29 1) (1 55- 1065) 
Total cholesterol (mmol/1) 3.4 4.6 
(2.3- 4.9) (2.6-8. 1) 
Free glycerol (mmol/l)tt 0.1 9 I.I S 
T riacylglycerol (mmol/l)tt 0.75 3.85 
age their body mass indices were more than 20% 
higher than those of rats fed a standard laboratory 
chow diet. The relative differences in body weights 
of the rats in the four dietary combination groups at 
this age were mirrored in the rats studied at 1 year 
of age. 
The early low-protein rats had a marked increase 
in their systolic blood pressures. In the study carried 
out by Langley and Jackson [14], maternal protein 
intake was restricted only during pregnancy, and 
their rat offspring also developed raised systolic 
blood pressures, suggesting that this is the critical 
period in . which blood pressure is programmed. 
Experiments are currently underway to define more 
precisely the critical period for such programming in 
our model. The increase in systolic blood pressure in 
low-protein rats was of a similar magnitude to that 
produced by making the rats obese. The increases 
were additive, so that the highest blood pressures 
were generally found in the early low-protein group 
who were subsequently cafeteria-fed. This suggests 
that the two risk factors are independent and may 
operate through different mechanisms. Glucose 
tolerance was worse in the cafeteria-fed rats. They 
also exhibited a marked hypertriacylglycerolaemia. 
A degree of insulin resistance in these rats is sug-
gested by their higher fasting plasma insulin concen-
trations. Unlike in a previous study [15], the early 
low-protein rats did not show a detectable deteriora-
tion in glucose tolerance. However, in the present 
study the rats were considerably younger than those 
in which impaired glucose tolerance was reported. 
Interestingly, in a study of individuals where hyper-
tension and NIDDM coexisted, the diagno:.is of 
hypertension preceded the diagnosis of diabetes 
eight times more often than in the opposite direc-
tion [20]. Thus the development of glucose intoler-
ance in the present model is not precluded from 
happening at a later age, and this dietary regime 
followed in the rat may be a useful model of the 
human situation. This is consistent with the 'thrifty 
phenotype hypothesis', where it has been hypothe-
sized that the exact timing of early growth impair-
ment ( combined with effects in adult life, such as 
physical inactivity and the development of obesity) is 
660 542 
(446- 976) (369-794) 
3.6 4.5 
(2.7- 4.8) (2.6- 8. 1) 
0.35 0.72 
0.82 2.19 
important in determining whether hypertension, 
impaired glucose tolerance or both conditions 
present subsequently [7]. 
Findings from human studies also suggest that 
both intrauterine growth retardation and adult 
obesity are important independent risk factors for 
the insulin resistance syndrome. In a study of 370 
64-year-old men, those men who had impaired 
glucose tolerance or newly diagnosed NIDDM were 
both born lighter and had significantly higher cur-
rent body mass indices than men with normal 
glucose tolerance [5]. The glucose intolerant men 
also had significantly raised systolic and dias_tolic 
blood pressures. In a survey of over 3000 36-year-
olds, high blood pressure was significantly associated 
with both low birth weight arid high current body 
mass indices [21 ]. The finding in the present study, 
that the effects of early growth retardation and later 
obesity on blood pressure are additive, suggests that 
in a low birth weight individual who is already at sig-
nificant risk of having raised blood pressure, further 
risk of hypertension can be avoided by keeping body 
weight down. This may be particularly important, as 
previous studies have shown that early and adult 
nutrition may interact to lead to conditions condu-
cive to the deposition of body fat. In one group of 
normotensive and non-diabetic young adults, birth 
weight was inversely related to truncal fat deposition [22]. Also, in a study of growth rates of children 
recovering from a period of protein calorie malnu-
trition, when they reached their expected weight for 
their height they had increased body fat in compari-
son with children who had been adequately 
nourished throughout [23]. It has been suggested 
that the period of malnutrition imposes mechanisms 
of nutritional thrift upon an individual, which 
become detrimental- to health if the individual 
encounters nutritional abundance [7]. 
The mechanism by which early low-protein may 
lead to hypertension is not clearly understood. 
Maternal low protein has been shown to reduce islet 
vascularization of the pancreas in rats [13], and it 
may be that maternal low protein is associated with 
a generalized alteration in vascularization which pre-
disposes an individual to hypertension. In a recent 
152 C. J. Petry et al. 
study of 210 subjects aged 8-24 years, systolic blood 
pressures were inversely related to birth weight and 
left ventricular masses were inversely related to 
body weights at 9 months and 2 years [24). This 
increase in left ventricular mass may have been 
necessary to overcome the resistance to blood flow 
caused by an altered vascular tone in growth-
retarded individuals. Hypertension would then be 
the result of a relative over-compensation. In the 
present study, an increase in left ventricular mass of 
the rat hearts may have been expected to cause an 
increase in the heart weights [25). However the 
140-day-old low-protein rats did not have increased 
heart weights, even when expressed relative to body 
weights. This suggests that this may not be the 
mechanism by which early protein restriction led to 
an increase in blood pressure. 
An alternative explanation for early protein 
restriction leading to hypertension involves growth 
retardation of the kidneys. Kidney growth has been 
shown to be particularly compromised in rat models 
using maternal protein restriction [26). It has been 
hypothesized that feta! renal growth retardation 
causes a deficiency of nephrons at birth, leading to 
an increased susceptibility to hypertension [27). Fur-
ther, it has been suggested that when kidney growth 
lags behind somatic growth, sodium retention is 
favoured, predisposing an individual to hypertension 
[28). Data from the present study are consistent with 
these theories. The kidney weights of the low-pro-
tein rats were substantially reduced in relation to 
those of control rats. The low-protein rats also had 
lower body weights, but when their kidney weights 
were expressed relative to their body weights they 
were still lower than those of the controls. If the 
mechanism of the early protein-restriction-associ-
ated hypertension involves a sodium-retentive renal 
mechanism, then it is predicted that further studies, 
involving salt-loading the rats, would result in blood 
pressure differences being exaggerated. 
In summary, this study has shown that early pro-
tein restriction and later diet-induced obesity are 
independent risk factors for the development of 
hypertension in rats. At 1 year of age, the early low-
protein animals did not show any detectable changes 
in glucose tolerance or plasma lipids. However, cafe-
teria-fed animals had worse glucose tolerances than 
animals fed a standard laborntory chow and also 
exhibited hypertriacylglycerolaemia. Thus early low-
protein rats who were cafeteria-fed were short and 
obese, with marked hypertension and mild glucose 
intolerance and hypertriacylglycerolaemia, key 
features of the insulin resistance syndrome. 
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